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Abstract 
The presence of organic micropollutants in wastewater imposes a problem to the water treatment 
industry. Such persistent compounds enter the sewer system after domestic or medical use, and 
are inefficiently removed by traditional wastewater treatment technologies and subsequently 
discharged into the aquatic environment.  
Chemical oxidation using ozone has been proven as an effective treatment process for a wide 
spectrum of micropollutants during bench-, pilot- and full-scale experiments in both wastewater 
and drinking water. However, a major disadvantage of ozonation is the formation of 
transformation products (TPs) instead of a full mineralization of parent compounds. Although 
there is still an overall lack of information regarding their toxicity, bioaccumulation, or occurrence, 
many of these compounds are suspected to have potential effects on humans and other species. 
A proper sample preparation method is required to enrich a wide range of micropollutants from 
water samples for a subsequent use in chemical analysis as well as toxicological evaluation. Solid 
phase extraction (SPE) has become the most common sample preparation technique in 
environmental analysis. 
In the first stage of research, the performance of several commercial SPE materials belonging to 
three different groups: reversed‐phase, mixed‐mode anion exchanger and mixed‐mode cation 
exchanger, was evaluated. Eight parent compounds and seventeen ozonated TPs with different 
physicochemical properties were extracted from pure water samples. Different pH values, washing 
and elution solvents were tested to optimize the procedure. Recoveries ≥ 91% were obtained by 
combining mixed‐mode strong anion and cation exchangers in tandem without pH adjustment.  
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to 
analyze the compounds of interest using the optimized SPE procedure. Full validation followed 
by trace determination of target compounds in different water matrices was performed. 
Consequently, recoveries between 90 and 110%, Linearity (> 0.99), method quantification limits 
(MQL’s) at low ng/L-range and low matrix effect (ME) were achieved.  
In the second stage of the study, suspect screening approach was used to examine the presence of 
structurally diverse organic compounds and their ozonated TPs in environmental water samples 
without reference standards. The suspect list was assembled after an extensive search to include 
245 candidates reported form laboratory experiments in literature. The analytical procedure was 
therefore optimized by combining liquid chromatography-quadrupole-time-of-flight-mass 
spectrometry (LC-Q-TOF-MS) based on the use of accurate mass with the optimized SPE method 
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exhibiting broad enrichment efficiency. The relative concentration levels of the suspects were 
determined and compared according to their peak areas in several advanced wastewater samples 
at different treatment levels and the final receiving water. Mass accuracy < 5 ppm, isotopic score 
≥ 80% and peak height > 1000 counts were obtained for all detected suspects. In addition, a 
plausible matching was shown between the retention times of TPs relative to parent compounds 
and the available values from literatures. The results showed that the studied wastewater treatment 
plant was efficient to degrade partially or completely organic micropollutants and the formed TPs 
after advanced treatment. 
The future focus will be to study the occurrence and toxicological relevance of various compound 
classes and TPs in different aquatic environments using the improved SPE procedure. 
Additionally, further confirmation of suspect screening data will be beneficial. 
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Kurzfassung 
Das Vorkommen organischer Spurenschadstoffe im Abwasser  stellt eine große Herausforderung 
für die Abwasseraufbereitungsindustrie dar. Die Schadstoffe gelangen nach häuslichem Gebrauch 
von Hygieneprodukten und Medikamenten in die städtischen Abwassersysteme und zu den 
kommunalen Kläranlagen. Da eine Vielzahl dieser Schadstoffe nicht durch traditionelle 
Abwasseraufbereitung abgebaut oder entfernt werden können,  gelangen die Schadstoffe nach dem 
Passieren der Kläranlagen in die Umwelt.  
Eine effektive Methode für den Abbau dieser Spurenschadstoffe ist die chemische Oxidation durch 
Ozon. Untersuchungen von Laboranlagen bis hin zu Pilotanlagen haben die Effizienz des 
Schadstoffabbaus durch Verwendung von Ozon in der Abwasserbehandlung und der 
Trinkwasseraufbereitung gezeigt. Dennoch bringt die Ozonbehandlung wesentliche Nachteile mit 
sich. Eine Vielzahl der Schadstoffe wird nicht vollständig mineralisiert, sondern nur teilweise 
abgebaut. Diese sogenannten Transformationsprodukte (TP) stellen ein bis heute ungeklärtes 
Risiko für den Menschen und die Umwelt dar. Nur wenig ist bekannt über das Vorkommen und 
Entstehen, die Toxizität und die Bioakkumulation dieser TPs. 
In Anbetracht der geringen Konzentrationen der Spurenschadstoffe, erfordert die Analyse der 
Umwelteinflüsse eine effiziente Anreicherungsmethode, die in der Lage ist, ein großes Spektrum 
an  TPs aus verschiedenen Matrizes zu binden. Hierbei stellt die Festphasenextraktion eine der am 
häufigsten verwendeten Extraktionstechniken im Bereich der Umweltanalyse dar.  
Im ersten Schritt dieser Forschungsarbeit  wurden verschiedene handelsübliche SPE Materialien 
aus drei verschiedenen Klassen getestet: reversed‐phase, mixed‐mode anion exchanger und mixed‐
mode cation exchanger. Acht Hauptverbindungen mit verschiedenen physikochemischen 
Eigenschaften und 17 nach Ozonbehandlung entstandene TPs wurden für die Evaluation der 
Anreicherungseffizienz verwendet. Im weiteren Verlauf der Untersuchung wurden die pH-Werte 
und die Wasch- und Elutionsmittel variiert um eine optimierte Anreicherung zu erhalten. 
Wiederfindungsraten von ≥ 91% wurde unter Verwendung einer Kombination aus im Tandem 
verwendeten mixed-mode strong anion und cation exchanger Materialien ohne pH-Wert 
Einstellung erreicht.  
Die Analyse der mit Hilfe der optimierten SPE Methode angereicherten Hauptkomponenten und 
TPs erfolgte über eine eigens entwickelte Flüssig Chromatographie Tandem Massen Spektrometer 
(LC-MS/MS) Methode. Die Validierung der Methode erfolgte über die Bestimmung der 
Hauptkomponenten und TPs aus realen Wasserproben mit verschiedenen Matrizes. 
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Wiederfindungsraten lagen bei 90 bis 110%, die Linearität lag bei R2 > 0.99 und die 
Nachweisgrenzen der Methoden lagen im Subnanogramm-Bereich pro Liter. Matrixeffekte konnte 
in keiner der extrahiert und analysierten Realproben beobachtet werden.  
Im zweiten Teil der Studien wurde ein sogenanntes suspect screening durchgeführt. Hierbei 
wurden die Wasserproben auf das Vorkommen einer Vielzahl von literaturbekannten organischen 
Substanzen und der korrespondierenden Nebenprodukte nach Ozonierung analysiert. Das suspect 
screening führte zu 245 potenzielle Kandidaten, welche bereits aus Laborversuchen und 
wissenschaftlichen Arbeiten bekannt sind. Die Auswahl der potenziellen Kandidaten erfolgte ohne 
Verwendung von Referenzstandards, daher wurde entschieden, im weiterem Verlauf der Studie 
die Analysemethode für die Verifizierung der Ergebnisse zu optimieren. Die Optimierung basierte 
auf der Verwendung eines LC-Q-TOF-MS Systems und basierte auf der Bestimmung der exakten 
Massen der mit optimierter SPE angereicherten Analyten. Das verwendete LC-Q-TOF-MS System 
ermöglichte neben dem Nachweis einer hohen Effizienz der Anreicherungsmethode auch die 
quantitative Analyse zahlreicher Abbauprodukte. Die relativen Konzentrationen der 
Ursprungssubstanzen und deren potenziellen Nebenprodukte zu verschiedenen Zeitpunkten der 
Abwasseraufbereitung konnte aus den detektierten Peakflächen abgeleitet werden. Die 
Massengenauigkeit der verifizierten Suspects lag bei < 5ppm mit einem Isotopenscore ≥ 80% und 
Peakhöhen > 1000 counts. Als zusätzliche Absicherung wurden die Ergebnisse einer 
Plausibilitätsprüfung unterzogen, bei der die experimentell erhaltenen Retentionszeiten mit 
literaturbekannten Werten  verglichen wurden.  
Die Ergebnisse dieser Arbeit haben gezeigt, dass die untersuchte Kläranlage in der Lage war, mit 
Hilfe der fortschrittlichen Behandlung durch Ozon eine Vielzahl der organischen 
Spurenschadstoffe vollständig oder partiell abzubauen.  
Zukünftig Studien werden mithilfe der entwickelten SPE Methode das Vorkommen, die 
Akkumulation und die Ökotoxizität diverser Substanzklassen und derer Transformationsprodukte 
in der aquatischen Umwelt verifizieren können. Die weitere Identifikation und Bestätigung von 
suspect screening Daten durch Verwendung der SPE Methode wird hierbei hilfreich sein.  
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1 General introduction 
1.1 Background 
The growing scarcity of water resources is one of the most critical environmental problems facing 
us in the near future. A long-lasting sustainability of safe water supply is regulated by stringent 
protection and management of water resources and an efficient reclamation of used water from 
different effluents. Recently, the pollution of water compartments by organic micropollutants such 
as pharmaceuticals and personal care products (PPCPs), flame retardants, pesticides, and 
endocrine disrupting compounds (EDCs) has attracted increased attention from scientific research 
and consequently public awareness. Many of these compounds persist at least partially during 
conventional wastewater treatment (WWT) and were detected in secondary efﬂuents and receiving 
surface waters (SWs) worldwide [1-5]. Thus, residues of these compounds might reach drinking 
water (DW) and cause potential risk on human health due to their biologically active nature if 
drinking water treatment (DWT) is not able to remove them completely.  
The presence of low concentrations of PPCPs has been associated with endocrine disruption [6], 
chronic toxicity [7, 8], and even the development of pathogen resistance [9]. At present, there are 
no legal regulations established to ensure these substances or new compounds and by-products 
from being discharged into SW bodies [10-13].  
Studies conducted in various parts of the world show the presence of micropollutants in potable 
water sources [14-18]. The presence of drugs in the German aquatic environment at concentrations 
up to 1 μg/L was reported [19]. Clofibric acid has been found in DW at concentrations of up to 
165 ng/L [20]. From 1996 and 1998, a comprehensive German study investigated the occurrence 
of 55 pharmaceuticals, 6 hormones, 9 metabolites, 6 biocides and 1 flame retardant in the 
discharges from 49 wastewater treatment plants (WWTPs) and in their respective receiving water 
bodies [21]. Concentrations at the µg/L level of 32 pharmaceuticals, 4 hormones, 5 metabolites, 
and 5 biocides were detected in the WWTP outflow. The receiving water bodies contained 
concentrations of beta-blockers and anti-epileptic agents in excess of 1 µg/L. Clofibric acid, 
diclofenac, ibuprofen, propyphenazone, primidone and carbamazepine were detected in the 
influent and effluent of municipal WWTPs at concentrations up to the μg/L level, as well as in 
groundwater (GW) aquifers near sources of contaminated water [22]. Estrone, 17β-estradiol, and 
17α-ethinylestradiol were studied in the water cycle of Berlin, Germany [23]. Detection limits in 
DW, SW, and WW effluent ranged from 0.1-0.4 ng/L. All three compounds were present in 
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influent WW at concentrations of 8.6-160 ng/L. Only E1 was detected in SWs and in GW, at levels 
around 1 ng/L and 0.1 ng/L, respectively. Two polycyclic musk fragrances galoxolide (1900 ng/L) 
and tonalide (580 ng/L) were measured in German influent WWTP [24]. Several compounds that 
were previously unreported in SWs were detected in the Lippe River, Germany and attributed to 
anthropogenic inputs [25, 26]. These compounds include a plasticizer (2,2,4-trimethyl-1,3-
pentandioldiisobutyrate) at up to 100 ng/L and a surfactant (2,4,7,9-tetramethyl-5-decyne-4,7-diol) 
at up to 660 ng/L. Numerous other PPCPs were also detected. 
Humans and animals treated with pharmaceuticals are the main source of micropollutants in the 
environment, although the points where these are released are diverse [27]. Hospitals and 
households are the main locations where PPCPs enter the WWTPs [28, 29]. Other sources of 
micropollutants in the environment include industrial discharge, septic tanks, which can directly 
contaminate GW [30], and pharmaceuticals used as growth promoters and feed additives in 
agriculture and aquaculture [31]. Land application of livestock manure may cause contamination 
by runoff into SWs and leaching into the GW. Similarly, landfills may be a source of 
contamination, if they contain disposed drugs or sewage sludge with sorbed chemicals [27], while 
households, hospitals and other facilities (e.g. schools, residential institutions) are the most 
significant points of release [32]. The most important routes of contamination of micropollutants 
into the environment are depicted in Fig. 1.1. 
 
 
Figure 1.1:     Origin and routes of micropollutants [33] 
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Municipal WWTPs are an important point source of micropollutants released into the environment 
and water bodies [14, 33]. A study stated that in 264 municipal WWTPs around the world, 118 
pharmaceutical compounds belonging to 17 different classes were found in the effluents [13]. 
The conventional technologies to treat WW are efficient in removing suspended solids and 
nutrients. However, they are not effective in removing the micropollutants that are present in trace 
quantities [21]. Hence, new treatment technologies or additional treatment processes are required 
to remove these compounds. 
The use of chemical oxidation procedures can constitute effective technologies for the removal of 
unwanted substances present in waters. Among these oxidation procedures, single oxidants such 
as chlorine, UV irradiation, hydrogen peroxide, and ozone, or combinations of these oxidants in 
the advanced oxidation processes (AOPs), such as UV/H2O2, O3/H2O2, UV/TiO2, and 
Fenton/photo-Fenton systems are frequently applied [34, 35]. 
Ozone and ozone based AOPs were shown to be effective in the oxidation of micropollutants both 
in water and WW matrices [36, 37]. The oxidation process occurs either directly or via the 
formation of hydroxyl and other radicals [38, 39]. This formation of radicals makes ozone a potent 
oxidant and effective agent to remove pharmaceuticals and other micropollutants from WW. 
Several studies have confirmed that ozone treatment can be very efficient in the oxidation of a 
wide range of micropollutants featuring electron-rich moieties such as activated aromatic rings, 
amine functions and double bonds (e.g. beta blockers, antibiotics, estrogens, anti-inflammatory 
drugs, plasticizers, flame retardants) [39-44]. Even for a medium ozone dose of 0.6 g O3 g
-1 
dissolved organic carbon, high removal rates (> 85%) have been observed for many 
micropollutants with different functional groups in a municipal WWTP upgraded with a full-scale 
post-ozonation [41]. In addition, ozonation has been found to reduce or to eliminate the 
pharmacological and biological effects of micropollutants [45]. Due to the significant advances in 
the ozone manufacturing technology in the last couple of decades and the experience gained by 
ozone treatment of water and WW, ozonation is now a mature technology [46]. These 
developments have led to a huge surge in research related to ozone treatment of secondary and 
tertiary treated municipal WW the world over in recent years. A study showed that municipal WW 
effluents spiked with 11 selected PPCPs and treated with ozone in a pilot-scale were oxidized as 
much as 90–99% at ozone doses ranging from 2 to 5 mg/L [47]. Removals greater than 90% were 
reported with ozone doses ranging from 0.1 to 30 mg/L for a vast range of compounds (pesticides, 
anti-inflammatories, antiepileptics, antibiotics and natural and synthetic estrogens) [48]. The 
impact of ozone was studied in 84 pollutants present in a secondary effluent from a conventional 
WWTP [49]. The contaminants analyzed included pharmaceuticals (analgesics, antidepressants, 
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anti-inflammatory, antibiotics, antiepileptics, beta-blockers and lipid regulators among others), 
PCPs (sunscreen agents, synthetic musks), stimulants (caffeine, nicotine) and some metabolites 
(clofibric acid, cotinine, several metabolites of dipyrone). The results showed high removals for 
most of the compounds. 
However, despite the high reactivity of ozone, recent studies revealed that ozonation of WW can 
lead to the formation of transformation products (TPs) with toxicophoric structures such as 
aldehyde and bialdehyde moieties [50] as well as to considerable developmental retardation of 
rainbow trouts (Oncorhynchus mykiss) [51]. For example, ozonation of water resources containing 
N,N-dimethylsulfamide, which is a biological TP of the fungicide tolylfluanide, has been recently 
shown to lead to the formation of carcinogenic N-nitroso-dimethylamine [52]. 
Since most TPs have a higher environmental mobility and persistence and, they are favored to 
occur in DW resources [4]. However, for most micropollutants the formation and identity of TPs 
and therefore their occurrence in water resources and finished DW is currently unknown.  
Many laboratory studies have proposed TPs after ozonation of different organic compounds but 
without screening their possible occurrence and distribution in environmental samples due to the 
lack of reference standards and a proper sample preparation technique which facilitates their 
detection as well as toxicological evaluation. 
 
The identification of micropollutants and TPs is highly challenging considering the large number 
of anthropogenic chemicals emitted intentionally or unintentionally into the environment. The 
different approaches used for the identification of these compounds in environmental water 
samples are classified in three principal categories (target analysis, suspect screening, and non‐
target screening) [53].   
For target analysis, a reference standard is necessary to determine the analyte concentration in the 
sample and to match the measured retention time (RT). A complete target analysis cannot be 
performed for all compounds of potential environmental relevance, as this would involve the 
purchase and measurement of hundreds, if not thousands, of chemicals for which reference 
standards are not always available. Thus, when analyzing complex samples, a balance is needed 
between extensive target analysis and screening methods, which can assist in tentatively 
identifying other potentially relevant compounds. Suspect screening relies on accurate mass and 
isotope information available for the precursor ion and additional evidence for tentative 
identification. Compounds that are expected to be in the samples (the “suspects”) can be screened 
using the exact mass of their expected ions, calculated from the molecular formula. Nontarget 
screening involves masses that are detected in the samples, but where no a priori information on 
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the underlying compound is available beforehand. Full identification of the nontarget mass is often 
difficult, with no guarantee of a successful outcome [53, 54]. High accuracy, high resolution data 
improve the chances of a unique molecular formula assignment to detected masses [55]. 
Currently, the detection of both micropollutants and TPs requires the use of chromatographic 
techniques hyphenated to mass spectrometry (MS). Due to the polar nature of TPs, the most 
commonly used separation technique is liquid chromatography (LC) [56, 57].  Different reviews 
have presented and discussed the use of LC-MS based techniques for the determination of 
micropollutants and their TPs in aqueous environmental samples [56, 58-60].  
Until recently, LC‐MS‐MS instruments with triple quadruple (QqQ) analyzers have been the most 
widely employed for quantitative target compounds analysis. But even though the sensitivity, 
selectivity, and efficiency characteristics of multiple reaction monitoring (MRM) approach are 
excellent, qualitative information needed to support the structural elucidation of analytes is lost 
[61]. In addition, QqQ instruments can only measure nominal masses, and when they are operated 
in the full scan mode, the sensitivity is low, restraining the analysis to a given number of analytes. 
High-resolution MS (HRMS) transcends the major limitations of LC-MS/MS systems for both 
suspect and non-target analysis. HRMS instruments like time-of-flight (TOF) or Orbitrap provide 
high-quality information by combining full mass spectrum data with high mass resolution and 
mass accuracy [62, 63]. In theory, the presence of an unlimited number of compounds can be 
investigated at the proper sensitivity, without requiring the preselection of analytes or even without 
having reference standards available.   
 
1.2 Sample preparation 
To analyze complex mixtures, such as water samples, a pretreatment procedure is useful to provide 
a sample fraction enriched with all the target analytes and as free as possible from other matrix 
components [64]. 
A survey showed that sample preparation accounted for nearly 61% of the time required to conduct 
an analytical task [65]. The operating principle of any sample preparation method is to allow 
analytes to partition between sample matrix and an extraction phase. 
The basic concept of sample preparation is to convert a real matrix into a sample suitable for 
analysis. Even the best analytical techniques cannot rectify problems generated by sloppy sample 
pretreatment. The main goals of sample preparation include removing of potential interferences, 
increasing the concentration of target analytes, producing a sample aliquot that will not damage 
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the column or instrument and providing a robust, reproducible method that is independent of 
variations in the sample matrix [66]. 
The best established methods to perform an accurate and precise environmental analysis are liquid‐
liquid extraction (LLE) and solid phase extraction (SPE) techniques.  
LLE uses two immiscible solvents to transfer the analytes from one media to the other. Although 
LLE has been used as a sample preparation procedure for analysis of trace organics for decades, it 
has become less popular over time. 
In addition to emulsion formation, difficulty in automation, and time consumption, LLE also 
requires large volumes of organic solvents, some of which are toxic and can also be expensive. 
LLE is a multi-step procedure that often results in loss of analytes during the process, frequently 
making sample preparation the major source of errors in the analysis, and making it impeditive for 
integration with the rest of the analytical process [67]. SPE, on the other hand, can overcome all 
of these drawbacks. 
From trace levels to industrial scale, SPE plays an important role in a broad range of applications. 
SPE refers to the exhaustive removal of chemical constituents from a flowing liquid sample via 
retention on a contained solid sorbent and subsequent recovery of selected constituents by elution 
from the sorbent. It is an increasingly being used sample preparation technique.  
SPE is the method of choice that is particularly well adapted to multi-residue analysis, including 
compounds with a wide range of polarity or characterized by various physicochemical properties 
[68]. 
Over time, SPE has been developed into different formats. The most common format of SPE is in 
form of a cartridge. Sorbent particles (nominally 50 μm in diameter) are packed with two 
polyethylene fritted disks above a male Luer tip in a disposable short column (generally an open 
polypropylene syringe barrel) that acts as a reservoir for the environmental samples and solvents, 
as seen in Fig. 1.2.  
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Figure 1.2:     Typical SPE cartridge 
 
SPE disks were first designed to treat large sample volumes with a higher flow rate than cartridges 
and to avoid blockages caused by suspended particles and matrix components [69]. SPE cartridges 
and disks share the same sorbent technology and the only difference between these two devices is 
the format. Cartridges can be easily fabricated in a laboratory environment, however, disks, so far, 
can only be produced in a manufacturing setting which results in a limited range of sorbent 
chemistry selection [70]. In addition, cartridges are easier to be scaled up for larger sample loads 
and better capable of a cleanup than disks. Because of the low selectivity of sorbents and the 
difficulty of manufacture, there are not many choices of commercial SPE disks in the market that 
makes disks significantly more costly than cartridges. Although SPE disks require a smaller elution 
volumes and can be operated at higher flow rates [71]. 
 
In SPE, the solid sorbent is usually consisting of chemically bonded silica particles or small 
particles of an organic polymer resin with pores to enhance the surface area for interaction between 
the liquid sample and the extractant [72]. Other sorbents also have been developed such as 
activated carbon, alumina, silica gel, and magnesium silicate [73]. 
Because of the very polar nature of the bare silica, it is not a good stationary phase for samples 
with aqueous solvent. Therefore, it needs to be modified to a more hydrophobic sorbent for 
application to aqueous systems. 
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SPE can be classified into three major groups based on different modified silicic stationary phases, 
in which different chemical mechanisms are applied to transfer the analytes from a particular 
matrix. These three groups are: normal phase, reversed phase, and ion exchange. Sorbent selection 
is based on considerations of the properties of the solution and the target analytes. 
If the analyte has a strong hydrophobic property, a sorbent can be modified to have a hydrophobic 
surface to separate the analyte. For a reversed phase separation, the cartridges are intended to 
extract nonpolar to moderately polar compounds from a polar or moderately polar matrix (e.g. 
water) with a nonpolar stationary phase [74]. The van-der-Waals forces between the bonds in the 
analyte and the functional groups on the sorbent surface separate the analyte from the polar 
solutions and the analyte is then retained on the SPE sorbent [67]. A nonpolar solvent is 
subsequently used to desorb the compound from the sorbent. Typical reversed phase materials 
include carbon-based media, polymer‐based media, polymer‐coated, and bonded silica media [67]. 
C18 cartridges, as the most widely used and traditional reversed phase extraction device, are 
utilized to partition dissolved organic compounds such as antibiotics, essential oils, drugs, esters, 
and fat‐soluble vitamins from different matrices. Other reversed phase sorbents have also been 
developed for specific needs. 
Normal phase SPE, on the other hand, is typically exploited to extract a polar solute from a mid-
polar to nonpolar matrix such as acetone, hexane and chlorinated solvents with a polar stationary 
phase. 
In addition to hydrophobic interaction, ionic interaction between an analyte and the sorbent in 
aqueous sample matrix can also be utilized. Ion exchange SPE can be used to extract compounds 
with charges in a solution. Anionic analytes can be attracted to the silica surface bonding with an 
aliphatic quaternary amine group. Cationic compounds are isolated on an aliphatic sulfonic acid 
group that is bonded to the silica surface. The electrostatic attraction forces between the charged 
functional group in the compound and the charged group bonded to the silica surface is the primary 
retention mechanism of ion exchange SPE [67]. With the further development of SPE technology, 
mixed‐mode sorbent systems that are combinations of reversed phase and ion‐exchange sorbent 
have become available. Some studies have already addressed that mixed‐mode sorbents are often 
advantageous and provide better separation (of target analytes from the matrix) than reversed phase 
or ion‐exchange SPE alone [75, 76]. 
 
A typical SPE procedure involves the following steps: 1. Column conditioning; 2. Sample loading; 
3. Interference removal, and 4. Analyte elution. This procedure is shown in Figure 1.3.  
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Figure 1.3:     Typical SPE procedure for enriching and eluting of analytes from water matrix [77] 
 
First, the modified silica surface needs to be conditioned with an organic solvent such as methanol 
in order to be active (wetted) and available for the analytes [73]. The purpose of the conditioning 
step is chain extension. During the extension process, an organic solvent is added to the matrix as 
a wetting agent to keep the chains fully extended for the interactions between the sorbent and 
analytes. After that, excess organic solvent is removed from the sorbent by Milli-Q water.  
In the second step, the sample containing analytes of interest is loaded onto the column with 
vacuum. The loading rate is necessary to be adjusted to ensure that the analytes will have enough 
contact time with the sorbent phase. 
An interference removal step usually follows sample loading. In this step, the cartridge would be 
rinsed with a suitable solvent to remove the interference that may affect accurate determination of 
the analytes. After that, the cartridge will be left with vacuum open to remove any remaining water. 
Water would also be considered as interference if water miscible solvents are used. 
The final and most important step is elution of the analytes from the sorbent. In order to use 
minimum volume of elution solvent, an appropriate solvent must be chosen to enhance the 
interactions between matrix and sorbent or between matrix and analytes, and minimize the 
interactions between sorbent and analytes. In addition to solvent selection, sufficient contact time 
between the sorbent and solvent is important to ensure a quantitative removal of the analytes from 
the sorbent. 
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A comprehensive literature review was done to show the use of SPE as an enrichment step prior 
to bio-tests in different aquatic environments as presented in Table 1.1. 
Bioassays are used to monitor the quality of water with regard to the presence of certain chemicals 
that are relevant for a toxic action to human and/or the natural environment.  
Simple biological systems are used to simulate the immediate effect of a compound or mixtures of 
compounds on living organisms [78]. It relies on detecting the response of organisms exposed to 
micropollutants relative to a control [79]. In contrast to chemical analysis, the results of bioassays 
reflect biological responses instead of chemical concentrations. 
The sample extraction process must be standardized and fully validated as its thoroughness will 
directly influence the quality of bioassay results.  
As can be deduced from Table 1.1, the frequently used SPE material is Oasis HLB (hydrophilic-
lipophilic balance). Two approaches (target and non-target) were examined to assess the toxicity 
of compounds in the final extracts using different in vivo, in vitro and in situ experiments. In target 
approach, the focus was on the presence of specific analyte(s) in water samples. Different 
analytical techniques were used for the detection and quantification purposes. The results 
represented the toxicological effects for each individual compound and/or a group of compounds. 
Limited number of these studies showed how efficient was the SPE material to enrich such 
compounds from water. According to non-target approach, toxicity results represented the effects 
for all substances in the extracts (i.e. mixture effect).  
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment 
SPE material Toxicological method Analytical method Water matrix Screening approach Ref. 
XAD-2  Salmonella/ Mammalian-Microsome mutagenic Assay NA DW Non-target [80] 
XAD-7  SOS/umu-test NA SW Non-target [81] 
Sep-pakC18  
Salmonella typhimurium in umu test assay 
(genotoxicity) 
NA WWTP Non-target [82] 
Octadecylsilane (C18) Yeast-based screen assay for estrogenic activity GC-MS WWTP  Target [83] 
ENV+; RP-C18  Estrogen Screen (E-SCREEN) assay GC-MS WWTP  Target [84] 
C18  Enzyme-Linked Lmmunosorbent Assay (ELISA) GC-MS; GC-MS/MS  SW and WWTP Target [85] 
Octylsilane, Isolute ENV+ and 
ENVI-Carb in series 
Yeast Estrogen Screen (YES) assay  GC-MS  SW Target [86] 
C18 and ENV+ in series Daphnia magna bioassay  GC–MS Stormwater Target [87] 
SDB-XC 
Estrogen receptor (ER)-binding assay, YES assay and 
ER-mediated chemically activated luciferase gene 
expression (ER-CALUX) assay 
NA SW and WWTP Non-target [88] 
RP-C18 
In situ hepatic vitellogenin expression from caged 
rainbow trout (Oncorhynchus mykiss); in vitro 
bioassays YES, ER- luciferase assay, primary rainbow 
trout hepatocytes) 
GC-Ion trap-MS/MS; 
LC-MS/MS; GC-MS 
SW and WWTP Target [89] 
Isolute C-18  
Acute toxicity: Microtox, and Ceriodaphnids; Chronic 
toxicity: Algae, Rotoxkit, Fish and Ceriodaphnids  
GC-MS WWTP  Target [90] 
XAD-2  
Salmonella/microsome assay (Ames test), the Arabinose 
resistance test (Ara test) and the SOS/umu test 
GC-MS Tap water Target [91] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Sep-Pak Plus tC18  
Plant bioassays (Tradescantia/Micronucleus test, Allium 
cepa test, Vicia faba test); Fish bioassays (Comet test in 
erythrocytes, Micronucleus test in erythrocytes); 
Mollusc bioassays (Comet test in hemocytes, 
Micronucleus test in hemocytes); In vitro tests with 
bacteria (Ames test, Mutatox, Microtox, SOS 
Chromotest); In vitro tests with yeast (Saccharomyces 
cerevisiae); In vitro tests with human cells 
Micronucleus test in lymphocytes, Comet test in 
lymphocytes, Enzymatic activity test, Cytotoxicity test); 
In vitro tests with ﬁsh cells (Enzymatic activity test, 
Cytotoxicity test) 
GC-MS DW Target [92] 
XAD-8 over XAD-2  
Salmonella Microplate Cytotoxicity Assay, Salmonella 
Preincubation Mutagenicity Assay, Mammalian Cell 
Microplate Cytotoxicity Assay and Single Cell Gel 
Electrophoresis (SCGE) Assay 
GC-MS DW Target [93] 
Mixed LiChrolut RP18 and 
LiChrolut EN 
YES assay and by measuring the blood plasma 
vitellogenin concentrations in exposed male rainbow 
trout (Oncorhynchus mykiss) 
GC-MS WWTP Target [94] 
Mixed LiChrolut RP18 and 
LiChrolut EN 
YES, production of zona radiata proteins in trout 
hepatocytes, and the induction of reporter gene 
expression in the transfected rainbow trout gonad cell 
line  
GC-MS WWTP Target [95] 
Isolut RP-C18; SPE Isolut 
C2/ENV+ 
Microtox test, Daphnia magna and Ceriodaphnia dubia 
tests 
GC-MS; LC-MS WWTP Target [96] 
RP-C18 YES bioassay 
GC-Ion trap-MS/MS; 
LC-MS/MS; GC-MS 
SW and WWTP Target [97] 
Sep-Pak Plus tC18  
Cytotoxicity assays (Short-term exposure , Long-term 
exposure, Neutral red uptake assay, Lactate 
dehydrogenase release assay); Comet assay; 
Micronuclei assay 
NA DW Non-target [98] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Octadecylsilane (C18) 
Daphnia magna, Chlorella vulgaris bioassays, 
Salmonella typhimurium, recombinant yeast screen, and 
Oryzias latipes embryolarval tests 
GC-MS WWTP  Target [99] 
Oasis HLB  Phytotoxicity assay LC-MS SW Target [100] 
Sep-Pak Plus tC18  
Mutagenicity in the Salmonella typhimurium reversion 
test; genotoxicity assays (the Allium cepa test) 
NA WWTP  Non-target [101] 
Oasis HLB  Algal bioassay GC-MS SW and GW Target [102] 
Oasis HLB Phytotoxicity assay LC–MS SW Target [103] 
C18-silica  Comet Assay and Micronucleus Assay  NA SW Non-target [104] 
Oasis HLB  YES assay  LC-MS/MS SW Target [105] 
Sep-Pak Plus tC18  
In vitro genotoxicity tests (Salmonella/microsome 
assay; SOS Chromotest; gene conversion; point 
mutation and mitochondrial deoxyribonucleic acid 
(DNA) mutability assays) and for a toxicity test 
(Microtox) 
NA DW Non-target [106] 
Supelclean C18 with 
octadecyl-bonded endcapped 
silica sorbent; Oasis HLB with 
n-vinylpyrrolidone and 
divinylbenzene copolymer 
sorbent; Isolute C2/C18(EC)  
 
ER-binding assay, a rainbow trout ER-binding assay, E-
SCREEN, and a rainbow trout androgen-receptor-
binding assay 
NA WWTP Non-target [107] 
Sep-Pak Vac C18  Daphnia magna test GC-MS WWTP Target [108] 
Oasis; SPE C18  
Bioluminescence inhibition tests based on Vibrio 
ﬁscheri 
GC-MS; LC–MS WWTP Target [109] 
Oasis HLB  Chlorophyll ﬂuorescence bioassay LC-MS  SW Target [110] 
Oasis HLB  In vitro estrogenic equivalent   GC-MS WWTP Target [111] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB  
Ethoxyresorufin O-deethylase (EROD) activity, 
vitellogenin induction (estrogenic activity), cytotoxicity 
(membrane stability and metabolic inhibition)  
GC-MS; LC-MS/MS  WWTP  Target [112] 
C18  Recombinant yeast assay  GC; GC-MS DWTP Target [113] 
Sep-Pak Plus tC18  
in vitro cytotoxic and genotoxic effects (DNA damage 
by the comet assay)  
NA DW Non-target [114] 
Strata-X  
Acute toxicity tests using the microbe Vibrio ﬁscheri, 
freshwater macroinvertebrates Daphnia magna and 
Moina macrocopa, and ﬁsh (Oryzias latipes)  
LC-MS/MS SW and WWTP Target [115] 
Isolute ENV+ and S-X3  Microtox assay for acute toxicity and YES assay GC-MS; GC-ECD  SW Target [116] 
Serdolit PAD-1  Umu short-term genotoxicity test NA WWTP Non-target [117] 
HLB Phytotoxicity assay  LC-MS SW Target [118] 
HZ-802 Cellar bioassay  NA WWTP Non-target [119] 
ENV+ and octadecylsilane  Growth inhibition assay  NA SW  Non-target [120] 
Oasis HLB  Recombinant yeast bioassay GC-MS WWTP Target [121] 
Sep-Pak Plus tC18  Salmonella (Ames) test  NA WWTP Non-target [122] 
XAD-8 over XAD-2  Salmonella mutagenicity assay NA DW Non-target [123] 
LiChrolut EN plus LiChrolut 
RP-C18; Empore SDB-RPS; 
Empore C18 
 
Inhibition of bacterial luminescence, Inhibition of algal 
growth, Inhibition of photosynthesis, Inhibition of 
acetylcholine esterase, YES assay, and Genotoxicity 
umuC test 
NA SW and WWTP Non-target [124] 
Oasis HLB  In vitro inflammatory responses  LC–MS/MS SW Target [125] 
Sep-Pak Plus tC18  Micronucleus and Comet assays NA DW Non-target [126] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB  
Umu assay, Yeast two-hybrid assay, Daphnia magna 
bioassay, and Japanese medaka embryo exposure test 
NA WWTP Non-target [127] 
Oasis HLB 
In vitro Cellular bioassays for the evaluation of hyroid 
and estrogenic activites 
LC-MS/MS  
SW, DWTP and 
WWTP 
Target [128] 
Empore C18 FF  
In vitro transthyretin, thyroid receptor, and luciferase 
assays 
NA 
paper manufacturing 
plants, SW and WWTP 
Non-target [129] 
XAD-2 
Micronucleus assay; Single cell gel electrophoreses 
assay  
NA SW Non-target [130] 
LiChrolut EN plus LiChrolut 
RP-C18  
Bioluminescence inhibition test, combined algae test, 
YES assay, acetylcholinesterase (AChE) inhibition 
assay, and umuC assay 
NA WWTP Non-target [45] 
Oasis HLB  
Bioluminescence inhibition test, AChE Inhibition 
Assay, Imaging-PAM Assay, E-SCREEN, Aryl 
hydrocarbon receptor-chemically activated fluorescent 
gene expression (AhR-CAFLUX) and umuC assay  
NA WWTP Non-target [131] 
Oasis HLB 3 bioassays (ﬁsh, Daphnia and algae) LC-MS/MS SW  Target [132] 
Oasis HLB 
Estrogenic activity (E-SCREEN assay), AhR-CAFLUX, 
neurotoxicity (AChE inhibition assay), phytotoxicity 
(PSII inhibition I-PAM assay) and genotoxicity (umuC 
assay) 
LC-MS/MS WWTP Target [133] 
Oasis C18  Recombinant yeast assay  NA WWTP Non-target [134] 
Oasis HLB 
YES, ER-CALUX, MELN, T47DKBluc, and E-
SCREEN assays 
GC-MS; GC-ECD; LC-
MS-MS  
SW and GW Target [135] 
XAD-4  Salmonella/Microsome Microsuspension Assay NA 
SW and industrial 
efﬂuent water 
Non-target [136] 
Suplco 
Toxicological tests on Spermatogenic cells, Sertoli cells 
and Leydig cells of male rats  
GC-ECD; GC-MS SW Target [137] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB  
Cytotoxicity, chronic toxicity, EROD activity, inhibition 
of the multixenobiotic resistance, genotoxicicity and 
estrogenic potential 
GC-MS; LC-Q-TOF-
MS 
WWTP Both [138] 
Oasis HLB 
In vitro bioassays. Yeast-based test (YES; yeast anti 
estrogen screen; yeast androgen screen; yeast anti 
androgen screen; yeast dioxin screen), Cytotoxicity 
assay, Estrogenic activity, Anti-androgenic activity and 
AhR agonistic activity 
NA WWTP Non-target [139] 
Oasis C18  
In vitro Bioassays (Estrogenic Activity, 
(Anti)Androgenic Activity (Anti)Progesteronic Activity 
and (Anti)Thyroidal Activity 
NA WWTP Non-target [140] 
Oasis HLB 
Baseline Toxicity (Bioluminescence inhibition in Vibrio 
ﬁscheri), Neurotoxicity (AChE), Phytotoxicity (Max-I-
PAM), Estrogenicity (E-SCREEN), AhR-CAFLUX and 
Genotoxicity (UmuC)  
NA 
Puriﬁed recycled water, 
DWTP and WWTP 
Non-target [141] 
Mixed C18-HD, Oasis HLB, 
Bakerbond SDB1, SDBXC, 
Isolute ENV+, and ENVI-Carb 
Plus 
Estrogenic activity using a human cancer cell line 
(MCF7, E-SCREEN) bioassays 
NA Bottled mineral water Non-target [142] 
Octadecyl C18FF  
Estrogenic activity (human and medaka estrogen 
receptor a bioassays) and total estrogens (ELISA) 
NA 
WWTP, freshwater and 
estuary 
Non-target [143] 
C18  
Green monkey kidney ﬁbroblast cell-based thyroid 
hormone reporter gene assay 
GC-ECD; LC-MS/MS; 
LC-UV  
SW Target [144] 
Oasis HLB  Bioluminescence inhibition test with Vibrio ﬁscheri  LC-Q-LIT-MS WWTP Target [145] 
Oasis HLB  YES bioassay GC-MS SW Target [146] 
Oasis HLB  
Microtox assay, E-SCREEN, and Photosynthesis 
inhibition 
LC-MS/MS WWTP Target [147] 
Oasis HLB  Ames and Comet assays NA SW Non-target [148] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued)  
BAKERBOND Polar Plus C18 
(Octadecyl)  
In bacteria (Salmonella/microsome assays), in a plant 
bioassay (micronucleus assay with root tip cells of 
Allium cepa), and in SCGE tests with mammalian cells  
NA WWTP Non-target [149] 
Oasis HLB  
Thyroid receptor agonistic activity test and thyroid 
receptor antagonistic activity test (Galactosidase assay)  
NA WWTP Non-target [150] 
Oasis HLB ER-CALUX assay GC-MS WWTP  Target [151] 
Sep-Pak Plus PS-2 
Umu genotoxicity test (using Salmonella typhimurium 
strain) 
NA SW and WWTP Non-target [152] 
Oasis HLB 
In vitro bioassays (YES, yeast androgen screen, and 
genotoxicity assay [umu/SOS])  
GC-MS 
Textile and dyeing 
plants, electronic and 
electroplate factories, 
pulp and paper mills, 
ﬁne chemical factories, 
and WWTP 
Target [153] 
XAD  In vitro mammalian cell toxicity  GC-MS; GC-TOF-MS  DW Target [154] 
Chromabond Easy  
Mutagenic activity (Ames test) and Genotoxicity (umu 
test) 
LC-MS/MS DW Target [155] 
HyperSep C18  YES assay NA WWTP Non-target [156] 
Oasis HLB  
In vitro cytotoxicity assays (bacterial cytotoxicity 
[Microtox], mammalian cell cytotoxicity); Reactive 
toxicity bioassays (umuC assay for genotoxicity, the 
Escherichia coli biosensor for reactive toxicity toward 
proteins, and the AREc32 assay for oxidative stress) 
GC-ECD; IC DWTP Target [157] 
Oasis HLB  In vitro Escherichia coli growth assay NA WWTP Non-target [158] 
Oasis HLB  
Thyroid hormone reporter gene assay based on the 
green monkey kidney ﬁbroblast  
GC-ECD SW and GW Target [159] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB 
In vitro bioassays: Nonspeciﬁc cytotoxicity (Microtox), 
speciﬁc effect of photosynthesis inhibition, estrogenic 
activity (ER-CALUX), dioxin-like (AhR-CAFLUX) 
activity and oxidative stress response (AREc32)  
NA SW Non-target [160] 
Oasis HLB  
Yeast and diatom culture bioassays; Estrogenity and 
dioxine like activity  
LC-MS-MS; GC-MS WWTP Target [161] 
Oasis HLB Daphnia magna assay GC-MS/MS  SW   [162] 
Oasis HLB 
Toxicity screening in a series of small scale or in vitro 
bioassays. The bioassays included determinations of 
cytotoxicity, EROD activity; inhibition of the 
multixenobiotic resistance, genotoxicicity and 
estrogenic potential 
GC-MS; LC-Q-TOF-
MS 
SW and WWTP Target [163] 
Chromabond HR-X  Growth inhibition test  LC-MS/MS  SW  Target [164] 
Sep-Pak Plus C18  YES assay  LDTD–MS/MS WWTP Target [165] 
Oasis HLB  
Non-speciﬁc toxicity (Microtox and combined algae 
test), the speciﬁc modes of action of phytotoxicity 
(combined algae test), dioxin-like activity (AhR-
CAFLUX), and estrogenicity (E-SCREEN); reactive 
toxicity encompassing genotoxicity (umuC) and 
oxidative stress (AREc32) 
NA Stormwater Non-target [166] 
Oasis MCX  
In vitro bioassays (Comet assay (genotoxicity, DNA 
strand breaks), the Ames ﬂuctuation assay 
(genotoxicity, gene mutations) and a panel of CALUX 
assays (endocrine disruption)) 
LC-LTQ Orbitrap-MS SW Target [167] 
Oasis HLB followed by 
Supelclean coconut charcoal  
Microtox bioassay (bioluminescence inhibition in 
Vibrio ﬁscheri); baseline toxicity; mixture effect 
GC-MS; LC-MS  
WWTP, recycled water, 
stormwater, SW and 
DW 
Target [168] 
Oasis HLB  
Bioluminescence inhibition assay with Vibrio ﬁscheri 
(Microtox), umuC, Escherichia coli and induction of 
oxidative stress response in AREc32 
GC-ECD WWTP Target [169] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB AREc32 bioassay cytotoxicity 
GC-MS/MS; LC-
MS/MS  
WWTP, DW, SW and 
stormwater 
Target [170] 
Oasis HLB  CALUX bioassays  NA SW Non-target [171] 
XAD-2  
Antioxidant response element-regulated genes and 
Antioxidant response element-luciferase reporter gene 
assays  
GC-MS; LC-MS/MS DW Target [172] 
Oasis HLB  Estrogenic activity by ER-CALUX assay 
LC-MS/MS; LC-LTQ 
Orbitrap-MS 
DWTP Target [173] 
Strata-X  Bioluminescent Microtox test  LC-MS/MS  SW  Target [174] 
Oasis HLB; SPE Strata-X  
Growth inhibition test on Pseudokirchneriella 
subcapitata and the immobilisation test on Daphnia 
magna 
LC-MS; AAS SW and GW Target [175] 
Oasis HLB 
Genotoxicity and mutagenicity in vitro (UmuC assay, 
Ames assay and Chronic toxicity); Genotoxicity in vivo 
(Comet assay) 
LC-MS/MS WWTP Target [176] 
Oasis HLB and Supelclean 
coconut charcoal cartridges in 
series 
Primary nonspeciﬁc assays (cytotoxicity to various cell 
types), speciﬁc (inhibition of AChE and endocrine 
receptor-mediated effects) and reactive toxicity 
(mutagenicity and genotoxicity), as well as markers of 
adaptive stress response (modulation of cytokine 
production) and xenobiotic metabolism (liver enzyme 
induction) 
LC-MS/MS; GC-
MS/MS; GC-ECD  
Recycled water: treated 
wastewater and product 
water (reclaimed water)  
Target [177] 
XAD-2 
In vivo toxicity test (Effects on reproduction, growth, or 
survival of Moina macrocopa, a freshwater waterﬂea 
and Oryzias latipes, Japanese medaka ﬁsh) 
GC-MS; GC–ECD; 
ICP-MS 
SW  Target [178] 
Oasis HLB  
In vitro bioassays: Bacterial toxicity (Microtox), 
genotoxicity (umuC), photosynthesis inhibition (Max-I-
PAM) and endocrine effects (E-SCREEN and AR-
CALUX);  in situ effects using mosquitoﬁsh (Gambusia 
holbrooki)  
LC-MS/MS 
WWTP and recycled 
water 
Target [179] 
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Table 1.1:     Overview of SPE and bioassay applications for water quality assessment (continued) 
Oasis HLB followed by 
Supelclean coconut charcoal  
103 bioassays GC-MS; LC-MS  
WWTP, recycled water, 
stormwater, SW and 
DW 
Target [180] 
SupelClean coconut charcoal 
and SupelSelect HLB 
Vibrio ﬁscheri bioluminescence inhibition assay, IPAM 
photosynthesis inhibition assay, umuC genotoxicity 
assay without metabolic activation, umuC genotoxicity 
assay with rat S9 metabolic activation, and AREc32 
oxidative stress response assay 
GC-MS/MS, LC-
MS/MS  
WWTP and an 
Advanced Water 
Recycling Plant  
Target [181] 
Oasis HLB 
Microtox assay, AREc32 assay, umuC assay, and 
CellSensor p53RE-bla HCT-116 assay  
GC-ECD Swimming pool water Target [182] 
AAS: Atomic absorption spectrometry; AChE: Acetylcholinesterase; AhR: Aryl hydrocarbon receptor; CAFLUX: Chemically activated fluorescent gene expression; CALUX: 
Chemically activated luciferase gene expression; DNA: deoxyribonucleic acid; DW: Drinking water; DWTP: Drinking water treatment plant; ECD: Electron capture detector; ELISA: 
Enzyme-linked lmmunosorbent assay; ER: Estrogen receptor; EROD: Ethoxyresorufin O-deethylase; E-SCREEN: Estrogen Screen; GC: Gas chromatography; GW: Ground water; 
IC: Ion chromatography; ICP: Inductively coupled plasma; LC: Liquid chromatography; LDTD: Laser diode thermal desorption; LIT: Linear ion trap; LTQ Linear trap quadrupole; 
MS: Mass spectrometry; MS/MS: Tandem mass spectrometry; NA: Not available; Q: Quadrupole; SCGE: Single cell gel electrophoresis; SW: Surface water; TOF: Time-of-flight; 
UV: Ultraviolet; WWTP: Wastewater treatment plant; YES: Yeast estrogen screen 
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The overall objective was the investigation of the occurrence of organic micropollutants and their 
ozonated TPs in surface water (Ruhr river) and several wastewater samples taken after different 
treatment processes of Duisburg-Vierlinden WWTP (before ozonation, after ozonation, and final 
effluent after biological treatment).  
The first aim was to develop a proper SPE method that would allow isolation of 25 target analytes 
with different physicochemical properties from various aqueous samples (Chapter 2). For this, 
different commercial SPE materials from two manufacturers were tested and other factors like 
sample pH and washing and elution solvents were optimized. An analytical method was developed 
and validated for analysis of the selected compounds in tap water, surface water and wastewater 
samples. The final procedure was then applied to investigate the presence of analytes in surface 
water and wastewater samples which were collected during two sampling campaigns. 
 
Another aim was to examine the possible occurrence of 245 suspect analytes in surface water and 
wastewater samples based on their exact mass using the previously developed SPE method 
(Chapter 3). An automated LC-HRMS method was used for screening operated in a full scan mode 
using different search criteria. The suspects were tracked in WWTP after each treatment step with 
regard to their degradation and/or formation and the release afterwards into surface water. 
 
At the end, the major conclusions from the work are summarized and an outlook on further 
investigations is given (Chapter 4). 
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2 Tandem anion and cation exchange solid phase 
extraction for the enrichment of micropollutants and 
transformation products from ozonation 
2.1 Abstract 
The presence of organic micropollutants and their transformation products (TPs) from biotic and 
abiotic processes in aquatic environments is receiving intense public and scientific attention. Yet 
a suitable sample preparation method that would enable extraction and enrichment of a wide range 
of such compounds from water is missing. The focus of this paper was to develop an enhanced 
solid phase extraction (SPE) protocol which enables isolation of parent compounds and low 
molecular weight metabolites (that are produced after treatment of water with ozone) from 
different water matrices. Ten SPE sorbents were evaluated with regard to their ability to extract 
acidic, neutral and basic compounds from water at several pH values. Highest recoveries (91-99%) 
for all analytes in pure water were obtained by combining strong anion and cation exchangers of 
two manufacturers in a tandem mode without pH adjustment. Tandem Oasis (MAX+MCX) was 
finally applied to extract the spiked analytes from tap water, surface water and several wastewater 
samples. The efficiency of the used SPE procedure was examined based on developed and 
optimized liquid chromatography-electrospray ionization-tandem mass spectrometry (LC–ESI-
MS/MS) method using multiple reaction monitoring (MRM) mode. Occurrence of some of the 
investigated TPs in environmental water matrices has been proven for the first time in this study. 
Method quantification limits (MQLs) for all compounds ranged in all matrices from 3.7 to 
15.3 ng/L. Recoveries (%RE) were between 90 and 110%. Intra-day and inter-day precision, 
expressed as relative standard deviation, varied from 0.7 to 5.9% and 1.8 to 10.3%, respectively. 
Matrix effect (%ME) evaluation demonstrated that even complex sample matrices did not show 
significant ion suppression or enhancement. The applicability of the method was shown during 
two sampling campaigns at Ruhr river and a wastewater treatment plant (WWTP) equipped with 
a polishing ozonation step after biological treatment. All parent compounds were found in every 
water matrix at concentrations ranging between low ng/L and low µg/L. Concentration levels of 
the detected TPs were in the lower ng/L range. Their concentrations increased after ozonation of 
treated wastewater but decreased substantially after a polishing biological treatment in the final 
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effluent and in the receiving surface water, thus demonstrating that occurrence at critical 
concentrations in aquatic ecosystems is rather unlikely. 
 
2.2 Introduction 
In recent years, the number of studies on the occurrence and fate of emerging contaminants such 
as pharmaceuticals, personal care products, industrial chemicals and disinfection by-products in 
the aquatic environment have increased steadily [1]. Effluents from wastewater treatment plants 
(WWTPs) constitute one of the most important sources of organic micropollutants released into 
the environment [2]. The occurrence of a large spectrum of micropollutants in the environment 
clearly shows that conventional WWTPs are not capable of fully eliminating these compounds [3-
5]. In order to reduce pollutant loads in the WW efﬂuents and improve receiving surface water 
quality, several technologies such as activated carbon adsorption [6-10], ozonation and advanced 
oxidation processes [11-16], and membrane filtration [17, 18] have been applied and discussed 
intensively. More specifically, ozone has demonstrated a high effectiveness in the degradation of 
micropollutants during wastewater treatment [19, 20]. A main drawback of ozonation is that it 
does not lead to a full mineralization of organic compounds but to the formation of transformation 
products (TPs), which might be potentially toxic [21]. 2,6-dichloroaniline for example, a toxic TP, 
has been shown to be formed during ozonation of diclofenac in an aqueous matrix [22]. 
The need for proper sample preparation techniques is still a challenging task. Up to date, no 
method specifically aiming at the extraction and enrichment of polar TPs produced during 
(advanced) wastewater treatment has been reported.  
Solid phase extraction (SPE) is one of the most important and frequently used sample preparation 
techniques for either matrix simpliﬁcation or trace enrichment, and has replaced classical liquid–
liquid extraction to a large extent [23]. SPE offers several benefits such as (i) high recoveries for 
compounds of interest, (ii) improvements of selectivity, specificity and reproducibility, (iii) 
potential application to a wide variety of sample matrices, and (iv) use of low solvent volumes 
during extraction steps [24].  
The choice of an appropriate SPE sorbent is the key point because it can control parameters such 
as affinity, selectivity and capacity. These parameters depend strongly on the interactions between 
the analytes of interest and the chosen sorbent but also on the type of sample matrix and its 
interactions with both the analyte and the sorbent [25, 26]. 
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The main aims of this work were: i) evaluation of various SPE sorbents for their ability to extract 
eight precursor compounds from a variety of therapeutic classes and several of their commercially 
available TPs from water. In addition to copolymers composed of both hydrophilic and lipophilic 
monomers, four strong anionic and cationic mixed-mode sorbents, and four weak anionic and 
cationic mixed-mode sorbents were included in this study. Experiments were also conducted to 
optimize sample pH and elution solvents; ii) development and validation of an analytical method 
for simultaneous determination of the selected analytes using liquid chromatography-electrospray 
ionization-tandem mass spectrometry (LC–ESI-MS/MS). The performance of the method has 
been evaluated in real waters in terms of linearity, method detection and quantification limits 
(MDL and MQL), recovery, precision, and the study of matrix effects; iii) applying the developed 
SPE-LC-ESI-MS/MS method to examine the presence of target compounds in surface waters and 
several wastewater samples collected at different steps of an advanced treatment processes 
including ozonation. 
 
2.3 Materials and methods 
2.3.1 Chemicals 
Methanol, acetonitrile, and water were supplied by Fisher Scientific GmbH (Nidderau, Germany) 
and were either of HPLC grade or LC-MS grade. Acetone (analytical grade), ammonium 
hydroxide (30%), ethanol (absolute), ethyl acetate (analytical grade) and formic acid (98-100%) 
were purchased from Merck (Darmstadt, Germany).  
Analyte standards were of high purity (≥97%). Anthranilic acid, p-benzoquinone, 1,2,4-
benzenetriol, 1H-benzotriazole, bisphenol A, carbamazepine, catechol, ciprofloxacin, 2,6-
dichloroaniline, diclofenac sodium salt, glyoxylic acid monohydrate, hydroquinone, maleic acid, 
malic acid, malonic acid, metoprolol tartarate salt, cis,cis-muconic acid (c,c-muconic acid), 
trans,trans-muconic acid (t,t-muconic acid), p-nitrophenol, oxalic acid, oxaloacetic acid, oxamic 
acid, paracetamol, succinic acid and sulfamethoxazole were purchased from Sigma-Aldrich 
(Steinheim, Germany). 
Physicochemical properties such as the acid dissociation constant (pKa), speciation at pH 7 and 
the octanol-water Partition Coefficient (log Pow) were predicted using JChem software for Excel, 
ChemAxon Ltd. (http://www.chemaxon.com) (Table 2.1). The chemical structures of compounds 
with their pKa values are listed in Table 5.1. 
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Table 2.1:     Compounds uses, molecular mass and physicochemical properties 
 
2.3.2 Sampling and sample preparation 
Two sampling campaigns were performed in April, 2014 and February, 2015 to grab water 
samples. 
Sample matrices included (a) 24-h composite wastewater (WW) samples at the municipal 
wastewater treatment plant (WWTP) located in Duisburg-Vierlinden (Germany) where samples 
were taken after diﬀerent treatment steps: before ozonation (WWBO3), after ozonation (WWAO3) 
and the final effluent after and additional biofilter (WWFE); (b) surface water (SW) from the Ruhr 
river at Essen-Werden (Germany); and (c) tap water (TW) from the working lab at the University 
of Duisburg-Essen (campus Essen, Germany).  
Compound Uses CAS No. 
Molecular 
mass in 
g/mol 
pKa 
Speciation 
at pH 7 
logPow 
1H-Benzotriazole Industry 95-14-7 119.1 0.58, 8.63 neutral 1.30 
Bisphenol A Industry  80-05-7 228.3 9.78, 10.39 neutral 4.04 
Catechol Bisphenol A (TP) [42] 120-80-9 110.1 9.34, 12.79 neutral 1.37 
p-Benzoquinone Bisphenol A (TP) [42] 106-51-4 108.1 - neutral 1.02 
c,c-Muconic acid Bisphenol A (TP) [42] 1119-72-8 142.1 3.87, 4.65 anionic 0.49 
t,t-Muconic acid Bisphenol A (TP) [42] 3588-17-8 142.1 3.87, 4.65 anionic 0.49 
Carbamazepine Anticonvulsant 298-46-4 236.3 - neutral 2.77 
Anthranilic acid Carbamazepine (TP) [43] 118-92-3 137.1 1.95, 4.89 anionic 1.45 
Glyoxylic acid Carbamazepine (TP) [43] 298-12-4 74.0 2.61 anionic -0.13 
Oxamic acid Carbamazepine (TP) [43] 471-47-6 89.1 2.49 anionic -1.07 
Ciprofloxacin Antibiotic 85721-33-1 331.3 5.76, 8.68 zwitterionic -0.81 
Diclofenac Analgesic 15307-79-6 296.1 4.00 anionic 4.26 
2,6-Dichloroaniline Diclofenac (TP) [22] 608-31-1 162.0 1.34 neutral 2.35 
Metoprolol Beta blocker 51384-51-1 267.4 9.67 cationic 1.76 
Paracetamol Analgesic 103-90-2 151.2 9.46 neutral 0.91 
Oxalic acid Paracetamol (TP) [44] 144-62-7 90.0 1.36, 4.11 anionic -0.26 
Oxaloacetic acid Paracetamol (TP) [44] 328-42-7  132.1 2.41, 3.58 anionic -0.04 
Malic acid Paracetamol (TP) [44] 6915-15-7 134.1 3.2, 5.13 anionic -1.11 
Malonic acid Paracetamol (TP) [44] 141-82-2 104.1 2.43, 5.92 anionic -0.33 
Maleic acid Paracetamol (TP) [44] 110-16-7  116.1 3.05, 5.91 anionic -0.04 
Succinic acid Paracetamol (TP) [44] 110-15-6 118.1 3.55, 5.69 anionic -0.40 
1,2,4-Benzenetriol Paracetamol (TP) [44] 533-73-3 126.1 9.39, 10.99 neutral 1.06 
Hydroquinone Paracetamol (TP) [44] 123-31-9  110.1 9.68, 11.55 neutral 1.37 
Sulfamethoxazole Antibiotic 723-46-6 253.3 1.97, 6.16 anionic 0.79 
p-Nitrophenol Sulfamethoxazole (TP) [45] 100-02-7 139.1 7.07 neutral 1.61 
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Grab samples were collected in solvent-rinsed amber glass bottles and stored at 4oC in the dark in 
order to minimize degradation. Prior to extraction, the transported samples were filtered with a 
bottle-top vacuum filtration unit through a glass microfiber filter (GF/F, 0.7 μm average pore size, 
47 mm diameter). 
Stock solutions at nominal concentrations of 100 µg/mL of each analyte were prepared by 
dissolving approximately 5 mg in 50 mL HPLC grade methanol or water depending on solubility 
and stored at 4 oC in the dark for increased stability. Working solutions, containing the 25 analytes, 
were prepared by volumetric dilution in water as required from stock solutions and stored at 4 oC 
in the dark until use. 
 
2.3.3 SPE procedure 
Various sorbents were investigated for sample pretreatment and analyte preconcentration 
including Oasis HLB, Oasis MAX, Oasis MCX, Oasis WAX, Oasis WCX, all of which were 
purchased from Waters (Eschborn, Germany), as well as Strata-X, Strata-X-A, Strata-X-C, Strata-
X-AW and Strata-X-CW from Phenomenex (Aschaffenburg, Germany). The physicochemical 
properties of SPE cartridges used are summarized in Table 2.2.  
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Table 2.2:     Physicochemical properties of SPE catrridges  
 
Prior to extraction, cartridges were first preconditioned with 2 x 3 mL methanol followed by 
equilibration with 2 x 3 mL water. Afterwards, they were connected via large volume adaptors to 
the sample bottles. One liter ultrapure water samples were spiked with 100 µL standard mixture 
with a concentration of 500 ng/mL for each compound to yield a final concentration in the sample 
of 50 ng/L. Subsequently, the samples were adjusted to several pH values (2, 5, 7, 9 and 12) and 
then passed through the cartridges by vacuum suction (maximum of 65 kPa) at a flow rate of ~ 15 
mL/min. After the extraction, the cartridges were rinsed with different organic solvents depending 
on the kind of sorbent, dried under vacuum for 30 minutes, wrapped in aluminum foil, and stored 
at -20 oC until elution. Different washing solvents were utilized based on SPE material type. Oasis 
HLB and Strata-X were washed with 2 mL of 100% water, while 2 mL of water-ammonia solution 
(95:5, v/v) mixture was the one for Oasis MAX, Oasis WCX, Strata-X-A and Strata-X-CW. The 
washing solvent for Oasis MCX, Oasis WAX, Strata-X-C and Strata-X-AW contained 2 mL of 
water-formic acid (98:2, v/v) mixture. 
Sorbent 
Particle 
size   
(µm) 
Pore 
size      
(Å) 
Surface 
area 
(m2/g) 
Sorbent 
mass 
(mg) 
Cartridge 
capacity 
(mL) 
Surface modification 
Oasis HLB 30 80 810 100, 200 6 
Divinylbenzene-N-vinylpyrrolidone 
copolymer 
Oasis MAX 30 80 810 100, 200 6 
Quaternary amine functionalized  
divinylbenzene-N-vinylpyrrolidone 
Oasis MCX 30 80 810 100, 200 6 
Sulfonated  divinylbenzene-N-vinyl-
pyrrolidone 
Oasis WAX 30 80 810 200 6 
Cyclic secondary/tertiary amine 
functionalized  divinylbenzene-N-
vinylpyrrolidone 
Oasis WCX 30 80 810 200 6 
Carboxy functionalized  divinylbenzene-
N-vinylpyrrolidone 
Strata-X 33 85 800 100, 200 6 
Polar functionalized styrene-divinyl-
benzene polymer 
Strata-X-A 33 85 800 100, 200 6 
Quaternary amine functionalized  styrene-
divinylbenzene polymer 
Strata-X-C 33 85 800 100, 200 6 
Sulfonated styrene-divinylbenzene 
polymer with polar surface modification 
Strata-X-AW 33 85 800 200 6 
Primary and secondary amine 
functionalized styrene-divinyl-benzene 
polymer 
Strata-X-CW 33 85 800 200 6 
Carboxylated styrene-divinyl-benzene 
polymer 
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The elution was assayed with 100% of methanol, 100% of ethyl acetate, and a mixture of 
methanol-ethyl acetate (70:30, v/v) for both Oasis HLB and Strata-X sorbents. For Oasis MCX, 
Oasis WAX, Strata-X-C and Strata-X-AW, mixtures of methanol-ammonia solution (95:5, v/v), 
ethyl acetate-ammonia solution (95:5, v/v), and methanol-ethyl acetate-ammonia solution 
(67.5:27.5:5, v/v) were tested. Mixtures of methanol-formic acid (98:2, v/v), ethyl acetate-formic 
acid (98:2, v/v), and methanol-ethyl acetate-formic acid (69:29:2, v/v) were examined for Oasis 
MAX, Oasis WCX, Strata-X-A and Strata-X-CW. After elution, the eluates were reduced in 
volume under vacuum before being solvent exchanged to water at a nominal final volume of 1 mL 
(exact volume determined by weighting the vial). 
For further investigation, two SPE cartridges (Oasis MAX & Oasis MCX, 100 mg/6 mL each),  
(Oasis HLB & Oasis MAX, 100 mg/6 mL each), and (Oasis HLB & Oasis MCX, 100 mg/6 mL 
each) were conditioned, equilibrated and connected together in a tandem configuration; as well as 
(Strata-X-A & Strata-X-C, 100 mg/6 mL each), (Strata-X & Strata-X-A, 100 mg/6 mL each), and 
(Strata-X & Strata-X-C, 100 mg/6 mL each). After enrichment, the cartridges were disconnected 
and followed the same washing and elution steps for each single one as detailed before. The 
gathered eluates from both cartridges were combined in a tube and reduced in volume under 
vacuum with solvent exchange to water as a final solvent until reaching 1 mL.  
 
2.3.4 SPE protocol for real water matrices 
200 mg/6 mL Oasis MAX and Oasis MCX cartridges were conditioned and equilibrated with 2 x 
3 mL methanol and 2 x 3 mL water respectively. The two cartridges were connected together in a 
tandem mode in which Oasis MAX was the cartridge connected directly to the sample reservoir 
while Oasis MCX was the subsequent one. 1 L tap water, SW and WW samples were filtered; left 
without pH adjustment; and spiked with 100 µL of the respective standard mixture (c = 500 
ng/mL). The extraction was carried out on a vacuum manifold via large volume adapters. After 
drying of the cartridges, the washing and elution were carried out for each cartridge individually. 
Oasis MAX was washed with 2 mL water-ammonia solution (95:5, v/v) mixture and eluted with 
6 mL methanol-ethyl acetate-formic acid (69:29:2, v/v) mixture. The Oasis MCX washing and 
elution solvents were 2 mL water-formic acid (98:2, v/v) and 6 mL methanol-ethyl acetate-
ammonia solution (67.5:27.5:5, v/v) mixtures, respectively. The gathered eluates from both 
cartridges were mixed together and reduced in volume under vacuum; and the final solvent was 
changed to 1 mL water.  
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2.3.5 Mass spectrometry 
The samples were analyzed on a liquid chromatograph coupled to a mass spectrometer (LC–
MS/MS). The chromatographic separation was performed on an Agilent 1200 system (Agilent 
Technologies, Waldbronn, Germany) consisting of a binary pump, a vacuum degasser, an 
autosampler and a thermostated column oven. The HPLC system was coupled to a Sciex API 
4000TM mass spectrometer (Applied Biosystems, Darmstadt, Germany) utilizing electrospray 
ionization (ESI). The mass spectrometer was operated in multiple reaction monitoring (MRM) to 
achieve the most sensitive and selective detection of the analytes. Each sample was run twice, in 
positive and negative ionisation mode.  
MS/MS parameters were optimized in continuous flow mode, injecting 1000 ng/mL standard 
solutions at a flow rate of 10 μL/min. Declustering potential (DP), collision energy (CE) and cell 
exit potential (CXP) parameters were optimized in the auto-tuning program of the Analyst 
software (Version 1.6.2). 
The chromatographic separation was performed on an XSELECT HSS T3 column (150 × 3.0 mm, 
particle size 3.5 µm, Waters, Germany) and a mobile phase consisting of 0.1% formic acid in water 
(A) and 0.1% formic acid in acetonitrile (B). The column was eluted isocratically for 7 min with 
0% B.  Over the following 8 min, the percentage of B was raised to 100% B, kept there for 9 min 
and finally lowered to 0% B in 1 min. Six min of re-equilibration was allowed prior to the next 
injection. The ﬂow rate and injection volume were set to 0.3 mL/min and 10 µL, respectively. 
 
2.3.6 Quantification and method validation 
Two MRM transitions were monitored for each analyte between the precursor ion and two most 
abundant fragment ions. The highest characteristic precursor ion/product ion MRM transition was 
used for quantification purpose, whereas the second one was chosen to confirm the existence of 
target analytes in the samples. However, the following analytes glyoxylic acid, oxalic acid, malic 
acid, malonic acid, and maleic acid, exhibited only one MRM transition due to their poor 
fragmentation.  
 Quantification was done using eight-point standard addition (n=5) by injecting different analyte 
masses prepared from the stock standard mixture. The concentration in the sample is obtained 
using the following equation (Eq. 1): 
 
Csample = Cadded×
Ssample
Ssample plus added - Ssample
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where Csample is the initial analyte concentration in the sample, Cadded is the analyte concentration 
resulting from the spiked mass in the sample volume, Ssample is the signal of the sample, and Ssample 
plus added is the signal which corresponds to the sample with the spiked standard. 
The linearity was estimated by spiking water samples to a final concentration ranging from 20 to 
10,000 ng/L. Blank samples (unspiked water samples) were also extracted and used as a quality 
control, but were not included in the regression analysis. 
The method detection limit (MDL) and method quantification limit (MQL) were defined and 
determined as the lowest observable concentration of analyte from spiked water samples giving a 
signal-to-noise ratio (S/N) of 3 and 10, respectively. Both were calculated based on repeated 
injections (n = 3) of a low level standard. 
Recovery (RE) tests were carried out by spiking the analytes at appropriate concentrations in 
various water samples prior to and after extraction. RE values were evaluated according to the 
following equation (Eq. 2): 
 
% RE = 
(P1-P2)
(P3-P2)
×100 
 
where P1 and P2  are measured peak areas of the analyte in the final extract of spiked and 
corresponding non-spiked water samples, respectively. P3 is the measured peak area of sample 
spiked after extraction in the reconstitution step. 
Therefore it is essential to study how extracts influence signal response during analysis. 
Matrix effects (ME) in the ESI source was determined in different water matrices (TW, SW, 
WWBO3, WWAO3, and WWFE). ME was calculated using the following equation (Eq. 3) as the 
percentage of analyte signal suppression or enhancement: 
 
% ME = [1-
(P3-P2)
P4
] ×100 
Where P2 and P3 are as described in Eq. 2, and P4 is the peak area of the analyte in the external 
standard (spiking solution). 
The signal of the analyte is suppressed if ME<100 %, whereas the signal of analyte is enhanced if 
ME>100 %. An ME of 100 % indicates no matrix effect.  
To ensure a correct quantification of analytes, method precision and accuracy expressed as relative 
standard deviation (%RSD), was obtained from the repeated injections (seven-fold) of an extracted 
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spiked water samples with a concentration in the middle of the linear range, and analyzed during 
the same day (repeatability/intra-day) and on different days (reproducibility/inter-day).  
 
2.4 Results and discussion 
2.4.1 LC-MS/MS performance 
Good chromatographic separation of the compounds under investigation was achieved using 
XSELECT HSS T3 LC column. A series of different mobile phases including methanol and 
acetonitrile as the organic modifier and water with added formic acid were investigated. Simple 
gradients of acetonitrile with 0.1% formic acid in both the aqueous and organic phases gave 
satisfactory separation of the 25 analytes. 
The chromatographic setup resulted in sharp peaks with baseline widths generally below 30 s (see 
Fig. 5.1). Retention times (RT) were between 4.6 and 22.7 min. RT shifts within a sequence were 
generally lower than 30 s.  
Mass spectrometry parameters were optimized by direct infusion of standards for each analyte 
individually. ESI was used as the ionization source in both negative and positive ion mode by 
injecting the final extract twice. Detection of the negative precursor ion [M-H]- was performed for 
12 compounds, whereas detection of the positive precursor ion [M+H]+ was performed for the 
other 13 compounds of interest. Precursor and product ions, collision energies, declustering 
potential and collision cell exit potential were determined under MS/MS conditions and are 
summarized in Table 2.3. 
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  Table 2.3:     Retention times and parameters for LC-MS/MS monitoring 
Compound 
Retention 
time  
(min) 
Precursor 
ion 
 (m/z) 
Product   
ion  
(m/z) 
DP 
(V) 
CE 
(V) 
CXP 
(V) 
Glyoxylic acid 4.6 73.1 
67.8 -50 -24 -5 
̶ ̶ ̶ ̶ 
Oxalic acid 5.9 88.6 
43.0 -30 -20 -1 
̶ ̶ ̶ ̶ 
1,2,4-Benzenetriol 6.3 125.2 
107.0 -55 -16 -5 
69.0 -55 -22 -5 
Oxamic acid 7.4 89.6 
82.0 41 49 4 
56.0 41 33 8 
Hydroquinone 8.6 111.0 
82.0 56 33 4 
65.0 56 27 10 
Oxaloacetic acid 9.5 133.3 
91.1 121 25 6 
65.0 121 45 2 
Paracetamol 10.0 152.2 
110.2 51 23 6 
65.1 51 43 10 
p-Benzoquinone 10.6 109.2 
81.1 71 19 4 
51.2 71 37 8 
Malic acid 11.1 132.7 
114.8 -45 -16 -1 
̶ ̶ ̶ ̶ 
Catechol 12.0 109.2 
91.0 -60 -28 -5 
62.8 -60 -34 -1 
Malonic acid 12.8 102.7 
41.1 -30 -30 -5 
̶ ̶ ̶ ̶ 
1H-Benzotriazole 13.5 119.9 
91.9 51 25 8 
64.9 51 33 4 
Maleic acid 14.0 117.1 
71.0 -30 -14 -11 
̶ ̶ ̶ ̶ 
Ciprofloxacin 14.9 332.1 
288.2 41 23 6 
244.9 41 31 4 
Succinic acid 15.7 117.0 
99.0 -30 -10 -3 
73.0 -30 -15 -5 
Metoprolol 16.3 268.0 
116.0 76 27 10 
74.0 76 35 6 
t,t-Muconic acid 17.2 141.1 
97.1 -40 -12 -5 
53.2 -40 -16 -1 
Sulfamethoxazole 17.8 253.9 
188.0 66 23 12 
155.8 66 21 14 
c,c-Muconic acid 18.6 141.1 
97.2 -30 -10 -5 
53.1 -30 -18 -1 
p-Nitrophenol 19.0 138.1 
107.8 -50 -24 -7 
50.2 -50 -58 -1 
Carbamazepine  19.5 236.9 
193.9 71 27 16 
179.1 71 49 12 
Bisphenol A 20.4 229.3 
107.0 26 35 6 
77.2 26 61 4 
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  Table 2.3:     Retention times and parameters for LC-MS/MS monitoring (continued) 
2,6-Dichloroaniline 21.1 163.2 
90.9 61 33 14 
57.1 61 57 8 
Anthranilic acid 21.8 138.1 
120.0 36 17 10 
92.0 36 29 6 
Diclofenac 22.7 293.8 
249.8 -50 -28 -15 
213.9 -50 -16 -7 
 
2.4.2 Choice of SPE material 
SPE efficiency is linked to a large number of parameters such as the selection of a proper sorbent, 
enrichment flow rate, pH adjustment, and the composition of washing and elution solvents used 
in each step of the procedure [28, 29].  
The selection of the most adequate SPE sorbent is one of the most important and time-consuming 
aspects of the method. The widely used Oasis HLB (hydrophilic-lipophilic balance) material, 
which provides hydrophilic (N-vinyl-pyrrolidone) and lipophilic (divinylbenzene-rings) groups 
for retention of polar and non-polar compounds, is one of the most used sorbent with enormous 
potential for the extraction of compounds with high polarity [30]. Strata-X is also one of the widely 
used materials which was included in this study. This material provides lipophilic and hydrophilic 
sorption properties via a backbone polydivinylbenzene resin containing piperidone groups. 
Consequently, in this work, several SPE cartridges have been compared and evaluated with regard 
to Oasis HLB and Strata-X as common baseline materials. The ten tested SPE cartridges contained 
the same amount of sorbent (200 mg) but differed in their retention nature (see Table 2.2). 
To cover the enrichment of ionic hydrophilic compounds, mixed mode sorbents containing ion-
exchange groups were added to the SPE material. The anion exchange materials Oasis MAX, 
Oasis WAX, Strata-X-A and Strata-X-AW were selected to target anionic compounds as well as 
hydrophilic and lipophilic components. Oasis MCX, Oasis WCX, Strata-X-C and Strata-X-CW 
were chosen to enrich hydrophilic, lipophilic, and positively charged compounds.  
Different elution solvents were assayed for each SPE material at neutral sample pH (see Tables 
5.2 and 5.3). Methanol-ethyl acetate (70:30, v/v) was the solvent selected for eluting compounds 
from Oasis HLB and Strata-X sorbents. A combination of methanol-ethyl acetate-formic acid 
(69:29:2, v/v) was chosen to elute compounds from Oasis MAX, Oasis WCX, Strata-X-A and 
Strata-X-CW cartridges, whereas a mixture of methanol-ethyl acetate-ammonia solution 
(67.5:27.5:5, v/v) was used as an eluting solvent for Oasis MCX, Oasis WAX, Strata-X-C and 
Strata-X-AW. For the tandem Oasis (MAX+MCX), Oasis (HLB+MAX), Oasis (HLB+MCX), 
Tandem anion and cation exchange SPE 
44 
Strata (X-A+X-C), Strata (X+X-A) and Strata (X+X-C) SPE modes, both washing and elution 
steps were done for each cartridge separately.  
Several papers reported a sample pH adjustment prior to extraction with values ranging from acidic 
to alkaline pH levels [29]. In this study, several pH values were assayed and varied recovery results 
were obtained for each extraction material (See Tables 5.4-5.8). However, concluding from these 
results, pH effects for most compounds were surprisingly low. Thus, samples were processed 
without pH adjustment in following experiments.  
The overall recoveries for all sorbents in pure water at optimized elution solvents and sample pH 
are listed in Table 2.4. As it can be seen, there are great differences in the retention of analytes 
among the SPE cartridges. Oasis HLB provided recoveries in the range between 61% for oxalic 
acid and 75% for hydroquinone. Strata-X achieved recoveries in the range between 60% for 
glyoxylic acid and 78% for anthranilic acid. The weak anionic and cationic exchangers, (Oasis 
WAX, Strata-X-AW) and (Oasis WCX, Strata-X-CW), showed unsatisfying recoveries for most 
compounds. Oasis MAX, Oasis MCX, Strata-X-A and Strata-X-C presented moderate recoveries 
for all compounds but still did not reach satisfactory values of ≥ 90%.  
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Table 2.4:     Comparison of analyte recoveries (%) and RSD (n=3) obtained on different SPE sorbents from the  
analysis of spiked pure water samples (without pH adjustement) at optimized elution solvents 
Compound 
Oasis 
HLB 
Oasis 
MAX 
Oasis 
MCX 
Oasis 
WAX 
Oasis 
WCX 
Strata- 
X 
Strata-
X-A 
Strata-
X-C 
Strata-
X-AW 
Strata-
X-CW 
1H-Benzotriazole 71 ± 4 75 ± 3 72 ± 2 56 ± 2 50 ± 1 74 ± 2 72 ± 5 72 ± 4 59 ± 2 53 ± 3 
Bisphenol A 72 ± 3 74 ± 1 77 ± 4 58 ± 4 45 ± 3 76 ± 1 73 ± 2 74 ± 6 56 ± 1 50 ± 2 
Catechol 70 ± 5 72 ± 4 75 ± 2 59 ± 3 54 ± 1 77 ± 4 73 ± 4 72 ± 2 55 ± 5 51 ± 4 
p-Benzoquinone 71 ± 2 76 ± 3 74 ± 3 56 ± 5 51 ± 2 76 ± 3 77 ± 1 73 ± 5 58 ± 3 55 ± 5 
c,c-Muconic acid 67 ± 2 77 ± 1 70 ± 2 56 ± 2 43 ± 3 63 ± 5 79 ± 3 71 ± 1 59 ± 4 48 ± 1 
t,t-Muconic acid 65 ± 5 80 ± 5 65 ± 4 55 ± 4 46 ± 2 62 ± 1 78 ± 2 70 ± 3 58 ± 2 43 ± 3 
Carbamazepine 72 ± 3 75 ± 2 75 ± 5 48 ± 3 43 ± 4 76 ± 2 76 ± 5 71 ± 2 44 ± 4 40 ± 2 
Anthranilic acid 73 ± 1 80 ± 4 73 ± 3 54 ± 1 48 ± 2 78 ± 4 78 ± 3 67 ± 1 58 ± 1 50 ± 4 
Glyoxylic acid 63 ± 4 81 ± 3 63 ± 2 51 ± 3 47 ± 4 60 ± 3 77 ± 2 68 ± 4 46 ± 5 43 ± 5 
Oxamic acid 69 ± 3 76 ± 1 66 ± 4 53 ± 5 50 ± 3 66 ± 1 80 ± 6 72 ± 2 56 ± 3 47 ± 1 
Ciprofloxacin 74 ± 2 80 ± 2 77 ± 4 59 ± 4 48 ± 2 72 ± 2 78 ± 4 80 ± 5 52 ± 2 45 ± 3 
Diclofenac 70 ± 3 76 ± 3 71 ± 1 54 ± 1 52 ± 3 70 ± 1 80 ± 1 73 ± 4 57 ± 5 49 ± 2 
2,6-Dichloroaniline 72 ± 1 71 ± 5 75 ± 3 55 ± 4 49 ± 5 76 ± 2 71 ± 3 72 ± 1 52 ± 2 47 ± 1 
Metoprolol 65 ± 2 73 ± 2 68 ± 2 53 ± 5 51 ± 1 69 ± 4 70 ± 2 81 ± 2 49 ± 4 48 ± 3 
Paracetamol 70 ± 4 72 ± 4 77 ± 3 52 ± 3 50 ± 2 74 ± 5 72 ± 5 72 ± 6 50 ± 2 48 ± 4 
Oxalic acid 61 ± 1 78 ± 2 65 ± 3 55 ± 2 53 ± 4 64 ± 2 79 ± 2 68 ± 4 59 ± 3 50 ± 2 
Oxaloacetic acid 64 ± 3 78 ± 3 67 ± 2 54 ± 4 52 ± 3 65 ± 5 77 ± 6 71 ± 1 51 ± 1 49 ± 5 
Malic acid 62 ± 2 79 ± 1 62 ± 1 58 ± 3 50 ± 4 66 ± 2 80 ± 3 70 ± 3 54 ± 3 53 ± 2 
Malonic acid 65 ± 5 77 ± 5 68 ± 3 53 ± 1 48 ± 2 64 ± 1 76 ± 5 73 ± 5 55 ± 4 51 ± 4 
Maleic acid 64 ± 3 78 ± 2 67 ± 2 57 ± 5 53 ± 4 65 ± 5 80 ± 2 71 ± 2 54 ± 1 50 ± 3 
Succinic acid 70 ± 2 77 ± 3 73 ± 3 55 ± 2 52 ± 3 69 ± 3 75 ± 4 75 ± 3 58 ± 5 55 ± 1 
1,2,4-Benzenetriol 71 ± 4 74 ± 2 77 ± 1 49 ± 2 46 ± 5 75 ± 6 76 ± 1 72 ± 1 53 ± 3 51 ± 4 
Hydroquinone 75 ± 1 73 ± 4 78 ± 2 53 ± 4 51 ± 3 77 ± 4 76 ± 2 71 ± 5 49 ± 4 48 ± 2 
Sulfamethoxazole 72 ± 4 78 ± 1 74 ± 2 57 ± 3 53 ± 2 71 ± 1 78 ± 5 73 ± 4 53 ± 1 49 ± 2 
p-Nitrophenol 70 ± 2 75 ± 3 72 ± 1 55 ± 1 52 ± 3 72 ± 2 74 ± 3 71 ± 5 50 ± 5 46 ± 3 
 
From the comparison of ten tested single SPE cartridges, it can be observed that no material has 
retained all compounds with high recovery yield. Therefore, it was concluded that combining two 
materials was required.  
Strong anionic and cationic exchangers yielded better recoveries compared with weak exchangers. 
These results were the inspiration to use Oasis MAX in combination with Oasis MCX; and Strata-
X-A in combination with Strata-X-C; because this will provide hydrophilic-lipophilic-anionic-
cationic interactions. The two ionic exchange materials were therefore used in a tandem mode to 
investigate recoveries for acidic, basic and neutral compounds. Oasis MAX was chosen as the first 
SPE material in flow direction to cover the ionic interactions of negatively charged compounds as 
Tandem anion and cation exchange SPE 
46 
well as uncharged hydrophilic and lipophilic compounds. Oasis MCX was used as the second SPE 
material to extract the positively charged compounds and also the rest of compounds that are not 
covered by the Oasis MAX material. To achieve a fair comparison between tandem and single 
SPE strategies, 100 mg of each Oasis MAX and Oasis MCX materials was used to obtain a total 
of 200 mg in a tandem mode as for single cartridges. The resulting developed SPE method is 
outlined in Fig. 2.1. 
Within this configuration, high recoveries (≥ 91%) were obtained for all compounds without 
exception as shown in Table 2.5. To further support the idea of simply leaving water samples 
without pH adjustment, several pH values were tested on the developed SPE tandem approach for 
both Oasis and Strata materials and recoveries ≥ 90% were obtained for all compounds (see Table 
5.9). The acquired data showed that there is no significant effect on recoveries using the tandem 
SPE approach by changing the pH value of water samples. Recoveries with this approach are 
superior to previously reported values for a few of the listed parent compounds using different 
sorbents. Gatidou et al. [31] showed, for example, poor extraction recovery (< 5%) for bisphenol 
A from wastewater samples using Isolute ENV+ sorbent. Additionally, Weigel et al. [32] showed 
low recoveries (38-50%) from spiked tap water samples for diclofenac, paracetamol, and 
metoprolol with extraction using Isolute ENV+. Sacher et al. [33] reported poor recovery for 
sulfamethoxazole (21%) and moderate recovery (74%) for carbamazepine in SW samples using 
RP-C18 extraction material. Tuc Dinh et al. [34] presented extraction recovery of 74% for 
ciprofloxacin from river water using C18 HD cartridges. Liu et al. [35] reported poor recovery 
(34%) for 1H-benzotriazole in spiked tap water samples using ENVI-18 as an extraction sorbent.  
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Table 2.5:     Comparison of analyte recoveries (%) and RSD (n=3) in different SPE tandem combinations from the  
                      spiked pure water samples (without pH adjustement) at optimized elution solvents 
Compound 
Tandem   
Oasis 
(MAX+MCX) 
Tandem 
Oasis 
(HLB+MAX) 
Tandem 
Oasis 
(HLB+MCX) 
Tandem 
Strata         
(X-A+X-C)    
Tandem 
Strata    
(X+X-A) 
Tandem 
Strata    
(X+X-C) 
1H-Benzotriazole 96 ± 3 81 ± 4 83 ± 6 92 ± 5 85 ± 4 88 ± 3 
Bisphenol A 92 ± 2 84 ± 3 79 ± 3 98 ± 2 81 ± 6 76 ± 2 
Catechol 97 ± 4 85 ± 5 82 ± 4 94 ± 5 80 ± 3 78 ± 4 
p-Benzoquinone 95 ± 3 85 ± 2 80 ± 3 96 ± 4 87 ± 2 83 ± 6 
c,c-Muconic acid 93 ± 5 78 ± 6 81 ± 5 95 ± 2 75 ± 4 85 ± 5 
t,t-Muconic acid 94 ± 3 77 ± 6 75 ± 3 92 ± 4 73 ± 3 72 ± 4 
Carbamazepine 96 ± 6 85 ± 3 81 ± 6 91 ± 6 88 ± 5 84 ± 2 
Anthranilic acid 95 ± 2 83 ± 5 78 ± 2 96 ± 5 80 ± 2 75 ± 5 
Glyoxylic acid 92 ± 4 82 ± 3 73 ± 4 94 ± 3 81 ± 6 76 ± 3 
Oxamic acid 93 ± 5 80 ± 2 75 ± 5 95 ± 4 84 ± 2 80 ± 4 
Ciprofloxacin 96 ± 4 86 ± 5 88 ± 3 91 ± 3 82 ± 4 85 ± 2 
Diclofenac 99 ± 3 84 ± 4 82 ± 3 94 ± 5 83 ± 5 80 ± 3 
2,6-Dichloroaniline 97 ± 5 83 ± 2 80 ± 4 95 ± 3 79 ± 3 77 ± 6 
Metoprolol 92 ± 4 79 ± 3 84 ± 2 99 ± 2 76 ± 3 81 ± 2 
Paracetamol 97 ± 2 84 ± 5 80 ± 3 94 ± 5 89 ± 4 84 ± 3 
Oxalic acid 95 ± 3 87 ± 6 81 ± 5 93 ± 4 80 ± 6 76 ± 5 
Oxaloacetic acid 92 ± 3 89 ± 4 76 ± 2 95 ± 3 84 ± 5 73 ± 4 
Malic acid 94 ± 6 86 ± 2 80 ± 3 92 ± 6 81 ± 3 77 ± 2 
Malonic acid 95 ± 5 81 ± 4 78 ± 6 92 ± 3 85 ± 5 82 ± 4 
Maleic acid 91 ± 4 85 ± 6 79 ± 2 95 ± 5 82 ± 4 74 ± 5 
Succinic acid 95 ± 5 87 ± 3 82 ± 4 90 ± 3 83 ± 3 80 ± 3 
1,2,4-Benzenetriol 93 ± 3 84 ± 5 83 ± 2 92 ± 2 80 ± 2 78 ± 6 
Hydroquinone 95 ± 2 82 ± 3 87 ± 3 90 ± 6 85 ± 4 89 ± 3 
Sulfamethoxazole 98 ± 6 80 ± 4 78 ± 2 95 ± 4 77 ± 3 74 ± 4 
p-Nitrophenol 92 ± 5 84 ± 3 80 ± 6 94 ± 5 88 ± 2 83 ± 6 
 
For further comparisons, tandem Oasis (HLB+MAX), Oasis (HLB+MCX), Strata (X+X-A) and 
Strata (X+X-C) were studied and the results showed that these combinations gave better recoveries 
than each single cartridge but still lower than those obtained by using a combination of strong 
anionic and cationic exchangers as listed in Table 2.5. 
Both tested SPE materials (Oasis and Strata) gave comparable recovery results. In the further study 
of matrix influences, Oasis materials were used with the tandem approach.  
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2.4.3 Method validation 
The performance characteristics of the SPE–LC–MS/MS method were established by validation 
with spiked water samples. Linearity, MDL and MQL, precision, recovery and matrix effect were 
evaluated for quantitative purposes. The linearity of each analyte was assessed in WWBO3 
samples and the mean correlation coefficients (R2) were higher than 0.9926 thus confirming the 
Pre-treat sample 
Sampling: 1 L water 
Filtration: GF/F filters 
  
  
SPE 
SPE Conditioning: 3x3 mL methanol 
SPE Equilibration: 3x3 mL water 
SPE Load: pre-treated sample on 
                   Tandem Oasis (MAX+MCX) 
Washing  
Oasis MAX: 95% water 
    (2 mL)       5% ammonium hydroxide 
Oasis MCX: 95% water 
    (2 mL)      2% formic acid 
  
Solvent exchange 
1 mL water 
  
Elution  
Oasis MAX: 69% methanol 
    (6 mL)       29% ethyl acetate 
                      2% formic acid 
Oasis MCX: 67.5% methanol 
    (6 mL)      27.5% ethyl acetate 
                      5% ammonium hydroxide 
Spiking: 100 µL of 500 ng/mL 
standard mixture 
(For recovery determination) 
  
Figure 2.1:     Schematic representation of the optimized sample preparation procedure 
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linearity of the method in spite of a very complex matrix (see Table 2.6).  To demonstrate the 
flexibility of the analytical procedure, calibration curves in the same concentration range were also 
constructed in TW, SW and the rest of WW samples. Excellent linearities with correlation 
coefficients > 0.99 were obtained for all analytes in all matrices.  
MDL and MQL values for the analytes in various matrices are presented in Table 2.6. It can be 
seen that the MDL and MQL values were the lowest in TW, followed by SW, WWFE, WWAO3, 
and finally WWBO3. This is probably due to the matrix effects impact. 
Recoveries (n=3) were very satisfying (≥ 90%) for all analytes in different water matrices as shown 
in Table 2.7.  
Nowadays mass spectrometry (MS) is largely used in environmental analysis due to its specificity 
and sensitivity. However, interferences are problems produced, mainly when electrospray is used 
in the ionization source. The presence of less volatile compounds, which can change the efficiency 
of droplet formation or evaporation, results in Ion suppression/enhancement. This in turn affects 
the amount of charged ions in the gas [36, 37]. The evaluation of ME is important to provide 
accurate and reproducible quantitative data. Table 2.7 summarizes ME on the analytes in various 
environmental matrices.  
A slight signal enhancement was observed in WWBO3, WWAO3, and WWFE for several analytes 
(bisphenol A, c,c-muconic acid, t,t-muconic acid, glyoxylic acid, oxamic acid, 2,6-dichloroaniline, 
oxalic acid, malonic acid, maleic acid, 1,2,4-benzenetriol and p-nitrophenol ). On the other hand, 
small ion suppression effects due to matrix constituents were also observed for the rest of 
compounds. No ME was observed for malic acid in both TW and SW. The influence of the matrix 
was negligible for all analytes in TW and SW. WWBO3 yielded a slightly higher matrix effect, 
followed by WWAO3, and then WWFE. 
The developed method was sufficiently precise for quantitative analysis of selected compounds in 
all water matrices. The results obtained are listed in Table 2.8, and showed that the methodology 
gave good precisions in all water samples even at low concentrations. 
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               Table 2.6:     Linearity, method detection and quantitation limits in different water matrices 
Compound 
Linearity 
(R2) 
 MDL (ng/L)  MQL (ng/L) 
TW SW WWBO3 WWAO3 WWFE  TW SW WWBO3 WWAO3 WWFE 
1H-Benzotriazole 0.9963  1.1 1.7 2.6 2.3 2.0  3.7 5.7 8.7 7.7 6.7 
Bisphenol A 0.9992  1.5 1.8 2.7 2.0 1.9  5.0 6.0 9.0 6.7 6.3 
Catechol 0.9926  2.0 2.4 3.0 2.7 2.5  6.7 8.0 10.0 9.0 8.3 
p-Benzoquinone 0.9934  2.4 2.5 3.3 3.0 2.9  8.0 8.3 11.0 10.0 9.7 
c,c-Muconic acid 0.9981  1.8 2.1 2.8 2.5 2.4  6.0 7.0 9.3 8.3 8.0 
t,t-Muconic acid 0.9957  2.0 2.2 2.7 2.4 2.3  6.7 7.3 9.0 8.0 7.7 
Carbamazepine 0.9988  1.3 1.5 2.4 2.2 1.8  4.3 5.0 8.0 7.3 6.0 
Anthranilic acid 0.9950  1.9 2.3 3.0 2.6 2.5  6.3 7.7 10.0 8.7 8.3 
Glyoxylic acid 0.9942  3.0 3.3 4.3 3.9 3.7  10.0 11.0 14.3 13.0 12.3 
Oxamic acid 0.9979  2.6 2.8 3.9 3.6 3.2  8.7 9.3 13.0 12.0 10.7 
Ciprofloxacin 0.9991  1.5 1.8 2.5 2.3 2.0  5.0 6.0 8.3 7.7 6.7 
Diclofenac 0.9984  1.4 1.9 2.3 2.2 2.0  4.7 6.3 7.7 7.3 6.7 
2,6-Dichloroaniline 0.9946  2.0 2.4 3.6 3.3 3.1  6.7 8.0 12.0 11.0 10.3 
Metoprolol 0.9978  1.8 2.1 3.1 2.8 2.5  6.0 7.0 10.3 9.3 8.3 
Paracetamol 0.9983  1.9 2.0 2.8 2.5 2.3  6.3 6.7 9.3 8.3 7.7 
Oxalic acid 0.9971  2.5 2.9 4.4 4.2 3.7  8.3 9.7 14.7 14.0 12.3 
Oxaloacetic acid 0.9958  2.7 3.1 4.6 4.0 3.5  9.0 10.3 15.3 13.3 11.7 
Malic acid 0.9939  2.8 3.0 4.2 3.9 3.8  9.3 10.0 14.0 13.0 12.7 
Malonic acid 0.9940  2.5 2.8 4.6 4.1 3.3  8.3 9.3 15.3 13.7 11.0 
Maleic acid 0.9965  2.1 2.5 4.2 3.6 3.1  7.0 8.3 14.0 12.0 10.3 
Succinic acid 0.9982  1.9 2.2 3.4 3.0 2.6  6.3 7.3 11.3 10.0 8.7 
1,2,4-Benzenetriol 0.9951  2.2 2.7 4.0 3.7 3.4  7.3 9.0 13.3 12.3 11.3 
Hydroquinone 0.9968  2.4 2.5 4.1 3.7 3.2  8.0 8.3 13.7 12.3 10.7 
Sulfamethoxazole 0.9976  1.3 1.5 2.9 2.6 2.3  4.3 5.0 9.7 8.7 7.7 
p-Nitrophenol 0.9954  2.4 2.6 4.3 3.5 3.0  8.0 8.7 14.3 11.7 10.0 
               TW: Tap water; SW: Surface water; WWBO3: Wastewater before ozonation; WWAO3: Wastewater after ozonation; WWFE: Wastewater final effluent
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                     Table 2.7:     Recovery (%RE) and matrix effect (%ME) in water samples obtained by applying tandem Oasis (MAX+MCX) SPE mode 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                    
Compound 
%RE (n=3)   %ME 
TW SW WWBO3 WWAO3 WWFE   TW SW WWBO3 WWAO3 WWFE 
1H-Benzotriazole 94 ± 5 93 ± 4 95 ± 2 107 ± 5 99 ± 2   99 ± 3 97 ± 6 87 ± 3 89 ±4 93 ± 1 
Bisphenol A 93 ± 4 98 ± 3 101 ± 4 102 ± 7 94 ± 3   101 ± 5 103 ± 1 109 ± 5 106 ± 3 104 ± 6 
Catechol 95 ± 3 93 ± 2 92 ± 3 94 ± 2 105 ± 5   99 ± 5 96 ± 2 90 ± 5 92 ± 1 95 ± 4 
p-Benzoquinone 99 ± 5 92 ± 5 95 ± 4 92 ± 2 90 ± 4   97 ± 2 95 ± 5 88 ± 2 90 ± 5 94 ± 3 
c,c-Muconic acid 96 ± 6 103 ± 5 97 ± 2 93 ± 5 90 ± 3   105 ± 6 102 ± 2 112 ± 6 108 ± 3 107 ± 5 
t,t-Muconic acid 102 ± 3 93 ± 4 92 ± 3 97 ± 4 102 ± 5   101 ± 3 105 ± 3 115 ± 3 113 ± 4 109 ± 1 
Carbamazepine 96 ± 3 94 ± 5 104 ± 5 96 ± 6 98 ± 2   98 ± 1 96 ± 1 85 ± 1 89 ± 2 92 ± 4 
Anthranilic acid 97 ± 3 90 ± 2 90 ± 3 94 ± 4 95 ± 6   95 ± 4 94 ± 5 87 ± 4 90 ± 1 91 ± 2 
Glyoxylic acid 91 ± 2 92 ± 6 91 ± 5 93 ± 2 90 ± 5   103 ± 2 105 ± 1 114 ± 2 112 ± 2 108 ± 3 
Oxamic acid 92 ± 1 94 ± 2 105 ± 4 92 ± 5 102 ± 4   107 ± 3 111 ± 3 111 ± 3 115 ± 4 114 ± 1 
Ciprofloxacin 98 ± 3 97 ± 4 96 ± 2 104 ± 4 93 ± 2   99 ± 2 97 ± 2 91 ± 2 93 ± 5 94 ± 3 
Diclofenac 95 ± 4 93 ± 2 93 ± 4 101 ± 5 95 ± 3   94 ± 4 93 ± 5 87 ± 4 88 ± 2 91 ± 4 
2,6-Dichloroaniline 91 ± 2 108 ± 3 94 ± 3 98 ± 5 91 ± 2   106 ± 3 109 ± 4 115 ± 3 114 ± 1 111 ± 5 
Metoprolol 92 ± 1 96 ± 3 103 ± 6 97 ± 2 110 ± 5   95 ± 1 92 ± 6 85 ± 1 87 ± 3 91 ± 2 
Paracetamol 101 ± 6 97 ± 1 106 ± 4 96 ± 3 94 ± 2   98 ± 5 95 ± 1 88 ± 5 92 ± 2 93 ± 3 
Oxalic acid 92 ± 4 91 ± 3 90 ± 5 93 ± 5 103 ± 6   101 ± 1 104 ± 3 113 ± 1 112 ± 5 109 ± 2 
Oxaloacetic acid 95 ± 2 96 ± 2 94 ± 5 91 ± 4 92 ± 4   97 ± 4 93 ± 4 84 ± 4 87 ± 6 89 ± 1 
Malic acid 98 ± 5 91 ± 4 91 ± 3 93 ± 5 106 ± 3   100 ± 5 100 ± 2 89 ± 5 93 ± 2 95 ± 4 
Malonic acid 90 ± 3 101 ± 3 95 ± 4 92 ± 3 93 ± 5   102 ± 2 106 ± 2 114 ± 2 110 ± 4 107 ± 5 
Maleic acid 93 ± 4 95 ± 5 92 ± 3 103 ± 4 90 ± 3   105 ± 4 109 ± 5 116 ± 4 114 ± 1 113 ± 3 
Succinic acid 91 ± 5 108 ± 3 96 ± 2 105 ± 2 92 ± 4   97 ± 3 96 ± 3 89 ± 3 90 ± 5 92 ± 1 
1,2,4-Benzenetriol 92 ± 2 97 ± 3 90 ± 4 94 ± 5 93 ± 2   101 ± 1 104 ± 5 112 ± 1 107 ± 4 105 ± 2 
Hydroquinone 96 ± 4 95 ± 1 93 ± 5 91 ±2 92 ± 3   98 ± 2 94 ± 1 88 ± 2 91 ± 5 93 ± 4 
Sulfamethoxazole 93 ± 5 104 ± 7 92 ± 3 97 ± 5 95 ± 2   96 ± 1 91 ± 4 84 ± 1 85 ± 2 89 ± 6 
p-Nitrophenol 95 ± 2 90 ± 4 102 ± 6 92 ± 3 94 ± 5   104 ± 4 105 ± 2 116 ± 4 112 ± 1 109 ± 3 
TW: Tap water; SW: Surface water; WWBO3: Wastewater before ozonation; WWAO3: Wastewater after ozonation; WWFE: Wastewater final effluent 
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                      Table 2.8:     Intra-day and inter-day precision for target compounds in all water matrices 
Compound 
 Intra-day, RSD (%, n=7)  Inter-day, RSD (%, n=7) 
 TW SW WWBO3 WWAO3 WWFE TW SW WWBO3 WWAO3 WWFE 
1H-Benzotriazole  3.7 3.0 2.0 1.5 4.7  3.0 4.3 7.6 1.8 5.7 
Bisphenol A  2.8 5.2 2.4 3.1 1.8  4.3 6.0 5.8 7.3 2.8 
Catechol  1.9 2.4 4.3 1.8 3.6  2.7 3.4 6.3 5.1 8.5 
p-Benzoquinone  4.1 3.2 5.2 2.5 1.0  5.1 5.7 8.1 4.2 2.9 
c,c-Muconic acid  2.5 0.8 3.4 3.1 1.4  4.6 8.3 2.4 4.9 5.2 
t,t-Muconic acid  3.2 5.0 2.8 4.6 3.8  6.2 6.7 5.6 3.3 7.9 
Carbamazepine  0.9 3.5 1.9 2.7 0.9  3.8 4.1 2.9 5.7 8.3 
Anthranilic acid  1.1 2.4 2.1 3.6 1.7  7.5 2.9 8.7 4.8 6.4 
Glyoxylic acid  2.6 3.1 4.0 2.2 1.3  4.9 8.4 3.5 7.2 5.0 
Oxamic acid  4.9 0.9 2.7 4.3 2.1  2.5 7.2 8.2 3.6 4.4 
Ciprofloxacin  3.5 1.2 1.8 3.7 2.5  6.7 2.4 3.6 6.0 5.1 
Diclofenac  2.2 4.6 2.5 4.1 1.8  3.4 4.7 5.8 3.2 6.8 
2,6-Dichloroaniline  0.7 2.4 2.9 3.3 4.2  2.8 5.4 3.4 2.9 7.2 
Metoprolol  4.2 3.9 2.2 1.7 3.0  5.3 3.6 4.1 7.8 2.2 
Paracetamol  3.7 2.0 2.6 3.8 1.4  7.6 2.8 5.2 3.7 7.0 
Oxalic acid  2.3 0.8 4.4 2.6 1.7  3.3 6.1 2.6 7.4 4.9 
Oxaloacetic acid  1.8 2.8 5.3 1.9 3.3  4.2 4.0 4.8 2.9 6.3 
Malic acid  4.1 4.6 2.9 2.4 0.9  2.9 10.3 7.3 4.6 6.9 
Malonic acid  3.4 2.7 4.8 3.1 1.2  6.8 8.4 5.4 6.1 4.5 
Maleic acid  0.9 1.5 3.7 4.9 4.0  4.0 3.7 2.1 5.9 8.3 
Succinic acid  1.3 3.4 2.1 4.7 2.6  3.2 9.2 4.5 2.6 7.1 
1,2,4-Benzenetriol  4.6 2.8 5.9 2.9 1.4  7.1 3.8 6.3 3.9 7.7 
Hydroquinone  2.8 2.3 3.4 1.5 3.0  5.6 4.9 7.4 5.2 6.5 
Sulfamethoxazole  5.0 1.1 2.5 4.0 3.8  4.8 8.0 3.0 7.2 5.4 
p-Nitrophenol  1.7 3.9 5.6 2.7 4.2  3.5 2.9 6.2 3.7 4.1 
                       TW: Tap water; SW: Surface water; WWBO3: Wastewater before ozonation; WWAO3: Wastewater after ozonation; WWFE: Wastewater final effluent 
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2.4.4 Environmental application 
The optimized SPE-LC-ESI-MS/MS method was applied for two sampling campaigns conducted 
in 2014 and 2015 at the Ruhr river and a WWTP located in North-Western Germany. 
As can be deduced from Fig. 2.2, all parent analytes were ubiquitous in WW and SW samples. 
The concentrations in WW were generally in the range of a few ng/L to several thousand ng/L 
depending on the treatment step and sampling period. In 2014, the levels of compounds in 
WWBO3 ranged between 391 (bisphenol A) and 3020 (carbamazepine) ng/L, 143 (bisphenol A) 
and 995 (carbamazepine) ng/L in WWAO3, and between 52 (bisphenol A) and 602 
(carbamazepine) ng/L in WWFE. In 2015, the concentrations varied from 227 (bisphenol A) to 
3410 (carbamazepine) ng/L in WWBO3, from 94 (bisphenol A) to 1190 (carbamazepine) ng/L in 
WWAO3, and from 43 (bisphenol A) to 652 (carbamazepine) ng/L in WWFE. 
As a result, the highest concentrations of all precursor compounds in two campaigns were obtained 
in WWBO3 samples followed by WWAO3, and then WWFE. This showed the degradation 
efficiency during advanced WWT using ozonation followed by a biologically active step. On the 
other hand, the TPs were detected only at low ng/L levels if at all, i.e., at much smaller 
concentrations than the parent analytes. Some analytes like hydroquinone and malonic acid were 
not detected in any of 2014 WW samples, same as glyoxylic acid and oxaloacetic acid in 2015. It 
can be noticed that 2014 and 2015 WWAO3 showed the highest concentration levels for TPs (if 
detected) comparing to the other WW samples.   
Regarding SW, all parent compounds were detected and quantified in both 2014 and 2015 
campaigns but with lower concentrations than in WW samples. The concentrations ranged from 
24 ng/L for bisphenol A to 129 ng/L for carbamazepine in 2014, while from 23 ng/L for 
ciprofloxacin to 166 ng/L for carbamazepine in 2015. TPs if present were at low concentrations 
(<50 ng/L) at both sampling dates. 1,2,4-benzenetriol, p-benzoquinone, 2,6-dichloroaniline, 
glyoxylic acid, hydroquinone, malonic acid, oxalic acid, oxaloacetic acid and oxamic acid, were 
not found in 2014 water samples, whereas several TPs were not detected too in 2015 such as 2,6-
dichloroaniline, glyoxylic acid, hydroquinone, malonic acid, c,c-muconic acid, t,t-muconic acid, 
oxaloacetic acid and oxamic acid. Succinic acid (30 ng/L) and malic acid (41 ng/L) were the 
predominant substances in 2014 and 2015 SW samples, respectively. The concentration values are 
presented in Table 5.10. TPs were observed to be at high concentrations in WWAO3 comparing to 
other WW and SW samples, which as a result confirms the formation of these compounds during 
an ozonation step. For all TPs a subsequent reduction of their concentration was noticed in both 
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WWFE and SW samples. This demonstrates the transient nature of the investigated TPS, i.e., their 
rapid further degradation in biologically active systems. 
All parent analytes were found in German SW and WW samples at concentrations varying 
between ng/L and µg/L as reported previously [38-41]. TPs were examined first-time in our study 
and no previous data were available for comparison.  
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Figure 2.2:     Concentration levels of parent compounds and TPs in water matrices at two sampling campaigns conducted in 2014 and 2015
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2.5 Conclusions 
Ten different SPE sorbents were compared for the isolation of twenty five selected micropollutants 
and TPs in water. Several procedures for sample pH adjustment and elution solvents have been 
investigated. Oasis and Strata SPE families showed comparable recovery values for the examined 
analytes. The best performance was achieved by combining strong anion and cation exchangers 
(Oasis MAX and Oasis MCX or Strata-X-A and Strata-X-C) in a tandem mode without any need 
for pH adjustment. This configuration yielded quantitative recoveries (≥ 90%) for all tested 
analytes. The application of the optimized method to TW, SW and several WW samples 
demonstrated its robustness to enrich and isolate acidic, neutral and basic compounds. The 
developed method represents a general extraction protocol and may solve several sample 
preparation problems since so far no procedure to enrich different compound classes from 
complicated water matrices with high recovery rates was available. Nobody yet described the use 
of tandem cartridges of strong anion and cation exchange materials and reported high recoveries 
for compounds with various physicochemical properties such as we achieved in this study. In so 
doing, the improved SPE method aids in satisfying the environmental community's need for 
reliable sample preparation methods to extract a wide range of compound classes in aquatic 
environments; especially those TPs with unknown ecotoxicological impacts produced during 
WWT. 
The study results showed also the developed LC-ESI-MS/MS method was robust and sensitive for 
simultaneous detection and quantification of target analytes in SW and WW samples collected 
during two sampling campaigns at the nanograms-per-liter concentration range. Trace analysis of 
TPs in real waters was done for the first time in our study. The proposed method showed good 
linearity, and intra- and inter-day precision. Moreover, various water matrices did not affect the 
analysis in the LC–MS/MS, which implies that clean extracts are obtained. This might allow in 
the future to use external calibration instead of standard addition for quantification. The 
concentration levels of parent analytes decreased after ozonation and further biological post-
treatment, which confirms the removal efficiency of these advanced treatment steps.  
Concentration levels of the detected TPs were in the lower ng/L range in all water samples. The 
highest values of these compounds were observed in WWAO3 samples which in most cases proved 
the formation of new oxidation products after ozonation step. Furthermore, the presence of TPs in 
environmental water samples indicates that the results of laboratory experiments for degradation 
of compounds with ozone may be transferred to real treatment plant conditions.  
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3 Suspect screening of micropollutants and their 
transformation products in advanced wastewater 
treatment 
3.1 Abstract 
Transformation products (TPs) of organic micropollutants are still rarely considered in aquatic 
environments. Many of these compounds can potentially be formed in the environment after 
biological or chemical degradation and analytical standards are typically lacking, therefore 
knowledge on the prevalence in aquatic environments remains deficient. 
In this study, the eﬃciency of a suspect screening strategy using solid phase extraction with broad 
enrichment efﬁciency, followed by liquid chromatography-electrospray ionization-quadrupole-
time-of-flight-mass spectrometry (LC–ESI-Q-TOF-MS) without reference standards was 
systematically evaluated for assessing the potential exposure of different compound classes and 
their ozonated TPs in surface water and several wastewater samples collected at different steps of 
an advanced treatment processes including ozonation. An automated molecular-feature analysis 
based on a list of 245 previously reported compounds and their TPs was used. Thresholds for blank 
subtraction, mass accuracy (5 ppm tolerance), peak height (minimum 1000 counts) and isotopic 
pattern score (≥ 80%) were applied to filter the picked peaks. The results showed that the number 
of successfully detected compounds using the search criteria was 189. A decrease in concentration 
levels was observed for parent compounds in wastewater after ozonation and after biological 
treatment processes, while formation of tentative TPs after ozonation accompanied by degradation 
after biological treatment was noticed. Some of the detected compounds were also found in surface 
water. Moreover, a plausible reliability for compound prediction was obtained when using relative 
retention time information as comparison criteria. Overall, the screening approach was fast and 
successful and can be expanded to other compound classes and TPs where reference standards are 
not readily accessible.
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3.2 Introduction 
A large number of chemicals used in households and industry including pharmaceuticals and 
personal care products (PPCPs), biocides, pesticides and many industrial chemicals are released 
into aquatic environments due to their incomplete removal in wastewater treatment plants 
(WWTPs) [1, 2].The occurrence and fate of contaminants of emerging concern in the environment 
has been studied extensively. Yet, relatively little attention has been paid to their transformation 
products (TPs) [3]. TPs of emerging contaminants can be found in the environment or WWTPs as 
a result of biotic and abiotic processes acting on parent compounds such as oxidation [4], 
hydrolysis [5], photolysis [6] and microbial metabolism [7]. TPs can be of significant concern 
especially if they reveal a biological activity or resistance to biodegradation [8-10]. Some TPs are 
equally active or even more active than the parent compounds on aquatic ecosystems and/or on 
humans [11-13]. However, many of the TPs are still undiscovered, and there is only little known 
with regard to their further environmental fate [14]. Lately, an international expert workshop 
concluded that the risks assessment of environmental TPs of PPCPs is among the top twenty key 
issues that need to be tackled by the research community [15]. 
Recently, researchers have started to study the formation of TPs during ozonation, which is 
considered one of the most promising technologies for advanced wastewater treatment [16]. 
Identification of TPs mostly relies on  mass spectrometry [17].  In addition to the direct reaction 
of ozone with many organic molecules, its decomposition is initially fast and produces hydroxyl 
radicals as secondary strong oxidant that nonselectively oxidizes nearly all organic compounds 
[18-20]. 
Undoubtedly, identification of TPs is a great challenge in environmental analysis. One of the 
reasons is the lack of analytical reference standards for most potential TPs. Furthermore, it is still 
obviously unknown to which extent results of laboratory degradation studies are representative of 
actual environmental conditions [21]. 
To overcome the limitations of unit resolution mass spectrometers, the recent emergence of 
modern high resolution mass spectrometry (HRMS) has opened new windows of opportunity for 
the analysis of a wide range of knowns and unknowns in complex samples including parent 
compounds, metabolites and TPs [22, 23]. Several recent publications demonstrated differences 
between low-resolution (LR) MS and HR capabilities and testified the growing importance of 
HRMS [24, 25]. 
Quadrupole-time-of-flight (Q-TOF) is among the mostly used analyzers which has shown to 
enable fast, sensitive, and reliable detection and identification of low molecular weight substances, 
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even in the absence of reference standards [26-29]. It allows recording full-scan chromatograms 
with high mass accuracy and resolution that make it possible to selectively search for given TPs 
based on their exact masses [30]. Three major approaches for post-measurement processing were 
detailed by Krauss et al. [22]; target analysis (with reference standards), suspect screening (with 
suspected compounds based on prior information but without reference standards), and finally 
non-target screening (neither prior information nor reference standards are available). 
Particularly suspect screening methods based on LC-HRMS have gained popularity [31]. Its main 
aim is detecting as many compounds as possible present in the samples. Subsequently, 
chromatograms can be searched for peaks with specific masses (calculated from the molecular 
formulas) to identify suspected targets from a list of compounds compiled beforehand. Thus, 
although exact mass screening methods are computationally rapid and many masses can be 
screened in a given sample, the gathering of evidence and confirmation of the screened masses 
remains very time-consuming. The application of suspect screening suffers from the large efforts 
of manual data evaluation. Consequently, systematic strategies with automated approaches are 
required to ﬁlter the search and facilitate “relevant” peaks identification. 
The objective of this study was to use an automated suspect screening approach based on solid 
phase extraction and LC-HRMS to detect potential organic contaminants and their ozonated TPs 
in actual environmental water samples. A list containing the accurate mass of each compound was 
thereby the only information required a priori. Our work focused also on giving an overview for 
examination of the suspects’ behavior (i.e. degradation and/or formation) in the studied WWTP 
after applying different advanced treatment processes.  
 
3.3 Experimental 
3.3.1 Chemicals 
Methanol, acetonitrile, and water were supplied by Fischer Scientific GmbH (Nidderau, Germany) 
and were either of HPLC grade or LC-MS grade. Acetone (analytical grade), ammonium 
hydroxide (30%), ethanol (absolute), ethyl acetate (analytical grade) and formic acid (98-100%) 
were purchased from Merck (Darmstadt, Germany). 
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3.3.2 Sample collection and pretreatment 
A sampling campaign was conducted in February, 2015 to grab four water samples. 
Municipal 24 h composite wastewater samples were collected from urban WWTP in Duisburg-
Vierlinden, Germany. Three samples were taken at diﬀerent stages of treatment: wastewater before 
ozonation, wastewater after ozonation and wastewater final effluent after biological treatment. 
This WWTP is designed for 30000 equivalent inhabitants and to treat up to 60000 m3/day of 
wastewater.  
Surface water samples were collected from the Ruhr river at Essen-Werden, Germany. Wastewater 
of nearly two million inhabitants is discharged into the Ruhr river that on the other hand is also 
used as raw water source to supply drinking water via bank filtration. 
All samples were collected in pre-cleaned amber glass bottles, transported immediately to the lab 
and stored in the dark at 4 oC until analysis in order to minimize degradation. Particulate matter 
was ﬁltered just before extraction through a glass microfiber filter (GF/F, 0.7 μm average pore 
size, 47 mm diameter, Merck, Darmstadt, Germany). Filtered samples were left without pH 
adjustment. 
 
3.3.3 Sample extraction 
Oasis MAX (200 mg, 6 mL) and Oasis MCX (200 mg, 6 mL) cartridges from Waters (Eschborn, 
Germany) were first conditioned and equilibrated with 2 x 3 mL methanol and 2 x 3 mL Milli-Q 
water respectively. Then, the two cartridges were connected together in tandem in which Oasis 
MAX was the cartridge connected directly to the sample reservoir while Oasis MCX was the 
subsequent one. 1 L water samples (including Milli-Q water as a blank) were passed through the 
cartridges by vacuum suction (maximum of 65 kPa) via large volume adapters at a flow rate of ~ 
15 mL/min. After the extraction, the cartridges were disconnected, dried under vacuum for 30 
minutes, wrapped in aluminum foil, and stored at -20 oC until washing and elution steps which 
were done within 24 h. The Oasis MAX cartridge was washed with 2 mL water-ammonia solution 
(95:5, v/v) and then eluted with 6 mL methanol-ethyl acetate-formic acid (69:29:2, v/v). Oasis 
MCX cartridge was washed and eluted with 2 mL water-formic acid (98:2, v/v) and 6 mL 
methanol-ethyl acetate-ammonia solution (67.5:27.5:5, v/v), respectively. Afterwards, the 
gathered eluates from both cartridges were mixed in a tube and reduced in volume under vacuum. 
The remaining solvent was changed to water and the final volume was set to 1 mL before transfer 
to HPLC vial (exact volume was determined by weighting the vials)
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3.3.4 Liquid chromatography-quadrupole-time-of-flight-mass spectrometry 
Liquid chromatography-electrospray ionization-quadrupole-time-of-flight-mass spectrometry 
(LC–ESI-Q-TOF-MS) operated in positive and negative ionization mode was used for analysis. 
The chromatographic separation was performed using a HPLC system (consisting of vacuum 
degasser, autosampler, and binary pump) (Agilent 1290 Infinity Series, Agilent Technologies) 
equipped with ProntoSIL C18 analytical column of 250 mm × 4.0 mm and 5.0 μm particle size 
(Bischoff, Leonberg, Germany). Gradient LC elution was performed with 0.1% formic acid in 
water as mobile phase A and 0.1% formic acid in acetonitrile as mobile phase B. For the analysis 
in both positive and negative mode, the optimized chromatographic method held the initial mobile 
phase composition (90% A) constant for 10 min, followed by a decrease in composition A to 
27.5% within 25 min, then to 0% in 10 min, kept there for 10 min, and finally up to 90% in 2 min. 
A 10-min post-run time back to the initial mobile phase composition was used after each analysis. 
The flow rate and injection volume were set in both modes to 0.5 mL min-1 and 20 μL, 
respectively.  
The HPLC system was connected to an Agilent 6560 Series Ion Mobility Q-TOF-MS (Agilent 
Technologies, Waldbronn, Germany). The instrument was operated in the 4 GHz HR mode. Ions 
are generated using an electrospray ion source with Agilent Jet Stream Technology. Full-scan 
HRMS data were recorded within a mass-to-charge (m/z) range of 45-1700 for each sample. 
Parameters for the Agilent Jet Stream Technology are the super-heated nitrogen sheath gas 
temperature (325 °C) and flow rate (12 L/min). Electrospray conditions were the following: 
capillary, 5000 V; nebulizer, 20 psi; drying gas, 5 L/min; gas temperature, 200 °C; skimmer 1 
voltage, -30 V; octapoleRFPeak, 750 V; fragmentor (in-source CID fragmentation), 275 V. The 
mass axis was calibrated using the mixtures provided by the manufacturer over specific m/z values. 
A sprayer with a reference solution was used as continuous calibration in ESI+ mode using the 
following reference masses: 121.050873 and 922.009798 m/z. With ESI- mode, reference masses 
were 119.036320 and 966.000725 m/z. For this work, the Ion Mobility Q-TOF-MS instrument was 
used as a Q-TOF system working in the MS mode for detection and identification of suspect 
compounds. The full-scan data recorder was processed with Agilent MassHunter Workstation 
Software (version B.06.00).
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3.3.5 Optimization of the suspect screening 
The theoretical monoisotopic exact mass, which was the only information a priori, was calculated 
for each compound based on the molecular formula using the Isotope Distribution Calculator tool 
of the Agilent software. The gathered data including compound name and exact mass were put in 
an Excel spreadsheet and saved into csv format. The created csv Excel file was employed as a 
database to be searched by the instrument software of the LC-Q-TOF-MS system.  
As ESI generally produces molecular ions [M+H]+ or [M−H]− [32], suspect screening was 
performed using these masses. Other adducts (e.g., Na+, K+, NH4
+, HCO2
−, and H3C2O2
−) were not 
included for simplicity. Due to the difficulty of predicting ionization behavior, all suspected 
substances were screened in positive and negative ionization mode in order to avoid missing 
compounds at the beginning of the workflow. Owing to the complexity of water samples, some 
filters were applied to reduce the total number of compounds extracted. Search criteria included 
an accurate mass tolerance of 5 ppm and an absolute abundance higher or equal to the height of 
1000 counts. Peaks from a blank sample were also subtracted for each detected compound. 
Taking into account the accurate mass, the software provides a score value, which is used to 
evaluate database search results. The score is reported on a scale of 0 to 100. When a formula is 
available as a database entry or target compound, a combined score is calculated which is based 
on mass, isotope abundance and isotope spacing. The overall score for a formula is calculated as 
a weighted average of individual probabilities. The automatic filter criteria for the compound 
quality score was set to be ≥ 80% 
 
3.4 Results and discussion 
A suspect list of parent compounds and tentative TPs produced during ozonation in laboratory 
experiments was compiled from literature and is summarized in Table 5.11. 
The automated screening method of the database is called a molecular-feature extraction algorithm 
software (Qualitative Mass Hunter). This software examines the whole chromatogram at once in 
order to search and group all ions which represent real compounds. The search software then 
compares the ions found with the specified adducts in the compound database and then creates a 
compound list for peaks which might represent real molecules. 
Fig. 3.1 shows an example of a total ion chromatogram of a wastewater sample after ozonation 
with an excerpt of the database result using the automatic screening method. 
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In order to isolate and enrich the analytes from water samples, a solid phase extraction method 
was previously developed using different compound classes and their ozonated TPs as target 
analytes.  
The concept of conﬁrmation by accurate mass has been addressed by many researchers in the field 
of water analysis (e.g. [33-35]).   
The reliability of the screening method depends on the ruggedness of the TOF instrument to 
provide consistently accurate mass measurements within a ﬁxed mass error tolerance. Typically, 
the measurement of accurate masses within 5 ppm is widely accepted for the veriﬁcation of the 
elemental composition [36]. The Q-TOF system used in this work has demonstrated mass accuracy 
values of < 4 ppm in all cases, regardless of the matrix or the concentration level (see Table 5.12). 
Based on the high mass accuracy unknown compounds can be assigned with a sum formula and it 
is often possible to differentiate between compounds with the same nominal mass but different 
elemental composition which will have different exact masses. With low-resolution mass 
spectrometry it is not possible to distinguish isobaric species. For example, ATL-TP2 and KPR-
TP4 have the same nominal masses of 224.26 and 224.25, respectively, but differ in their sum 
formula and the instrument was able to discriminate between them according to their exact mass.  
+ TIC 
Scan 
Figure 3.1:     Total ion chromatogram and a short list database obtained by LC-Q-TOF-MS screening of a wastewater 
                       sample after ozonation 
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In addition to the use of accurate mass, database searching with isotope pattern recognition will 
enhance the performance of the method and provide extra information to the findings based on the 
isotopic signals. This is particularly useful for confirmatory purposes on those compounds 
containing chlorine, bromine, sulfur, etc. The application of this filter allowed a reduction in the 
number of proposed elemental compositions that would fit for a certain mass window. 
Consequently, isotopic score values ≥ 80% were obtained for all suspects.  
 
The score value is calculated by the software considering not only the accurate mass but also the 
isotopic distribution. As an example to illustrate the usefulness of this parameter to match the 
findings, the mass, isotope abundance and isotope spacing for diclofenac TP (DFC-TP1), which 
has a formula of C14H11Cl2NO3, are shown in Fig. 3.2. Anyway, the score value in this case was 
100. 
Note that the accurate mass defect when going from the X peak to the X + 2 and the X + 4 peak 
was 1.997 mass unit, which is a result of the presence of the 37Cl isotope, and is accounted for by 
the difference in mass between 35Cl and 37Cl. Also note that the abundances of the X + 2 and X + 4 
isotopic patterns match a compound containing two Cl atoms. In addition, the X + 1 isotope shows 
a positive mass defect of 1.0033 mass unit for 13C. 
 
Examining data in Table 5.13, which show the peak areas for compounds in different water 
matrices, it was noted that all 34 parent compounds were detected in all four samples except 
imazalil, which was not presented in both wastewater effluent and surface water samples. 
Acyclovir was detected in wastewater samples but not found in surface water. The number of 
integrated TPs peaks was 155 compared to a total TPs number of 211. Roughly, 100% of the 
detected TPs were present in wastewater after ozonation, while 9%, 52% and 34% were 
determined in wastewater before ozonation, wastewater final effluent and surface water, 
respectively.  
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The suspect compounds were present in environmental water samples at variable concentration 
values deduced from the largely varying peak areas. Relative peak area (RPA) was calculated for 
each compound. Fig. 3.3 summarizes the statistical data of the presumed compounds in box-
whisker plots. For parent compounds, the highest peak areas were recorded for compounds in 
wastewater before ozonation, so other values were calculated relative to it. An obvious decrease 
in RPAs was observed for all compounds after ozonation and further biological post-treatment. 
The results indicate that these compounds have been discharged into WWTP at high 
concentrations and degraded partially or completely after advanced treatment and then released 
into surface water but at low levels. 
Regarding TPs, highest PAs were obtained for compounds in wastewater after ozonation and 
represented a basis for comparison where RPAs were calculated in other water samples. Almost 
zero RPAs were estimated for the suspects in wastewater before ozonation while decreasing in the 
values after adding bio-filters (final effluent) was perceived. Due to the elevated concentrations of 
the TPs in wastewater after ozonation, most of chemical formulas might belong to compounds 
formed after applying ozonation as a treatment process. However, some of these compounds were 
also detected in surface water as a result of formation and emission via WWTP. 
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Figure 3.2:     Example for the detected substance (diclofenac transformation product DFC-TP1) in the suspect  
screening showing a chromatogram peak and measured spectra 
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Figure 3.3:     Example for the detected substance (diclofenac transformation product DFC-TP1) in the suspect 
screening showing a chromatogram peak and measured spectra 
        WW before O3: wastewater before ozonation; WW after O3: wastewater after ozonation 
 
To use a retention time (RT) of the analyte as an additional criterion to explain our findings, 
relative retention times (RRT) of the TPs need to be evaluated. They are calculated by dividing 
the RT of each TP to the RT of its parent compound and then compare the results with the values 
obtained from previous studies in case of availability as listed in Table 5.11. Since C18 is the 
HPLC stationary phase used in all cases, we can expect a similar retention behavior for TPs relative 
to their parent compounds. Fig. 3.4 shows a plot of RRTs obtained from our work and previous 
studies. As can be seen, RRTs matched very well. As an example, bisphenol A (BPA) TPs 1-3 
were released before BPA (RRT <1) as in literature and in the same order where BPA-TP1 eluted 
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first, then BPA-TP2 and finally BPA-TP3. Another example is Roxithromycin (ROX) where 
RRTs were <1 for ROX-TP1 and ROX-TP2 while RRTs >1 were obtained for ROX-TP3, 4, 5 in 
the same elution order for all. Remaining deviations can be explained due to the use of kind and 
percentage of organic modifiers chosen in each study.  
 
 
Figure 3.4:     Relative retention time (RRT) comparison for TPs between experimental results and literature values. 
                       Solid line represents the 1:1 fit, N: number of data points, RMSE: root mean squared error 
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3.5 Conclusions 
A combination of nonselective extraction together with selective and sensitive detection by HRMS 
allowed the establishment of a suspect screening approach without reference standards, covering 
emerging contaminants and their tentative TPs in surface water and wastewater samples taken 
after different treatment processes. The Q-TOF molecular-feature extraction algorithm to screen 
for compounds using only exact mass as a priori information was proven to be fast and effective 
when accompanied by automatic filters such as mass tolerance, peak intensity, and isotope pattern 
recognition. Mass accuracy < 5 ppm and isotopic score ≥ 80% were obtained for all detected 
suspects regardless of the complexity of water samples. A decrease in peak areas, which 
corresponds to decrease in concentrations, were observed for all parent compounds in wastewater 
after ozonation, followed by wastewater final effluent, and then surface water. This is an indication 
that the studied WWTP is working well to degrade these compounds.  
In contrast, the detected TPs were found to be at higher relative concentration levels in wastewater 
after ozonation, however, a decrease or disappearance was observed in wastewater final effluent 
and surface water. Almost no peaks were found in wastewater before ozonation. This demonstrates 
the formation of these compounds during treatment with ozone as well as subsequent reduction of 
their concentration in biologically active systems. Furthermore, the results also showed a plausible 
matching between RRTs in our study and values obtained from literatures. 
Commonly, laboratory studies offer the advantage of proposing TPs under well-defined conditions 
with appropriate control that facilitates the establishment of differences in the samples that contain 
the compounds. However, the identification of these compounds in the environment is still rare. 
Therefore, the sample preparation and analytical approach introduced in this study in addition to 
the collected suspect list will be very useful to further study and confirm our results using MS/MS 
and/or other methodologies.
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4 General conclusions and outlook 
The results obtained in this thesis clearly demonstrate that transformation products (TPs) produced 
after ozonation are of potential environmental concern. A proper sample preparation method that 
would allow isolation of such compounds and others from aquatic environments is missing. Solid 
phase extraction (SPE) has been widely used in many applications and proven to be an effective 
technique especially in environmental water area. Development of a SPE method is a challenging 
task due to the fact that organic substances vary in their characteristics and therefore several 
parameters like the selection of sorbent, adjustment the sample pH, selection of organic solvents 
for washing and elution steps, and others are needed to be well optimized. The method will not 
only enhance the analytical analysis but also will help the biologists to examine the potential 
toxicological effects that might harm the environmental systems; since they mostly use random 
SPE sorbents for the enrichment of water samples without testing their selectivity in advance.  
 
During the development of a SPE method, it was noticed that leaving water samples without pH 
adjustment was the simplest and more appropriate option since no significant effect was observed. 
Also, the tested materials from both Phenomenex and Waters manufacturers gave comparable 
results. The final developed procedure allowed the enrichment of hydrophilic-lipophilic-anionic-
cationic compounds. The improved SPE procedure was successfully transferred to real water 
samples (tap water, surface water and several wastewaters), and recoveries between 90 and 110% 
were obtained. This is the first time in research area to describe the use of strong anion and cation 
exchange sorbents in tandem in order to extract a wide variety of organic compounds from 
different water bodies at high recovery rates. Studying the effect of other factors on recovery like 
water sample volume, sample loading flow rate, and cartridges storage time (after enrichment and 
before elution), will be significant for future investigations. 
Robust and sensitive analytical method for the analysis of micropollutants and TPs was developed. 
This allowed, for the first time, the detection of target TPs in the aquatic environment. However, 
no significant unwanted effects were observed when utilizing mass spectrometry (MS) as a 
detection technique even in the presence of complex matrices. This was due to the high efficiency 
of SPE procedure to reduce or eliminate the concentration of interfering substances which 
influence the ionization yields. It is therefore, recommended to those developing methods for trace 
enrichment of organic micropollutants in complex matrices that selective sample clean-up will be 
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sufficient in order to achieve the desired levels of sensitivity with no effects on analyte recovery. 
Adding a surrogate standard to samples prior to extraction would be useful in the future for 
quantification purposes. A notable conclusion from the research undertaken in this study is that a 
general and reliable SPE protocol was presented for both enrichment and clean-up purposes, 
therefore it is recommended to be used in the field of environmental water analysis. 
It is shown that all parent compounds were detected in wastewater samples after each treatment 
step in two sampling campaigns. A decrease in their concentrations was observed after ozonation 
and further biological post-treatment. The results obtained highlight that the degradation of parent 
compounds in advanced wastewater treatment via ozonation is in general not leading to a complete 
mineralization but rather results in the formation of more polar TPs, and biological treatment 
process in a final polishing step was capable to degrade them partially or completely. Furthermore, 
the presence of all parent compounds and some TPs in the Ruhr river is attributed to their 
incomplete removal in WWTP even after biological treatment.  
 
Studying the occurrence of TPs in environmental water matrices is highly challenging. Many 
laboratory studies focused on the ozonation of organic compounds and proposing molecular 
structures for the newly formed TPs but only few of them tracked these compounds in real water 
samples. The main reason was the lack of reference standards. HRMS instruments, such as Q-
TOF-MS, opened up a new horizon to overcome the limitation of unavailable authentic standards 
by screening compounds depending only on their accurate masses. Therefore, molecular formulas 
and exact masses for a wide spectrum of organic micropollutants and their ozonated TPs were 
compiled and search criteria defined in order to reduce the number of hits. The results showed that 
all parent compounds were at higher concentrations in wastewater before ozonation, followed by 
a decrease after ozonation and after biological treatment. Also, TPs were found at high levels in 
wastewater after ozonation, which means these compounds were formed as a result of using ozone. 
Some of the suspects were also detected in surface water but at lower concentrations than in 
wastewater samples. Furthermore, a good matching was observed between the obtained values of 
relative retention times and the reported ones from previous studies. This is crucial to assess 
whether TPs can be more or less polar than parent compounds as well as among themselves.  
The results of suspect screening gave a general picture to the possible formation of TPs in WWTP 
and the discharge to receiving waters. Therefore, this subject must be studied widely because these 
compounds might complicate the situation when they are of more concern than parent compounds 
even if they present at low concentration levels. A future challenge would be to test the efficiency 
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of different treatment processes for their ability to remove such compounds in order to be 
implemented after ozonation in addition to biological treatment.  
 
The inclusion of more micropollutants into analysis list using the developed SPE method should 
be addressed in the future. The behavior of these compounds during wastewater treatment 
processes requires investigation starting from influent to the final effluent using high frequency 
flow dependent sampling. This should also be expanded by studying several WWTPs and other 
environmental matrices like surface and ground waters. As this research focused on ozonated TPs, 
it will be necessary to study their presence in different WWTPs running ozonation by grabbing 
more samples and making comparisons during the same and different years. Another important 
thing is to expand the research by including another abiotic and biotic TPs and tracking them 
during wastewater treatment as well as in receiving waters by means of target or suspect screening 
depending on the availability of relevant standards. A future challenge would be to check the 
toxicological effects of compounds in the extracts, obtained after applying the developed SPE 
method in different environmental waters, using different bioassays especially in the presence of 
TPs where little information have been reported. This is of paramount importance to determine 
whether there is any danger to human health or unacceptable damage to the natural environment. 
From designed mixture toxicity studies, it is noticed that even if single chemicals are present below 
concentrations that cause a visible effect, they may contribute to the mixture effect [1, 2]. Chemical 
analysis of a limited suite of compounds does not allow assessment of the potential biological 
adverse effects of water sample as the cumulative effect of the mixture of chemicals that may be 
present cannot be easily integrated [3-5]. Bioassays have been utilized as complementary 
monitoring tools for the assessment of possible biological effects of chemicals that are present in 
a particular water sample [6, 7]. These bioanalytical tools are designed to quantify non-specific 
toxicity or particular toxic modes of action (e.g. estrogenicity, genotoxicity, phytotoxicity) 
induced by a sample on a biological organism or a biological process [3]. Moreover, studying the 
possibility of packing the two SPE sorbents in one cartridge and transferring the procedure to a 
fully automated SPE-LC-MS/MS system would save additional work and time. Further 
development on analytical methods seems to be necessary, using more sensitive UPLC-MS/MS 
systems to analyze the compounds of interest at less time and lower detection limits. 
Multidimensional LC separation is also an option to be considered especially in suspect and non-
target screening of substances due to its advantage to provide sufficient resolving power for the 
separation of components in complex matrices [8-11]. In addition to LC, it is also necessary to 
take GC into consideration by developing a method for analysis of volatile compounds present in 
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the extracts. Another field for future research is to quantify and compare the matrix effects from 
large volume injection method and the improved SPE procedure for the analysis of contaminants 
in different water matrices using ESI and other ion sources. A further confirmation to the suspect 
screening findings is necessary by using MSn fragmentation and/or NMR as a tool for unequivocal 
identification. The main drawback of NMR is the poor sensitivity compared to MS [12, 13], so it 
is more efficient to use SPE and NMR linked to MS [14].
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     Table 5.1:     Structures of compounds with pKa values 
Compound Chemical structure Compound Chemical structure 
1H-Benzotriazole      
 
c,c-Muconic acid 
 
Bisphenol A 
 
t,t-Muconic acid 
 
Catechol 
 
Carbamazepine 
 
p-Benzoquinone 
 
Anthranilic acid 
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     Table 5.1:     Structures of compounds with pKa values (continued) 
Compound Chemical structure Compound Chemical structure 
Glyoxylic acid 
 
2,6-Dichloroaniline 
 
Oxamic acid 
 
Metoprolol 
 
Ciprofloxacin 
 
Paracetamol 
 
Diclofenac 
 
Oxalic acid 
 
  
Supplementary 
83 
     Table 5.1:     Structures of compounds with pKa values (continued) 
Compound Chemical structure Compound Chemical structure 
Oxaloacetic acid 
 
1,2,4-Benzenetriol 
 
Malic acid 
 
Hydroquinone 
 
Malonic acid 
 
Sulfamethoxazole 
 
Maleic acid 
 
p-Nitrophenol 
 
Succinic acid 
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Table 5.2:     Recoveries (%) and RSD (n=3) for different SPE materials obtained by eluting of compounds with ethyl acetate 
Compound 
Oasis    
HLB (1) 
Oasis   
MAX (2) 
Oasis   
MCX (3) 
Oasis   
WAX (3) 
Oasis   
WCX (2) 
Strata-        
X (1) 
Strata-      
X-A (2) 
Strata-      
X-C (3) 
Strata-      
X-AW (3) 
Strata-      
X-CW (2) 
1H-Benzotriazole 60 ± 4 54 ± 3 48 ± 5 43 ± 2 40 ± 1 55 ± 2 50 ± 3 46 ± 4 40 ± 3 37 ± 4 
Bisphenol A 62 ± 1 57 ± 5 51 ± 2 40 ± 4 36 ± 3 64 ± 5 59 ± 1 50 ± 5 42 ± 1 39 ± 3 
Catechol 56 ± 3 50 ± 2 45 ± 4 37 ± 1 32 ± 5 60 ± 1 55 ± 5 41 ± 2 39 ± 4 36 ± 1 
p-Benzoquinone 59 ± 4 54 ± 1 50 ± 2 46 ± 3 44 ± 4 56 ± 4 50 ± 2 47 ± 4 42 ± 2 40 ± 5 
c,c-Muconic acid 53 ± 3 65 ± 3 51 ± 5 40 ± 4 31 ± 2 51 ± 2 61 ± 3 50 ± 2 41 ± 5 35 ± 4 
t,t-Muconic acid 51 ± 2 62 ± 4 47 ± 3 43 ± 3 38 ± 1 50 ± 3 65 ± 5 52 ± 2 46 ± 1 31 ± 3 
Carbamazepine 60 ± 5 55 ± 2 52 ± 4 38 ± 1 35 ± 5 56 ± 1 52 ± 1 48 ± 5 33 ± 3 30 ± 2 
Anthranilic acid 55 ± 1 60 ± 3 45 ± 2 40 ± 3 37 ± 4 54 ± 4 64 ± 4 50 ± 3 44 ± 2 38 ± 4 
Glyoxylic acid 50 ± 3 63 ± 1 48 ± 3 43 ± 5 40 ± 1 46 ± 2 58 ± 2 42 ± 1 37 ± 3 33 ± 5 
Oxamic acid 52 ± 2 61 ± 3 50 ± 2 41 ± 4 38 ± 2 55 ± 5 60 ± 1 48 ± 5 38 ± 2 32 ± 1 
Ciprofloxacin 64 ± 3 68 ± 2 60 ± 4 45 ± 1 41 ± 2 60 ± 4 66 ± 5 57 ± 2 42 ± 4 30 ± 3 
Diclofenac 60 ± 5 65 ± 4 57 ± 2 42 ± 3 39 ± 5 52 ± 1 69 ± 2 61 ± 4 46 ± 1 41 ± 4 
2,6-Dichloroaniline 58 ± 1 52 ± 3 46 ± 3 37 ± 5 33 ± 2 54 ± 3 48 ± 4 42 ± 2 32 ± 3 30 ± 5 
Metoprolol 54 ± 3 59 ± 5 58 ± 1 35 ± 4 36 ± 3 50 ± 2 54 ± 2 60 ± 3 38 ± 2 36 ± 2 
Paracetamol 61 ± 4 55 ± 1 52 ± 2 45 ± 3 40 ± 5 64 ± 2 58 ± 3 55 ± 5 41 ± 4 39 ± 3 
Oxalic acid 47 ± 2 61 ± 4 43 ± 5 40 ± 1 36 ± 2 49 ± 4 65 ± 1 47 ± 2 44 ± 5 40 ± 1 
Oxaloacetic acid 52 ± 5 57 ± 2 47 ± 3 44 ± 2 34 ± 4 48 ± 1 54 ± 5 42 ± 1 40 ± 3 36 ± 3 
Malic acid 45 ± 3 55 ± 4 42 ± 2 36 ± 5 33 ± 3 42 ± 5 51 ± 3 38 ± 4 35 ± 2 30 ± 5 
Malonic acid 51 ± 1 62 ± 3 46 ± 2 42 ± 4 37 ± 1 55 ± 2 62 ± 1 50 ± 5 46 ± 1 41 ± 3 
Maleic acid 54 ± 3 66 ± 1 50 ± 3 45 ± 2 38 ± 5 50 ± 4 61 ± 2 47 ± 1 40 ± 4 34 ± 2 
Succinic acid 62 ± 2 65 ± 3 57 ± 1 40 ± 4 36 ± 2 60 ± 1 68 ± 4 54 ± 3 47 ± 2 40 ± 4 
1,2,4-Benzenetriol 58 ± 5 52 ± 2 44 ± 4 38 ± 1 34 ± 3 54 ± 3 50 ± 2 40 ± 2 38 ± 1 31 ± 5 
Hydroquinone 60 ± 3 54 ± 5 51 ± 2 35 ± 3 31 ± 1 64 ± 2 56 ± 3 54 ± 5 36 ± 4 33 ± 2 
Sulfamethoxazole 53 ± 4 61 ± 2 49 ± 4 42 ± 5 36 ± 3 57 ± 5 65 ± 3 53 ± 1 40 ± 2 36 ± 1 
p-Nitrophenol 61 ± 2 64 ± 3 57 ± 1 38 ± 3 40 ± 5 58 ± 4 61 ± 2 53 ± 3 35 ± 2 31 ± 4 
 (1) 100% ethyl acetate; (2) ethyl acetate-formic acid (98:2, v/v); (3) ethyl acetate-ammonia solution (95:5, v/v) 
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Table 5.3:     Recoveries (%) and RSD (n=3) for different SPE materials obtained by eluting of compounds with methanol 
Compound 
Oasis      
HLB (1) 
Oasis    
MAX (2) 
Oasis    
MCX (3) 
Oasis    
WAX (3) 
Oasis    
WCX (2) 
Strata-        
X (1) 
Strata-      
X-A (2) 
Strata-      
X-C (3) 
Strata-      
X-AW (3) 
Strata-      
X-CW (2) 
1H-Benzotriazole 65 ± 3 68 ± 1 65 ± 2 51 ± 1 47 ± 5 67 ± 1 66 ± 4 62 ± 3 51 ± 5 45 ± 2 
Bisphenol A 66 ± 2 69 ± 5 62 ± 1 53 ± 4 40 ± 3 70 ± 4 67 ± 2 66 ± 5 50 ± 2 42 ± 1 
Catechol 62 ± 3 66 ± 2 63 ± 4 51 ± 2 50 ± 1 66 ± 2 62 ± 1 60 ± 2 47 ± 4 45 ± 3 
p-Benzoquinone 66 ± 2 70 ± 4 65 ± 1 50 ± 3 46 ± 5 71 ± 3 70 ± 3 66 ± 4 53 ± 1 48 ± 2 
c,c-Muconic acid 60 ± 5 71 ± 3 62 ± 5 45 ± 1 37 ± 4 57 ± 4 67 ± 5 58 ± 2 47 ± 3 40 ± 5 
t,t-Muconic acid 55 ± 2 72 ± 5 60 ± 1 50 ± 4 40 ± 5 55 ± 2 72 ± 3 55 ± 3 52 ± 1 37 ± 3 
Carbamazepine 67 ± 1 64 ± 3 61 ± 2 42 ± 3 38 ± 2 69 ± 5 68 ± 2 63 ± 1 39 ± 4 35 ± 1 
Anthranilic acid 63 ± 3 72 ± 4 58 ± 3 47 ± 5 40 ± 4 60 ± 2 67 ± 5 53 ± 2 50 ± 2 42 ± 3 
Glyoxylic acid 54 ± 5 76 ± 2 56 ± 3 45 ± 4 41 ± 1 55 ± 3 70 ± 1 60 ± 5 42 ± 3 38 ± 5 
Oxamic acid 61 ± 2 70 ± 1 60 ± 4 46 ± 2 43 ± 2 57 ± 5 66 ± 2 52 ± 3 41 ± 5 37 ± 4 
Ciprofloxacin 68 ± 1 74 ± 4 71 ± 2 50 ± 1 43 ± 3 65 ± 4 70 ± 2 63 ± 1 45 ± 3 38 ± 2 
Diclofenac 63 ± 5 68 ± 3 65 ± 5 49 ± 2 44 ± 4 58 ± 2 74 ± 4 69 ± 3 52 ± 4 45 ± 1 
2,6-Dichloroaniline 68 ± 4 65 ± 2 64 ± 3 46 ± 5 41 ± 2 70 ± 1 65 ± 3 60 ± 5 42 ± 1 38 ± 3 
Metoprolol 62 ± 3 67 ± 5 60 ± 4 46 ± 3 40 ± 1 61 ± 4 64 ± 1 72 ± 2 44 ± 2 41 ± 4 
Paracetamol 68 ± 5 64 ± 2 66 ± 1 47 ± 4 45 ± 2 71 ± 2 64 ± 3 60 ± 2 45 ± 5 42 ± 3 
Oxalic acid 56 ± 2 70 ± 5 54 ± 2 50 ± 1 47 ± 5 58 ± 3 72 ± 2 52 ± 5 48 ± 3 43 ± 1 
Oxaloacetic acid 60 ± 4 70 ± 3 63 ± 5 48 ± 4 43 ± 1 60 ± 2 68 ± 5 57 ± 4 44 ± 1 40 ± 5 
Malic acid 52 ± 3 69 ± 1 56 ± 2 51 ± 3 45 ± 2 61 ± 5 71 ± 2 61 ± 1 47 ± 2 43 ± 3 
Malonic acid 60 ± 2 72 ± 4 63 ± 1 45 ± 4 39 ± 5 57 ± 1 66 ± 3 56 ± 2 50 ± 1 43 ± 2 
Maleic acid 57 ± 4 71 ± 3 60 ± 4 51 ± 1 42 ± 3 58 ± 3 70 ± 2 61 ± 1 46 ± 5 41 ± 4 
Succinic acid 64 ± 1 68 ± 5 61 ± 3 47 ± 5 41 ± 2 62 ± 2 71 ± 4 60 ± 5 52 ± 2 44 ± 3 
1,2,4-Benzenetriol 67 ± 5 64 ± 1 62 ± 5 42 ± 3 38 ± 4 69 ± 4 69 ± 3 63 ± 3 46 ± 4 42 ± 1 
Hydroquinone 70 ± 1 63 ± 3 67 ± 4 44 ± 2 43 ± 5 70 ± 2 65 ± 4 60 ± 2 41 ± 3 38 ± 2 
Sulfamethoxazole 66 ± 3 71 ± 1 64 ± 2 52 ± 5 45 ± 3 66 ± 5 70 ± 2 67 ± 5 47 ± 1 42 ± 5 
p-Nitrophenol 64 ± 5 66 ± 4 67 ± 1 44 ± 2 43 ± 2 64 ± 3 67 ± 1 61 ± 4 40 ± 3 38 ± 4 
(1) 100% methanol; (2) methanol-formic acid (98:2, v/v); (3) methanol-ammonia solution (95:5, v/v) 
  
Supplementary 
86 
        Table 5.4:     Recoveries (%) and RSD (n=3) for different SPE materials at adjusted pH value (pH=2) 
Compound 
Oasis   
HLB 
Oasis  
MAX 
Oasis  
MCX 
Oasis 
WAX 
Oasis  
WCX 
Strata-     
X 
Strata-    
X-A 
Strata-    
X-C 
Strata-    
X-AW 
Strata-    
X-CW 
1H-Benzotriazole 74 ± 1 75 ± 3 71 ± 2 57 ± 2 51 ± 3 71 ± 2 73 ± 4 70 ± 1 55 ± 2 50 ± 3 
Bisphenol A 77 ± 2 74 ± 2 75 ± 1 50 ± 4 45 ± 2 75 ± 4 76 ± 1 72 ± 3 52 ± 1 48 ± 2 
Catechol 74 ± 1 73 ± 4 74 ± 3 49 ± 2 47 ± 3 78 ± 1 76 ± 3 71 ± 2 53 ± 3 45 ± 5 
p-Benzoquinone 75 ± 2 74 ± 3 73 ± 2 50 ± 5 44 ± 4 76 ± 3 75 ± 5 70 ± 4 56 ± 2 51 ± 3 
c,c-Muconic acid 72 ± 3 71 ± 1 68 ± 4 56 ± 2 49 ± 2 73 ± 2 74 ± 3 73 ± 1 54 ± 3 46 ± 1 
t,t-Muconic acid 74 ± 4 73 ± 3 70 ± 2 50 ± 2 43 ± 3 71 ± 1 72 ± 2 71 ± 3 47 ± 1 41 ± 2 
Carbamazepine 73 ± 2 70 ± 2 71 ± 2 54 ± 4 51 ± 2 77 ± 3 76 ± 4 70 ± 2 51 ± 4 46 ± 2 
Anthranilic acid 74 ± 3 73 ± 3 75 ± 1 53 ± 1 47 ± 4 75 ± 4 72 ± 1 75 ± 3 55 ± 3 50 ± 3 
Glyoxylic acid 73 ± 5 72 ± 3 64 ± 4 49 ± 2 46 ± 5 76 ± 3 70 ± 5 66 ± 4 54 ± 5 51 ± 4 
Oxamic acid 70 ± 3 70 ± 1 68 ± 4 53 ± 3 50 ± 2 68 ± 5 68 ± 2 70 ± 1 52 ± 3 47 ± 2 
Ciprofloxacin 73 ± 2 74 ± 2 82 ± 1 56 ± 2 51 ± 4 70 ± 3 70 ± 1 79 ± 2 53 ± 4 50 ± 1 
Diclofenac 78 ± 4 73 ± 4 77 ± 3 52 ± 3 47 ± 2 76 ± 1 71 ± 2 70 ± 4 55 ± 2 51 ± 4 
2,6-Dichloroaniline 72 ± 2 71 ± 2 80 ± 2 56 ± 5 51 ± 1 74 ± 2 70 ± 5 78 ± 3 52 ± 4 46 ± 3 
Metoprolol 65 ± 1 72 ± 3 83 ± 4 58 ± 4 50 ± 3 67 ± 4 67 ± 2 81 ± 1 56 ± 3 47 ± 4 
Paracetamol 77 ± 2 74 ± 4 72 ± 1 56 ± 2 52 ± 2 79 ± 2 76 ± 3 74 ± 2 50 ± 1 44 ± 2 
Oxalic acid 71 ± 4 76 ± 3 69 ± 2 50 ± 2 46 ± 4 68 ± 3 78 ± 4 70 ± 3 54 ± 2 50 ± 5 
Oxaloacetic acid 73 ± 3 78 ± 3 70 ± 2 52 ± 3 47 ± 5 70 ± 4 70 ± 2 68 ± 5 48 ± 4 44 ± 3 
Malic acid 72 ± 2 75 ± 1 68 ± 3 54 ± 1 50 ± 3 76 ± 3 76 ± 1 72 ± 2 51 ± 5 47 ± 4 
Malonic acid 74 ± 4 74 ± 2 73 ± 2 57 ± 5 48 ± 3 71 ± 5 72 ± 2 74 ± 4 54 ± 2 51 ± 5 
Maleic acid 76 ± 3 75 ± 4 74 ± 3 53 ± 3 44 ± 1 78 ± 2 77 ± 4 72 ± 3 50 ± 3 45 ± 2 
Succinic acid 77 ± 1 77 ± 2 76 ± 4 50 ± 1 46 ± 2 74 ± 3 75 ± 2 74 ± 3 52 ± 2 48 ± 4 
1,2,4-Benzenetriol 79 ± 2 76 ± 1 69 ± 4 52 ± 5 43 ± 2 81 ± 5 77 ± 3 72 ± 4 47 ± 1 42 ± 3 
Hydroquinone 76 ± 1 73 ± 3 72 ± 2 49 ± 4 47 ± 5 78 ± 4 74 ± 5 70 ± 3 51 ± 2 49 ± 4 
Sulfamethoxazole 78 ± 4 71 ± 2 79 ± 1 53 ± 3 49 ± 1 75 ± 2 73 ± 1 75 ± 2 55 ± 2 52 ± 1 
p-Nitrophenol 77 ± 3 75 ± 4 72 ± 2 56 ± 4 52 ± 3 74 ± 4 75 ± 3 70 ± 5 53 ± 1 50 ± 3 
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        Table 5.5:     Recoveries (%) and RSD (n=3) for different SPE materials at adjusted pH value (pH=5) 
Compound 
Oasis  
HLB 
Oasis 
MAX 
Oasis 
MCX 
Oasis 
WAX 
Oasis 
WCX 
Strata-     
X 
Strata-    
X-A 
Strata-    
X-C 
Strata-    
X-AW 
Strata-    
X-CW 
1H-Benzotriazole 72 ± 3 74 ± 2 77 ± 2 55 ± 4 50 ± 1 74 ± 1 72 ± 3 73 ± 1 52 ± 3 47 ± 2 
Bisphenol A 78 ± 1 75 ± 1 76 ± 4 53 ± 1 51 ± 4 73 ± 4 74 ± 2 75 ± 3 55 ± 4 48 ± 3 
Catechol 76 ± 4 72 ± 5 76 ± 2 58 ± 5 55 ± 2 74 ± 2 73 ± 4 74 ± 1 53 ± 3 50 ± 2 
p-Benzoquinone 74 ± 2 78 ± 3 71 ± 5 50 ± 2 47 ± 5 72 ± 3 80 ± 1 68 ± 5 56 ± 2 53 ± 3 
c,c-Muconic acid 70 ± 3 77 ± 2 70 ± 3 55 ± 1 53 ± 2 63 ± 2 78 ± 4 74 ± 2 51 ± 5 48 ± 1 
t,t-Muconic acid 68 ± 1 79 ± 3 72 ± 1 53 ± 4 46 ± 3 64 ± 4 75 ± 3 71 ± 1 56 ± 2 54 ± 3 
Carbamazepine 74 ± 2 73 ± 2 75 ± 3 52 ± 5 47 ± 4 75 ± 1 75 ± 4 72 ± 2 52 ± 3 45 ± 2 
Anthranilic acid 73 ± 3 79 ± 2 72 ± 4 56 ± 3 51 ± 2 79 ± 3 79 ± 1 68 ± 2 55 ± 1 50 ± 4 
Glyoxylic acid 63 ± 5 81 ± 3 70 ± 3 48 ± 2 45 ± 5 65 ± 5 77 ± 2 69 ± 3 52 ± 3 51 ± 2 
Oxamic acid 67 ± 2 77 ± 4 76 ± 5 55 ± 2 50 ± 4 64 ± 4 76 ± 3 73 ± 5 50 ± 5 47 ± 2 
Ciprofloxacin 75 ± 3 78 ± 2 83 ± 1 57 ± 3 50 ± 2 73 ± 1 78 ± 3 84 ± 2 47 ± 4 42 ± 1 
Diclofenac 72 ± 2 77 ± 1 74 ± 3 53 ± 4 49 ± 1 70 ± 2 80 ± 1 70 ± 4 51 ± 2 50 ± 4 
2,6-Dichloroaniline 76 ± 4 72 ± 3 70 ± 4 57 ± 1 51 ± 5 75 ± 4 71 ± 3 73 ± 5 57 ± 4 53 ± 3 
Metoprolol 66 ± 3 70 ± 1 81 ± 2 52 ± 3 45 ± 1 68 ± 3 68 ± 5 82 ± 2 54 ± 2 49 ± 5 
Paracetamol 75 ± 2 73 ± 3 73 ± 1 55 ± 4 52 ± 3 73 ± 4 73 ± 1 71 ± 3 51 ± 3 46 ± 4 
Oxalic acid 64 ± 5 79 ± 5 68 ± 2 51 ± 5 47 ± 4 64 ± 5 77 ± 2 66 ± 1 54 ± 2 48 ± 5 
Oxaloacetic acid 69 ± 3 77 ± 4 71 ± 2 58 ± 2 56 ± 5 66 ± 3 78 ± 5 73 ± 4 56 ± 5 52 ± 2 
Malic acid 63 ± 4 80 ± 2 70 ± 5 54 ± 4 49 ± 2 69 ± 4 81 ± 1 71 ± 2 50 ± 3 46 ± 4 
Malonic acid 67 ± 2 78 ± 3 71 ± 2 50 ± 3 47 ± 4 65 ± 1 75 ± 3 70 ± 4 52 ± 5 48 ± 2 
Maleic acid 66 ± 4 79 ± 3 76 ± 3 52 ± 1 45 ± 3 64 ± 2 80 ± 4 72 ± 1 48 ± 3 40 ± 4 
Succinic acid 72 ± 2 76 ± 1 73 ± 4 56 ± 3 50 ± 2 69 ± 5 74 ± 1 75 ± 3 55 ± 4 47 ± 3 
1,2,4-Benzenetriol 76 ± 4 73 ± 2 70 ± 4 54 ± 4 51 ± 5 73 ± 2 76 ± 3 73 ± 5 58 ± 5 53 ± 3 
Hydroquinone 79 ± 3 74 ± 5 74 ± 2 49 ± 5 47 ± 2 77 ± 3 75 ± 5 69 ± 4 53 ± 3 50 ± 5 
Sulfamethoxazole 75 ± 1 75 ± 2 69 ± 4 53 ± 3 49 ± 1 73 ± 2 77 ± 4 72 ± 3 54 ± 1 46 ± 3 
p-Nitrophenol 78 ± 4 73 ± 3 74 ± 3 55 ± 4 50 ± 3 75 ± 1 73 ± 3 72 ± 5 50 ± 3 45 ± 2 
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        Table 5.6:     Recoveries (%) and RSD (n=3) for different SPE materials at adjusted pH value (pH=7) 
Compound 
Oasis  
HLB 
Oasis 
MAX 
Oasis 
MCX 
Oasis 
WAX 
Oasis 
WCX 
Strata-     
X 
Strata-    
X-A 
Strata-    
X-C 
Strata-    
X-AW 
Strata-    
X-CW 
1H-Benzotriazole 76 ± 4 75 ± 3 72 ± 1 55 ± 1 53 ± 3 73 ± 2 73 ± 4 70 ± 3 52 ± 3 50 ± 2 
Bisphenol A 74 ± 3 74 ± 1 73 ± 3 52 ± 4 48 ± 2 77 ± 3 71 ± 1 73 ± 2 55 ± 1 51 ± 4 
Catechol 75 ± 5 71 ± 4 74 ± 4 51 ± 2 49 ± 1 75 ± 1 74 ± 3 70 ± 4 50 ± 5 46 ± 1 
p-Benzoquinone 72 ± 2 73 ± 5 70 ± 3 56 ± 4 53 ± 4 77 ± 3 75 ± 2 75 ± 5 52 ± 2 50 ± 3 
c,c-Muconic acid 68 ± 1 78 ± 3 71 ± 1 52 ± 3 50 ± 2 62 ± 2 79 ± 4 70 ± 1 52 ± 4 46 ± 1 
t,t-Muconic acid 63 ± 2 80 ± 4 70 ± 3 51 ± 4 48 ± 1 60 ± 4 80 ± 3 72 ± 4 48 ± 2 45 ± 5 
Carbamazepine 75 ± 3 74 ± 1 73 ± 2 48 ± 1 43 ± 3 77 ± 1 77 ± 4 71 ± 2 54 ± 1 47 ± 1 
Anthranilic acid 72 ± 2 80 ± 3 69 ± 2 45 ± 3 42 ± 3 78 ± 3 77 ± 2 66 ± 5 53 ± 2 44 ± 4 
Glyoxylic acid 60 ± 3 82 ± 4 67 ± 4 54 ± 2 50 ± 5 58 ± 3 79 ± 4 68 ± 3 51 ± 3 49 ± 3 
Oxamic acid 65 ± 2 78 ± 2 70 ± 5 56 ± 3 52 ± 2 68 ± 5 81 ± 2 71 ± 4 55 ± 2 51 ± 4 
Ciprofloxacin 73 ± 2 79 ± 3 80 ± 3 55 ± 2 50 ± 3 73 ± 3 80 ± 4 77 ± 2 57 ± 4 53 ± 2 
Diclofenac 69 ± 4 78 ± 1 76 ± 3 56 ± 1 53 ± 1 71 ± 2 79 ± 5 75 ± 3 59 ± 2 57 ± 3 
2,6-Dichloroaniline 74 ± 2 69 ± 1 71 ± 4 50 ± 3 44 ± 3 77 ± 5 72 ± 3 72 ± 1 57 ± 4 52 ± 2 
Metoprolol 66 ± 3 71 ± 2 80 ± 2 54 ± 3 46 ± 2 70 ± 1 72 ± 3 80 ± 2 58 ± 3 50 ± 4 
Paracetamol 78 ± 1 71 ± 4 70 ± 3 55 ± 2 50 ± 1 75 ± 2 71 ± 4 73 ± 3 53 ± 1 47 ± 4 
Oxalic acid 59 ± 3 78 ± 5 73 ± 5 53 ± 5 48 ± 4 63 ± 4 81 ± 2 70 ± 3 54 ± 5 50 ± 3 
Oxaloacetic acid 64 ± 4 79 ± 4 70 ± 2 52 ± 2 46 ± 5 62 ± 3 77 ± 5 68 ± 1 55 ± 4 52 ± 1 
Malic acid 61 ± 2 77 ± 2 71 ± 3 55 ± 3 49 ± 2 63 ± 5 80 ± 3 72 ± 2 50 ± 4 45 ± 5 
Malonic acid 66 ± 4 76 ± 3 72 ± 3 49 ± 5 44 ± 4 62 ± 3 77 ± 1 75 ± 4 53 ± 2 51 ± 1 
Maleic acid 67 ± 1 78 ± 1 74 ± 2 53 ± 2 50 ± 2 66 ± 2 79 ± 4 70 ± 5 47 ± 5 42 ± 4 
Succinic acid 70 ± 3 79 ± 2 75 ± 4 52 ± 4 48 ± 1 68 ± 4 76 ± 3 76 ± 1 54 ± 1 48 ± 5 
1,2,4-Benzenetriol 77 ± 5 75 ± 4 73 ± 2 54 ± 5 51 ± 4 76 ± 5 75 ± 2 72 ± 4 55 ± 2 54 ± 3 
Hydroquinone 75 ± 3 71 ± 2 77 ± 3 58 ± 3 55 ± 5 78 ± 3 77 ± 4 72 ± 3 53 ± 2 47 ± 3 
Sulfamethoxazole 71 ± 4 79 ± 1 71 ± 2 51 ± 2 46 ± 1 69 ± 2 79 ± 3 73 ± 4 55 ± 3 46 ± 1 
p-Nitrophenol 73 ± 3 76 ± 4 72 ± 1 55 ± 3 52 ± 4 73 ± 4 75 ± 2 71 ± 3 51 ± 1 50 ± 3 
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        Table 5.7:     Recoveries (%) and RSD (n=3) for different SPE materials at adjusted pH value (pH=9) 
Compound 
Oasis  
HLB 
Oasis 
MAX 
Oasis 
MCX 
Oasis 
WAX 
Oasis 
WCX 
Strata-     
X 
Strata-    
X-A 
Strata-    
X-C 
Strata-    
X-AW 
Strata-    
X-CW 
1H-Benzotriazole 73 ± 1 75 ± 4 73 ± 3 55 ± 4 49 ± 2 70 ± 4 75 ± 2 71 ± 3 56 ± 1 51 ± 4 
Bisphenol A 78 ± 2 77 ± 1 71 ± 4 53 ± 2 51 ± 1 75 ± 3 76 ± 1 72 ± 2 55 ± 3 52 ± 1 
Catechol 78 ± 1 76 ± 2 70 ± 2 50 ± 3 47 ± 3 80 ± 1 79 ± 3 68 ± 4 57 ± 2 51 ± 3 
p-Benzoquinone 71 ± 4 72 ± 3 73 ± 1 58 ± 1 51 ± 2 75 ± 2 72 ± 5 76 ± 1 55 ± 4 50 ± 4 
c,c-Muconic acid 66 ± 3 80 ± 5 72 ± 2 53 ± 2 46 ± 3 63 ± 5 81 ± 3 72 ± 2 47 ± 3 42 ± 4 
t,t-Muconic acid 64 ± 2 78 ± 3 68 ± 5 48 ± 1 43 ± 2 66 ± 2 80 ± 1 70 ± 3 56 ± 3 51 ± 4 
Carbamazepine 73 ± 2 72 ± 4 75 ± 3 54 ± 2 47 ± 1 75 ± 4 75 ± 3 73 ± 1 48 ± 2 43 ± 3 
Anthranilic acid 67 ± 3 83 ± 5 67 ± 1 50 ± 4 44 ± 2 79 ± 1 81 ± 2 65 ± 2 51 ± 2 48 ± 3 
Glyoxylic acid 63 ± 4 80 ± 2 69 ± 3 53 ± 3 49 ± 2 67 ± 3 77 ± 5 66 ± 4 50 ± 2 43 ± 5 
Oxamic acid 66 ± 2 76 ± 4 74 ± 3 50 ± 1 46 ± 3 63 ± 4 73 ± 2 71 ± 3 56 ± 2 50 ± 1 
Ciprofloxacin 70 ± 3 81 ± 2 78 ± 5 57 ± 5 53 ± 1 75 ± 1 82 ± 3 80 ± 2 52 ± 1 47 ± 3 
Diclofenac 67 ± 2 82 ± 4 74 ± 3 56 ± 2 52 ± 4 66 ± 2 78 ± 4 74 ± 3 54 ± 1 49 ± 2 
2,6-Dichloroaniline 76 ± 5 68 ± 3 73 ± 2 53 ± 4 49 ± 3 76 ± 2 70 ± 3 73 ± 1 50 ± 3 46 ± 1 
Metoprolol 72 ± 3 70 ± 1 76 ± 4 50 ± 2 49 ± 5 74 ± 3 70 ± 2 79 ± 3 56 ± 1 52 ± 3 
Paracetamol 75 ± 4 75 ± 2 73 ± 1 52 ± 3 45 ± 4 73 ± 2 77 ± 4 71 ± 1 57 ± 2 51 ± 1 
Oxalic acid 60 ± 2 79 ± 4 67 ± 2 54 ± 4 50 ± 1 61 ± 4 82 ± 1 70 ± 3 51 ± 3 45 ± 2 
Oxaloacetic acid 65 ± 4 76 ± 2 70 ± 5 59 ± 3 53 ± 2 60 ± 3 75 ± 5 71 ± 2 55 ± 1 50 ± 4 
Malic acid 68 ± 3 78 ± 5 69 ± 2 51 ± 5 47 ± 5 65 ± 5 79 ± 3 73 ± 2 53 ± 2 45 ± 2 
Malonic acid 63 ± 5 80 ± 2 70 ± 1 54 ± 2 46 ± 1 66 ± 3 80 ± 2 72 ± 5 56 ± 4 50 ± 3 
Maleic acid 66 ± 2 79 ± 4 74 ± 3 55 ± 4 49 ± 2 65 ± 2 77 ± 4 71 ± 3 52 ± 1 49 ± 1 
Succinic acid 68 ± 3 80 ± 1 74 ± 3 53 ± 2 51 ± 4 66 ± 3 80 ± 4 75 ± 1 55 ± 3 50 ± 1 
1,2,4-Benzenetriol 74 ± 4 74 ± 2 70 ± 5 51 ± 2 50 ± 1 75 ± 5 76 ± 3 71 ± 4 57 ± 3 53 ± 4 
Hydroquinone 77 ± 3 75 ± 5 72 ± 2 54 ± 1 48 ± 3 75 ± 4 73 ± 2 73 ± 3 58 ± 5 54 ± 2 
Sulfamethoxazole 65 ± 4 78 ± 2 73 ± 4 45 ± 2 40 ± 2 63 ± 2 75 ± 4 69 ± 2 48 ± 4 47 ± 3 
p-Nitrophenol 68 ± 2 77 ± 4 75 ± 3 52 ± 1 49 ± 3 65 ± 2 79 ± 3 72 ± 5 55 ± 5 51 ± 4 
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        Table 5.8:     Recoveries (%) and RSD (n=3) for different SPE materials at adjusted pH value (pH=12) 
Compound 
Oasis  
HLB 
Oasis 
MAX 
Oasis 
MCX 
Oasis 
WAX 
Oasis 
WCX 
Strata-     
X 
Strata-    
X-A 
Strata-    
X-C 
Strata-    
X-AW 
Strata-    
X-CW 
1H-Benzotriazole 71 ± 1 76 ± 3 71 ± 2 56 ± 3 50 ± 3 68 ± 2 78 ± 4 72 ± 1 50 ± 2 47 ± 3 
Bisphenol A 68 ± 3 80 ± 2 70 ± 4 52 ± 2 49 ± 2 66 ± 1 77 ± 3 74 ± 2 47 ± 1 41 ± 2 
Catechol 72 ± 5 75 ± 1 72 ± 3 57 ± 5 49 ± 5 69 ± 2 75 ± 4 70 ± 5 55 ± 3 50 ± 4 
p-Benzoquinone 73 ± 1 70 ± 4 75 ± 3 54 ± 3 46 ± 3 77 ± 3 75 ± 1 74 ± 4 51 ± 2 45 ± 3 
c,c-Muconic acid 66 ± 4 81 ± 2 70 ± 5 52 ± 1 47 ± 2 61 ± 1 79 ± 3 73 ± 1 57 ± 4 51 ± 1 
t,t-Muconic acid 65 ± 2 80 ± 5 71 ± 3 50 ± 2 45 ± 4 59 ± 2 78 ± 1 70 ± 3 52 ± 2 50 ± 3 
Carbamazepine 77 ± 3 68 ± 2 77 ± 2 57 ± 4 54 ± 3 80 ± 4 74 ± 3 75 ± 1 51 ± 3 44 ± 2 
Anthranilic acid 69 ± 2 81 ± 4 68 ± 1 54 ± 3 50 ± 5 77 ± 3 80 ± 5 69 ± 3 54 ± 5 46 ± 1 
Glyoxylic acid 67 ± 4 82 ± 3 70 ± 5 53 ± 2 46 ± 4 69 ± 2 83 ± 5 72 ± 4 55 ± 1 50 ± 4 
Oxamic acid 66 ± 2 80 ± 5 72 ± 3 55 ± 2 48 ± 5 67 ± 4 77 ± 3 71 ± 4 52 ± 4 48 ± 3 
Ciprofloxacin 71 ± 1 80 ± 3 72 ± 4 50 ± 2 49 ± 3 72 ± 3 78 ± 1 70 ± 2 56 ± 3 51 ± 1 
Diclofenac 65 ± 3 81 ± 2 76 ± 3 56 ± 1 54 ± 2 69 ± 2 80 ± 4 74 ± 3 49 ± 2 45 ± 3 
2,6-Dichloroaniline 74 ± 2 69 ± 4 75 ± 2 57 ± 3 53 ± 2 78 ± 3 71 ± 4 70 ± 1 53 ± 2 47 ± 5 
Metoprolol 77 ± 4 73 ± 1 71 ± 4 54 ± 3 48 ± 1 75 ± 5 73 ± 2 68 ± 3 56 ± 4 52 ± 1 
Paracetamol 71 ± 2 80 ± 3 75 ± 2 55 ± 2 51 ± 2 68 ± 2 78 ± 1 70 ± 4 51 ± 4 44 ± 2 
Oxalic acid 65 ± 1 76 ± 5 65 ± 3 58 ± 3 50 ± 4 60 ± 4 80 ± 2 67 ± 5 53 ± 2 45 ± 4 
Oxaloacetic acid 64 ± 4 80 ± 3 69 ± 1 53 ± 5 46 ± 5 67 ± 3 76 ± 1 71 ± 4 51 ± 3 49 ± 2 
Malic acid 66 ± 2 81 ± 1 65 ± 5 50 ± 3 45 ± 3 64 ± 1 78 ± 4 74 ± 5 48 ± 5 43 ± 4 
Malonic acid 65 ± 5 78 ± 4 72 ± 2 52 ± 5 43 ± 2 63 ± 3 82 ± 2 67 ± 3 52 ± 2 48 ± 5 
Maleic acid 67 ± 3 76 ± 2 70 ± 4 51 ± 2 50 ± 3 66 ± 2 78 ± 5 65 ± 4 55 ± 3 47 ± 2 
Succinic acid 65 ± 2 81 ± 3 76 ± 5 56 ± 4 52 ± 2 67 ± 4 78 ± 3 75 ± 2 51 ± 2 48 ± 3 
1,2,4-Benzenetriol 71 ± 5 76 ± 2 72 ± 4 51 ± 3 47 ± 5 68 ± 5 79 ± 1 73 ± 4 54 ± 4 51 ± 3 
Hydroquinone 72 ± 4 77 ± 2 70 ± 3 57 ± 5 51 ± 4 70 ± 2 75 ± 4 72 ± 3 50 ± 2 47 ± 5 
Sulfamethoxazole 68 ± 1 80 ± 3 71 ± 2 54 ± 4 51 ± 1 64 ± 3 81 ± 4 67 ± 3 52 ± 1 45 ± 2 
p-Nitrophenol 70 ± 3 79 ± 5 70 ± 2 55 ± 2 53 ± 4 66 ± 1 76 ± 3 68 ± 1 53 ± 3 49 ± 1 
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                             Table 5.9:     Recoveries (%) and RSD (n=3) for the developed tandem configuration of both Oasis and Strata families at different pH values 
Compound 
pH 2  pH 5  pH 7  pH 9  pH 12 
Oasis Strata  Oasis Strata  Oasis Strata  Oasis Strata  Oasis Strata 
1H-Benzotriazole 95 ± 5 91 ± 2  95 ± 2 94 ± 4  95 ± 5 90 ± 3  95 ± 6 91 ± 4  92 ± 4 94 ± 3 
Bisphenol A 94 ± 4 94 ± 5 94 ± 4 92 ± 2 90 ± 2 92 ± 4  94 ± 3 92 ± 2  95 ± 3 91 ± 4 
Catechol 92 ± 3 92 ± 2 92 ± 6 93 ± 6 92 ± 3 91 ± 3 92 ± 5 96 ± 5  93 ± 6 90 ± 3 
p-Benzoquinone 94 ± 5 91 ± 6 93 ± 2 92 ± 5 93 ± 6 93 ± 5 91 ± 2 92 ± 3  95 ± 4 92 ± 6 
c,c-Muconic acid 90 ± 4 91 ± 3 96 ± 4 94 ± 3 91 ± 2 92 ± 2 93 ± 4 94 ± 4  94 ± 6 92 ± 4 
t,t-Muconic acid 91 ± 4 93 ± 5 94 ± 5 90 ± 5 95 ± 4 94 ± 5 97 ± 2 95 ± 6  91 ± 3 94 ± 3 
Carbamazepine 92 ± 2 92 ± 6 94 ± 2 94 ± 3 90 ± 5 90 ± 3 94 ± 3 93 ± 3  93 ± 5 95 ± 5 
Anthranilic acid 94 ± 3 93 ± 2 97 ± 3 91 ± 4 92 ± 3 93 ± 6 96 ± 5 94 ± 6  92 ± 3 93 ± 6 
Glyoxylic acid 91 ± 6 93 ± 4 93 ± 6 90 ± 5 95 ± 4 91 ± 6 92 ± 3 90 ± 5  93 ± 6 95 ± 5 
Oxamic acid 90 ± 4 91 ± 3 91 ± 3 90 ± 3 90 ± 6 95 ± 3 90 ± 4 91 ± 3  95 ± 2 91 ± 3 
Ciprofloxacin 92 ± 3 90 ± 5 97 ± 2 94 ± 5 93 ± 3 96 ± 5 95 ± 2 94 ± 4  93 ± 4 94 ± 5 
Diclofenac 95 ± 3 92 ± 3 94 ± 4 92 ± 2 95 ± 5 98 ± 3 96 ± 6 92 ± 2  95 ± 5 93 ± 3 
2,6-Dichloroaniline 93 ± 4 91 ± 6 95 ± 3 95 ± 6 92 ± 6 94 ± 5 94 ± 4 93 ± 4  90 ± 3 91 ± 5 
Metoprolol 94 ± 3 96 ± 4 93 ± 5 94 ± 5 95 ± 3 96 ± 3 93 ± 2 95 ± 5  91 ± 5 93 ± 3 
Paracetamol 96 ± 3 92 ± 2 95 ± 2 92 ± 3 96 ± 5 92 ± 4 90 ± 5 92 ± 3  94 ± 2 92 ± 2 
Oxalic acid 91 ± 5 93 ± 6 92 ± 6 94 ± 6 92 ± 6 93 ± 6 92 ± 6 95 ± 6  92 ± 5 93 ± 5 
Oxaloacetic acid 94 ± 6 91 ± 5 94 ± 4 94 ± 4 94 ± 4 90 ± 4 90 ± 5 91 ± 4  94 ± 6 91 ± 6 
Malic acid 90 ± 4 94 ± 6 91 ± 3 92 ± 6 90 ± 4 91 ± 5 91 ± 3 93 ± 6  90 ± 4 94 ± 3 
Malonic acid 93 ± 3 91 ± 2 90 ± 4 90 ± 5 93 ± 2 90 ± 2 90 ± 5 91 ± 4  92 ± 3 94 ± 5 
Maleic acid 91 ± 6 93 ± 3 93 ± 5 94 ± 4 90 ± 5 92 ± 4 95 ± 4 90 ± 3  91 ± 5 92 ± 6 
Succinic acid 92 ± 4 90 ± 2 92 ± 2 90 ± 3 92 ± 3 93 ± 6 93 ± 2 95 ± 5  92 ± 2 90 ± 4 
1,2,4-Benzenetriol 92 ± 5 93 ± 6 90 ± 4 91 ± 5 91 ± 6 90 ± 4 90 ± 6 92 ± 6  95 ± 4 93 ± 5 
Hydroquinone 90 ± 4 92 ± 5 91 ± 5 93 ± 6 93 ± 3 94 ± 3 92 ± 4 90 ± 4  94 ± 6 92 ± 3 
Sulfamethoxazole 94 ± 3 93 ± 2 95 ± 3 92 ± 2 95 ± 5 92 ± 2 95 ± 2 93 ± 3  95 ± 4 96 ± 2 
p-Nitrophenol 92 ± 5 90 ± 4 90 ± 6 91 ± 6 92 ± 4 90 ± 5 93 ± 5 95 ± 6  92 ± 3 90 ± 5 
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                                   Table 5.10:     Concentration levels (ng/L) of the compounds of interest in water matrices sampled in April 2014 and February 2015 from  
                                                           wastewater treatment plant (WWTP) and Ruhr river in Germany 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     SW: Surface water; WWBO3: Wastewater before ozonation; WWAO3: Wastewater after ozonation; WWFE: Wastewater final effluent 
 
Compound 
2014  2015 
WWBO3 WWAO3 WWFE SW WWBO3 WWAO3 WWFE SW 
1H-Benzotriazole 1950 742 395 87  2340 816 472 110 
Bisphenol A 391 143 52 24  227 94 43 26 
Catechol 39 142 56 24  27 88 43 21 
p-Benzoquinone 21 64 41 ND  ND 40 29 22 
c,c-Muconic acid ND 38 ND 25  ND 33 23 ND 
t,t-Muconic acid ND 40 ND 21  ND 28 ND ND 
Carbamazepine 3020 995 602 129  3410 1190 652 166 
Anthranilic acid 24 85 39 23  34 55 32 22 
Glyoxylic acid ND 35 25 ND  ND ND ND ND 
Oxamic acid 22 37 25 ND  ND 28 ND ND 
Ciprofloxacin 418 145 70 26  351 119 48 23 
Diclofenac 2540 936 501 95  3050 1090 616 147 
2,6-Dichloroaniline ND 57 30 ND  ND 29 23 ND 
Metoprolol 2390 881 464 106  2680 1040 542 132 
Paracetamol 719 218 128 35  937 341 179 43 
Oxalic acid 24 67 ND ND  39 88 33 26 
Oxaloacetic acid ND 50 24 ND  ND ND ND ND 
Malic acid 25 126 67 23  76 214 113 41 
Malonic acid ND ND ND ND  ND 35 22 ND 
Maleic acid 47 173 94 24  65 154 71 38 
Succinic acid 37 184 104 30  68 102 88 35 
1,2,4-Benzenetriol ND 47 24 ND  ND 32 ND 24 
Hydroquinone ND ND ND ND  ND 26 ND ND 
Sulfamethoxazole 1480 457 287 70  1160 409 231 57 
p-Nitrophenol 25 81 36 26  44 131 64 27 
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Figure 5.1:     LC-ESI-MS/MS chromatograms for 25 analytes in spiked surface water 
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Figure 5.1:     LC-ESI-MS/MS chromatograms for 25 analytes in spiked surface water (continued) 
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Figure 5.1:     LC-ESI-MS/MS chromatograms for 25 analytes in spiked surface water (continued) 
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Figure 5.1:     LC-ESI-MS/MS chromatograms for 25 analytes in spiked surface water (continued) 
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Figure 5.1:     LC-ESI-MS/MS chromatograms for 25 analytes in spiked surface water (continued) 
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5.3 Suspect screening of micropollutants and their 
transformation products in advanced wastewater treatment 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32] 
Compound Uses Lab study (water matrix) Analytical method Analytical column 
Mobile 
phase 
RT (min) 
[literature] 
Ref. 
Bisphenol A (BPA) Industry Pure water 
LC-UV, LC–MS and 
MS/MS 
Uptispher HDO C18     
(3.0 x 250 mm, 5 µm)  
MeOH/H2O  45.11 [1] 
BPA-TP1 Ozonated TP     11.47 [1] 
BPA-TP2 Ozonated TP     28.46 [1] 
BPA-TP3 Ozonated TP     41.98 [1] 
BPA-TP4 Ozonated TP      [1] 
BPA-TP5 Ozonated TP      [1] 
Caffeine (CAFF) 
Psychoactive 
drug 
Pure water LC-TOF-MS 
ZORBAX, SB-C18  
(3.0 x 250 mm, 5 µm) 
ACN/H2O NA [2] 
CAFF-TP1 Ozonated TP     NA [2] 
CAFF-TP2 Ozonated TP     NA [2] 
CAFF-TP3 Ozonated TP      [2] 
CAFF-TP4 Ozonated TP     NA [2] 
CAFF-TP5 Ozonated TP     NA [2] 
CAFF-TP6 Ozonated TP     NA [2] 
Estrone sulfate (EST-S) 
Steroid 
hormone 
DWTP  LC-LTQ Orbitrap-MS 
Gemini C18  
(2.0 x 50 mm, 3 µm) 
ACN/H2O 9.25 [3] 
EST-S-TP1 Ozonated TP     6.71 [3] 
EST-S-TP2 Ozonated TP     6.78 [3] 
EST-S-TP3 Ozonated TP     6.92 [3] 
EST-S-TP4 Ozonated TP     7.55 [3] 
EST-S-TP5 Ozonated TP     7.57 [3] 
EST-S-TP6 Ozonated TP     7.74 [3] 
EST-S-TP7 Ozonated TP     8.00 [3] 
EST-S-TP8 Ozonated TP     8.13 [3] 
EST-S-TP9 Ozonated TP     8.50 [3] 
Trimethoprim (TMP) Antibiotic Pure water LC-MS-MS 
TC-C18                         
(4.6 x 150 mm, 5 µm) 
MeOH/H2O 15.41 [4] 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32]   
                       (continued) 
TMP-TP1  Ozonated TP     9.45 [4] 
TMP-TP2 Ozonated TP      [4] 
TMP-TP3 Ozonated TP     12.22 [4] 
TMP-TP4 Ozonated TP      [4] 
TMP-TP5 Ozonated TP     11.88 [4] 
TMP-TP6 Ozonated TP      [4] 
TMP-TP7 Ozonated TP     5.54 [4] 
TMP-TP8 Ozonated TP     8.16 [4] 
TMP-TP9 Ozonated TP      [4] 
TMP-TP10 Ozonated TP     9.00 [4] 
TMP-TP11 Ozonated TP     14.01 [4] 
TMP-TP12 Ozonated TP     11.05 [4] 
TMP-TP13 Ozonated TP      [4] 
TMP-TP14 Ozonated TP     9.34 [4] 
TMP-TP15 Ozonated TP     2.72 [4] 
Roxithromycin (ROX) Antibiotic Pure water, sewage efﬂuent  UPLC-Q-TOF-MS 
ACQUITY BEH C18      
(2.1 x 10 mm, 1.7 µm) 
ACN-
MeOH/H2O 
6.40 [5] 
ROX-TP1 Ozonated TP     6.00 [5] 
ROX-TP2 Ozonated TP     6.35 [5] 
ROX-TP3 Ozonated TP     6.50 [5] 
ROX-TP4 Ozonated TP     7.35 [5] 
ROX-TP5 Ozonated TP     6.70 [5] 
Methylbenzotriazole (MBZ) Anticorrosive DWTP 
HPLC-Q-TOF-MS, 
HPLC-MS/MS, HPTLC 
Zorbax Eclipse XDB-C18 
(2.1 x 100 mm, 1.8 µm) 
MeOH/H2O  NA [6] 
MBZ-TP1 Ozonated TP     5.70 [6] 
MBZ-TP2 Ozonated TP     9.50 [6] 
MBZ-TP3 Ozonated TP     9.00 [6] 
MBZ-TP4 Ozonated TP     5.40 [6] 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32]   
                       (continued) 
MBZ-TP5 Ozonated TP     8.60 [6] 
MBZ-TP6 Ozonated TP      [6] 
MBZ-TP7 Ozonated TP      [6] 
MBZ-TP8 Ozonated TP      [6] 
MBZ-TP9 Ozonated TP      [6] 
MBZ-TP10 Ozonated TP      [6] 
MBZ-TP11 Ozonated TP      [6] 
Imazalil (IMZ) Fungicide Pure water, WWTP effluent LC-LTQ Orbitrap-MS 
Hypersil Gold aQ C18  
(2.1 x 150 mm, 5.0 µm) 
MeOH/H2O  12.50 [7] 
IMZ-TP1  Ozonated TP     6.17 [7] 
IMZ-TP2 Ozonated TP      [7] 
IMZ-TP3 Ozonated TP     6.03 [7] 
IMZ-TP4 Ozonated TP     4.66 [7] 
Ketoprofen (KPR) 
Anti-
inflammatory  
Pure water LC-UV, LC–MS 
LiChroCART C18        
(125 mm, 4.5 µm) 
ACN/H2O 4.20 [8] 
KPR-TP1  Ozonated TP      [8] 
KPR-TP2 Ozonated TP     3.90 [8] 
KPR-TP3 Ozonated TP     4.90 [8] 
KPR-TP4 Ozonated TP     6.20 [8] 
Levoﬂoxacin (LVX) Antibiotic Pure water LC-UV, LC–MS 
Luna C18               
(3.0x150 mm, 3.0 µm) 
MeOH/H2O  20.88 [9] 
LVX-TP1  Ozonated TP      [9] 
LVX-TP2 Ozonated TP     17.69 [9] 
LVX-TP3 Ozonated TP     21.77 [9] 
LVX-TP4 Ozonated TP     9.45 [9] 
LVX-TP5 Ozonated TP      [9] 
LVX-TP6 Ozonated TP     27.73 [9] 
LVX-TP7 Ozonated TP     41.47 [9] 
Chlorophene (CLP) Biocide  Pure water LC-TOF-MS 
XDB-C18                      
(4.6 x 50 mm, 1.8 µm) 
ACN/H2O 17.20 [10] 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32]   
                       (continued) 
CLP-TP1 Ozonated TP     11.66 [10] 
CLP-TP2 Ozonated TP     15.02 [10] 
CLP-TP3 Ozonated TP      [10] 
CLP-TP4 Ozonated TP     9.94 [10] 
CLP-TP5 Ozonated TP     10.20 [10] 
CLP-TP6 Ozonated TP     8.74 [10] 
CLP-TP7 Ozonated TP      [10] 
CLP-TP8 Ozonated TP     7.75 [10] 
CLP-TP9 Ozonated TP     8.43 [10] 
CLP-TP10 Ozonated TP     10.05 [10] 
Acyclovir (ACV) Antiviral  Pure water, WWTP effluent 
LC-LTQ Orbitrap-MS, 
NMR 
Synergi Hydro C18       
(4.0 x 250 mm, 4.0 µm) 
MeOH/H2O NA [11] 
ACV-TP1 Ozonated TP     NA [11] 
1H-benzotriazole (BZT)  Anticorrosive Pure water LC-TOF-MS 
XDB-C18                      
(4.6 x 50 mm, 1.8 µm) 
ACN/H2O 7.30 [12, 13] 
BZT-TP1  Ozonated TP     3.71 [12] 
BZT-TP2 Ozonated TP      [12] 
BZT-TP3 Ozonated TP     1.85 [12] 
BZT-TP4 Ozonated TP     1.34 [12] 
BZT-TP5 Ozonated TP Pure water, SW, WWTP LC-Q-TOF-MS 
 HALO C18                   
(4.6 x 50 mm, 2.7 µm) 
MeOH/H2O  [13] 
BZT-TP6 Ozonated TP Pure water, SW, WWTP LC-Q-TOF-MS 
 HALO C18                   
(4.6 x 50 mm, 2.7 µm) 
MeOH/H2O  [13] 
BZT-TP7 Ozonated TP Pure water, SW, WWTP LC-Q-TOF-MS 
 HALO C18                   
(4.6 x 50 mm, 2.7 µm) 
MeOH/H2O  [13] 
Methylindole (MLD) Multi usages Pure water LC-TOF-MS 
XDB-C18                      
(4.6 x 50 mm, 1.8 µm) 
ACN/H2O 14.60 [12] 
MLD-TP1 Ozonated TP     13.75 [12] 
MLD-TP2 Ozonated TP     9.23 [12] 
MLD-TP3 Ozonated TP     3.77 [12] 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32]   
                       (continued) 
MLD-TP4 Ozonated TP     6.38 [12] 
MLD-TP5 Ozonated TP     10.60 [12] 
Imidacloprid (ICR) Insecticide Pure water 
HPLC-DAD,           
HPLC-Q-Trap-MS 
Kinetex C18                  
(2.1 x 150 mm, 1.7 µm) 
ACN/H2O 13.20 [14] 
ICR-TP1  Ozonated TP      [14] 
ICR-TP2 Ozonated TP      [14] 
ICR-TP3 Ozonated TP     5.70 [14] 
ICR-TP4 Ozonated TP      [14] 
ICR-TP5 Ozonated TP      [14] 
ICR-TP6 Ozonated TP     7.90 [14] 
ICR-TP7 Ozonated TP     9.90 [14] 
ICR-TP8 Ozonated TP      [14] 
ICR-TP9 Ozonated TP      [14] 
Propranolol (PRL) Beta blocker Pure water, WWTP effluent HPLC-UV, LC–MS 
Synergi 4u Hydro C18  
(3.0 x 250 mm, 4.0 µm) 
ACN/H2O 48.5 [15] 
PRL-TP1  Ozonated TP     32.50 [15] 
PRL-TP2 Ozonated TP     26.90 [15] 
PRL-TP3 Ozonated TP     41.80 [15] 
PRL-TP4 Ozonated TP     20.10 [15] 
Carbamazepine (CBZ) Anticonvulsant WWTP effluent 
HPLC-MS/MS,      
UPLC-Q-TOF-MS/MS 
Kinetex C18                  
(2.1 x 100 mm, 2.6 µm) 
MeOH/H2O  NA [16] 
CBZ-TP1 Ozonated TP     2.84 [16] 
CBZ-TP2 Ozonated TP     2.20 [16] 
CBZ-TP3 Ozonated TP     2.75 [16] 
CBZ-TP4 Ozonated TP     2.02 [16] 
CBZ-TP5 Ozonated TP     2.73 [16] 
CBZ-TP6 Ozonated TP     2.47 [16] 
CBZ-TP7 Ozonated TP     2.51 [16] 
CBZ-TP8 Ozonated TP     2.88 [16] 
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Table 5.11:     Suspect list including compounds, uses, lab study water matrices, analytical methods, analytical columns, and the used mobile phases obtained from literatures [1-32]   
                       (continued) 
CBZ-TP9 Ozonated TP     3.11 [16] 
CBZ-TP10 Ozonated TP     3.44 [16] 
CBZ-TP11 Ozonated TP     0.90 [16] 
CBZ-TP12 Ozonated TP      [16] 
CBZ-TP13 Ozonated TP     1.51 [16] 
CBZ-TP14 Ozonated TP     1.95 [16] 
CBZ-TP15 Ozonated TP     2.65 [16] 
Triclosan (TCS) 
Antibacterial & 
antifungal  
Pure water, WWTP  
HPLC-MS/MS,          
GC-MS 
Synergi 4u Polar C18    
(2.0 x 150 mm, 4.0 µm) 
MeOH/H2O 30.78 [17] 
TCS-TP1  Ozonated TP     24.76 [17] 
TCS-TP2 Ozonated TP      [17] 
TCS-TP3 Ozonated TP     27.56 [17] 
TCS-TP4 Ozonated TP      [17] 
Aminopyrine (AMP) Analgesic Purw water, SW UPLC-Q-TOF-MS  
Acquity C18                  
(2.1 x 50 mm, 1.7 µm) 
ACN/H2O 3.92 [18] 
AMP-TP1 Ozonated TP      [18] 
AMP-TP2 Ozonated TP      [18] 
AMP-TP3 Ozonated TP      [18] 
AMP-TP4 Ozonated TP      [18] 
AMP-TP5 Ozonated TP      [18] 
AMP-TP6 Ozonated TP     1.42 [18] 
AMP-TP7 Ozonated TP     3.89 [18] 
AMP-TP8 Ozonated TP     5.24 [18] 
AMP-TP9 Ozonated TP     6.97 [18] 
AMP-TP10 Ozonated TP      [18] 
AMP-TP11 Ozonated TP     7.17 [18] 
AMP-TP12 Ozonated TP     4.94 [18] 
AMP-TP13 Ozonated TP     1.84 [18] 
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                       (continued) 
Clarithromycin (CMC) Antibiotic Pure water, WWTP HPLC-MS/MS, NMR 
LUNA C8                      
(2.0 x 20 mm, 5.0 µm) 
MeOH/H2O 1.66 [19] 
 CMC-TP1 Ozonated TP     NA [19] 
 CMC-TP2 Ozonated TP      [19] 
Atenolol (ATL) Beta blocker Pure water LC-Q-TOF-MS 
SB-C18                          
(2.1 x 100 mm, 1.8 µm) 
ACN/H2O 2.365 [20] 
ATL-TP1 Ozonated TP     1.463 [20] 
ATL-TP2 Ozonated TP     1.108 [20] 
ATL-TP3 Ozonated TP     3.816 [20] 
ATL-TP4 Ozonated TP     1.279 [20] 
ATL-TP5 Ozonated TP      [20] 
ATL-TP6 Ozonated TP     1.827 [20] 
ATL-TP7 Ozonated TP      [20] 
ATL-TP8 Ozonated TP     1.270 [20] 
ATL-TP9 Ozonated TP     1.204 [20] 
17β-Estradiol (ESD) Steroid hormone Pure water, DWTP GC–MS    NA [21] 
ESD-TP1 Ozonated TP     NA [21] 
ESD-TP2 Ozonated TP     NA [21] 
Diclofenac (DFC) Analgesic Pure water 
LC-DAD, LC-Q-Trap-
MS, NMR, FT-IR 
Nucleodur C18              
(3.0 x 250 mm) 
ACN/H2O 40.40 [22] 
DFC-TP1 Ozonated TP     19.10 [22] 
DFC-TP2 Ozonated TP     18.30 [22] 
Metoprolol (MPL) Beta blocker Pure water LC-Q-TOF-MS 
SB-C18                           
(2.1 x 100 mm, 1.8 µm) 
ACN/H2O 6.328 [23] 
MPL-TP1 Ozonated TP     0.981 [23] 
MPL-TP2 Ozonated TP     1.072 [23] 
MPL-TP3 Ozonated TP     5.058 [23] 
MPL-TP4 Ozonated TP     3.110 [23] 
MPL-TP5 Ozonated TP     3.182 [23] 
MPL-TP6 Ozonated TP      [23] 
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MPL-TP7 Ozonated TP      [23] 
Sulfamethoxazole (SMZ) Antibiotic Pure water LC-Q-TOF-MS 
XDB-C18                      
(4.6 x 50 mm, 1.8 µm) 
ACN/H2O NA [24] 
SMZ-TP1 Ozonated TP     NA [24] 
SMZ-TP2 Ozonated TP     NA [24] 
SMZ-TP3 Ozonated TP     NA [24] 
SMZ-TP4 Ozonated TP      [24] 
Ciprofloxacin (CFX) Antibiotic Pure water, WW effluent LC-Q-Trap-MS 
Inertsil ODS-3 C18       
(2.0 x150 mm, 5.0 µm) 
MeOH/H2O 24.77 [25] 
CFX-TP1 Ozonated TP     22.22 [25] 
CFX-TP2 Ozonated TP     35.14 [25] 
CFX-TP3 Ozonated TP     31.70 [25] 
CFX-TP4 Ozonated TP     30.40 [25] 
CFX-TP5 Ozonated TP     30.04 [25] 
CFX-TP6 Ozonated TP     34.90 [25] 
CFX-TP7 Ozonated TP     28.20 [25] 
CFX-TP8 Ozonated TP      [25] 
CFX-TP9 Ozonated TP     36.97 [25] 
CFX-TP10 Ozonated TP      [25] 
CFX-TP11 Ozonated TP      [25] 
CFX-TP12 Ozonated TP      [25] 
CFX-TP13 Ozonated TP      [25] 
CFX-TP14 Ozonated TP     20.69 [25] 
CFX-TP15 Ozonated TP     18.47 [25] 
CFX-TP16 Ozonated TP     17.18 [25] 
Norfloxacin (NFX) Antibacterial Pure water, WW effluent LC-Q-Trap-MS/MS  
Inertsil ODS-3 C18       
(2.0 x 150 mm, 5.0 µm) 
MeOH/H2O 23.91 [25] 
NFX-TP1 Ozonated TP     21.16 [25] 
NFX-TP2 Ozonated TP     34.12 [25] 
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NFX-TP3 Ozonated TP     30.42 [25] 
NFX-TP4 Ozonated TP     29.22 [25] 
NFX-TP5 Ozonated TP      [25] 
NFX-TP6 Ozonated TP      [25] 
NFX-TP7 Ozonated TP     35.83 [25] 
NFX-TP8 Ozonated TP      [25] 
NFX-TP9 Ozonated TP      [25] 
NFX-TP10 Ozonated TP     16.75 [25] 
NFX-TP11 Ozonated TP     7.84 [25] 
NFX-TP12 Ozonated TP     11.61 [25] 
NFX-TP13 Ozonated TP     19.57 [25] 
NFX-TP14 Ozonated TP     17.41 [25] 
NFX-TP15 Ozonated TP     16.02 [25] 
Paracetamol (PCM) Analgesic Pure water GC–MS, NMR   NA [26] 
PCM-TP1 Ozonated TP     NA [26] 
Acesulfame (ACF) Sweetener 
Pure water, DWTP, Tap 
water, WWTP 
LC-Q-TOF-MS, NMR, 
IC-ICP/MS  
Synergie Hydro C18     
(3.0 x 250 mm, 4.0 µm) 
MeOH/H2O NA [27] 
ACF-TP1 Ozonated TP     NA [27] 
Cephalexin (CPX) Antibiotic WW effluent 
HPLC-UV, LC-MS/MS, 
NMR, FT-IR 
Nucleosil C18               
(2.0 x 250 mm, 5.0 µm) 
ACN/H2O 39.50 [28] 
CPX-TP1 Ozonated TP     22.00 [28] 
CPX-TP2 Ozonated TP     23.50 [28] 
CPX-TP3 Ozonated TP     32.50 [28] 
Penicillin G (PG) Antibacterial WW effluent 
HPLC-UV, LC-MS/MS, 
NMR, FT-IR 
Discovery Amide          
(3.0 x 250 mm, 5.0 µm) 
ACN/H2O 12.50 [28] 
PG-TP1 Ozonated TP     6.80 [28] 
Progesterone (PGT) Steroid hormone Pure water LC-Ion Trap-MS 
Uptispher HDO C18     
(3.0 x 250 mm, 5.0 µm) 
MeOH/H2O 51.11 [29] 
PGT-TP1 Ozonated TP     7.43 [29] 
PGT-TP2 Ozonated TP     37.58 [29] 
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Tramadol (TMD) Analgesic Pure water 
HPLC-UV/FLD, LC-Q-
LIT-MS, LTQ-FT-MS, 
GC-MS 
Synergie Hydro C18   
(10.0 x 250 mm, 4.0 µm) 
ACN/H2O NA [30] 
TMD-TP1 Ozonated TP     NA [30] 
TMD-TP2 Ozonated TP     NA [30] 
TMD-TP3 Ozonated TP     NA [30] 
TMD-TP4 Ozonated TP     NA [30] 
TMD-TP5 Ozonated TP     NA [30] 
TMD-TP6 Ozonated TP     NA [30] 
TMD-TP7 Ozonated TP      [30] 
Venlafaxine (VFX) Antidepressant WW effluent HPLC-MS/MS, GC-MS 
ACE-C18                       
(2.1 x 250 mm) 
MeOH/H2O NA [31] 
VFX-TP1 Ozonated TP     NA [31] 
Bezafibrate (BZR) Lipid regulator Pure water HPLC-MS Synergy Polar 4 C18   ACN/H2O 9.80 [32] 
BZR-TP1 Ozonated TP     3.20 [32] 
BZR-TP2 Ozonated TP      [32] 
BZR-TP3 Ozonated TP     6.40 [32] 
BZR-TP4 Ozonated TP     8.70 [32] 
ACN: Acetonitrile; DAD: Diode array detector; DWTP: Drinking water treatment plant; FLD: Fluorescence detector; FT: Fourier transform; GC: Gas chromatography; H2O: Water; 
HPLC: High performance liquid chromatography; IC: Ion chromatography; ICP: Inductively coupled plasma; IR: Infrared; LC: Liquid chromatography; LIT: Linear ion trap; LTQ: 
Linear trap quadrupole; MeOH: Methanol; MS: Mass spectrometry; MS/MS: Tandem mass spectrometry; NA: Not available; NMR: Nuclear magnetic resonance; Q: Quadrupole; SW: 
Surface water; TLC: Thin layer chromatography; TOF: Time-of-flight; TP: Transformation product; UPLC: Ultra-performance liquid chromatography; UV:Ultraviolet; WW: 
Wastewater; WWTP: Wastewater treatment plant 
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         Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search 
Compound Formula Exact mass Polarity Formula-2  
Calculated  
mass 
Measured 
mass 
Mass error 
(ppm) 
RT (min) 
[Experimental] 
Bisphenol A (BPA) C15H16O2 228.1150 [M+H]+ C15H17O2 229.1229 229.1232 1.31 32.94 
BPA-TP1 C15H16O5 276.0998 [M-H]- C15H15O5 275.0919 275.0925 2.18 7.12 
BPA-TP2 C9H12O2 152.0837 [M-H]- C9H11O2 151.0759 151.0762 1.99 20.21 
BPA-TP3 C15H16O3 244.1099 [M+H]+ C15H17O3 245.1178 245.1172 -2.45 30.71 
BPA-TP4 C19H18O5 326.1154        
BPA-TP5 C28H28O6 460.1886        
Caffeine (CAFF) C8H10N4O2 194.0804 [M-H]- C8H9N4O2 193.0726 193.0727 0.52 31.10 
CAFF-TP1 C8H10N4O5 242.0651 [M+H]+ C8H11N4O5 243.0729 243.0733 1.65 25.47 
CAFF-TP2 C8H12N4O4 228.0859 [M+H]+ C8H13N4O4 229.0937 229.0931 -2.62 24.63 
CAFF-TP3 C7H10N4O3 198.0753        
CAFF-TP4 C5H8N2O3 144.0535 [M+H]+ C5H9N2O3 145.0613 145.0615 1.38 16.57 
CAFF-TP5 C6H9N3O4 187.0593 [M+H]+ C6H10N3O4 188.0671 188.0674 1.60 20.71 
CAFF-TP6 C8H10N4O4 226.0702 [M+H]+ C8H11N4O4 227.0780 227.0787 3.08 16.79 
Estrone sulfate (EST-S) C18H22SO5 350.1188 [M+H]+ C18H23O5S 351.1266 351.1263 -0.85 43.35 
EST-S-TP1 C18H22SO7 382.1086 [M-H]- C18H21SO7 381.1008 381.1012 1.05 29.10 
EST-S-TP2 C18H18SO8 394.0722 [M-H]- C18H17SO8 393.0644 393.0651 1.78 29.57 
EST-S-TP3 C18H20SO7 380.0930 [M-H]- C18H19SO7 379.0851 379.0848 -0.79 29.67 
EST-S-TP4 C18H22SO6 366.1137 [M-H]- C18H21SO6 365.1059 365.1063 1.10 33.69 
EST-S-TP5 C18H20SO8 396.0879 [M-H]- C18H19SO8 395.0801 395.0807 1.52 33.86 
EST-S-TP6 C18H22SO8 398.1035 [M-H]- C18H21SO8 397.0957 397.0968 2.77 33.99 
EST-S-TP7 C18H24SO8 400.1192 [M+H]+ C18H25SO8 401.1270 401.1279 2.24 34.49 
EST-S-TP8 C18H18SO7 378.0773 [M-H]- C18H17SO7 377.0695 377.0690 -1.33 37.81 
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EST-S-TP9 C18H20SO6 364.0981 [M+H]+ C18H21SO6 365.1059 365.1052 -1.92 40.33 
Trimethoprim (TMP) C14H18N4O3 290.1379 [M+H]+ C14H19N4O3 291.1457 291.1455 -0.69 40.05 
TMP-TP1  C13H18N4O4 294.1328 [M+H]+ C13H19N4O4 295.1406 295.1412 2.03 21.83 
TMP-TP2 C14H18N4O5 322.1277        
TMP-TP3 C14H20N4O5 324.1434 [M+H]+ C14H21N4O5 325.1512 325.1518 1.85 26.28 
TMP-TP4 C14H18N4O6 338.1226        
TMP-TP5 C13H16N4O3 276.1222 [M+H]+ C13H17N4O3 277.1301 277.1309 2.89 26.06 
TMP-TP6 C13H15N3O4 277.1063        
TMP-TP7 C12H16N4O4 280.1172 [M+H]+ C12H17N4O4 281.1250 281.1259 3.20 15.88 
TMP-TP8 C14H18N2O6 310.1165 [M+H]+ C14H19N2O6 311.1243 311.1239 -1.29 16.90 
TMP-TP9 C14H18N4O7 354.1175        
TMP-TP10 C14H20N4O7 356.1332 [M+H]+ C14H21N4O7 357.1410 357.1419 2.52 17.85 
TMP-TP11 C11H13N3O3 235.0957 [M+H]+ C11H14N3O3 236.1035 236.1031 -1.69 32.18 
TMP-TP12 C14H18N4O4 306.1328 [M+H]+ C14H19N4O4 307.1406 307.1411 1.63 24.88 
TMP-TP13 C11H16N4O7 316.1019        
TMP-TP14 C5H6N4O 138.0542 [M+H]+ C5H7N4O 139.0620 139.0624 2.88 20.88 
TMP-TP15 C5H8N4O 140.0698 [M+H]+ C5H9N4O 141.0776 141.0773 -2.13 9.88 
Roxithromycin (ROX) C41H76N2O15 836.5246 [M+H]+ C41H77N2O15 837.5324 837.5331 0.84 34.55 
ROX-TP1 C33H62N2O13 694.4252 [M+H]+ C33H63N2O13 695.433 695.4339 1.29 24.73 
ROX-TP2 C40H74N2O15 822.5089 [M+H]+ C40H75N2O15 823.5167 823.5155 -1.46 31.61 
ROX-TP3 C40H74N2O16 838.5038 [M+H]+ C40H75N2O16 839.5117 839.5111 -0.71 35.56 
ROX-TP4 C41H74N2O16 850.5038 [M+H]+ C41H75N2O16 851.5117 851.5129 1.41 38.68 
ROX-TP5 C41H76N2O16 852.5195 [M+H]+ C41H77N2O16 853.5273 853.5289 1.87 34.92 
Methylbenzotriazole (MBZ) C7H7N3 133.0640 [M+H]+ C7H8N3 134.0718 134.0715 -2.24 23.32 
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MBZ-TP1 C5H5N3O2 139.0382 [M-H]- C5H4N3O2 138.0304 138.0307 2.17 16.84 
MBZ-TP2 C7H5N3O 147.0433 [M-H]- C7H4N3O 146.0354 146.0358 2.74 18.77 
MBZ-TP3 C7H7N3O 149.0589 [M+H]+ C7H8N3O 150.0667 150.0666 -0.67 18.48 
MBZ-TP4 C7H5N3O2 163.0382 [M+H]+ C7H6N3O2 164.0460 164.0455 -3.05 17.25 
MBZ-TP5 C7H7N3O2 165.0538 [M+H]+ C7H8N3O2 166.0617 166.0621 2.41 17.93 
MBZ-TP6 C7H5N3O3 179.0331        
MBZ-TP7 C7H7N3O3 181.0487        
MBZ-TP8 C7H5N3O4 195.0280        
MBZ-TP9 C7H7N3O4 197.0437        
MBZ-TP10 C7H5N3O5 211.0229        
MBZ-TP11 C7H5N3O6 227.0178        
Imazalil (IMZ) C14H14Cl2N2O 296.0483 [M+H]+ C14H15Cl2N2O 297.0561 297.0558 -1.01 45.99 
IMZ-TP1  C13H12Cl2N2O2 298.0276 [M+H]+ C13H13Cl2N2O2 299.0354 299.0363 3.01 25.21 
IMZ-TP2 C11H12Cl2N2O2 274.0276        
IMZ-TP3 C11H11Cl2NO3 275.0116 [M+H]+ C11H12Cl2NO3 276.0194 276.0185 -3.26 28.61 
IMZ-TP4 C13H15Cl2NO5 335.0327 [M+H]+ C13H14Cl2NO5 334.0249 334.0243 -1.80 26.33 
Ketoprofen (KPR) C16H14O3 254.0943 [M+H]+ C16H15O3 255.1021 255.1026 1.96 32.35 
KPR-TP1  C15H14O 210.1045       
KPR-TP2 C15H14O2 226.0994 [M+H]+ C15H15O2 227.1072 227.1078 2.64 30.30 
KPR-TP3 C15H14O3 242.0943 [M-H]- C15H13O3 241.0865 241.0871 2.49 36.33 
KPR-TP4 C15H12O2 224.0837 [M+H]+ C15H13O2 225.0916 225.0911 -2.22 43.66 
Levoﬂoxacin (LVX) C18H20FN3O4 361.1438 [M+H]+ C18H21FN3O4 362.1516 362.1522 1.66 19.70 
LVX-TP1  C17H20FN3O6 381.1336        
LVX-TP2 C16H20FN3O5 353.1387 [M+H]+ C16H21FN3O5 354.1465 354.1469 1.13 16.69 
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LVX-TP3 C17H18FN3O4 347.1281 [M+H]+ C17H19FN3O4 348.1360 348.1354 -1.72 24.33 
LVX-TP4 C16H20FN3O4 337.1438 [M+H]+ C16H21FN3O4 338.1516 338.1512 -1.18 12.18 
LVX-TP5 C16H18FN3O4 335.1281        
LVX-TP6 C18H20FN3O5 377.1387 [M+H]+ C18H21FN3O5 378.1465 378.1473 2.12 27.19 
LVX-TP7 C13H11FN2O4 278.0703 [M+H]+ C13H12FN2O4 279.0781 279.0779 -0.72 38.15 
Chlorophene (CLP) C13H11ClO 218.0498 [M-H]- C13H10ClO 217.0420 217.0423 1.38 42.84 
CLP-TP1 C7H5ClO3 171.9927 [M-H]- C7H4ClO3 170.9849 170.9852 1.75 33.15 
CLP-TP2 C13H11ClO2 234.0448 [M+H]+ C13H12ClO2 235.0526 235.0532 2.55 35.95 
CLP-TP3 C13H10O4 230.0579        
CLP-TP4 C12H7ClO10 345.9728 [M-H]- C12H6ClO10 344.9649 344.9656 2.03 22.77 
CLP-TP5 C12H12O3 204.0786 [M+H]+ C12H13O3 205.0865 205.0863 -0.98 25.10 
CLP-TP6 C11H10O4 206.0579 [M+H]+ C11H11O4 207.0657 207.0660 1.45 22.42 
CLP-TP7 C12H8O10 312.0117        
CLP-TP8 C12H12O5 236.0685 [M+H]+ C12H13O5 237.0763 237.0761 -0.84 20.91 
CLP-TP9 C11H10O5 222.0528 [M-H]- C11H9O5 221.0450 221.0457 3.17 22.14 
CLP-TP10 C9H12O10 280.0430 [M+H]+ C9H13O10 281.0509 281.0504 -1.78 23.13 
Acyclovir (ACV) C8H11N5O3 225.0862 [M-H]- C8H10N5O3 224.0784 224.0789 2.23 34.64 
ACV-TP C8H13N5O5 259.0917 [M+H]+ C8H14N5O5 260.0995 260.0987 -3.08 33.38 
1H-benzotriazole (BZT) C6H5N3 119.0483 [M+H]+ C6H6N3 120.0562 120.0565 2.50 19.79 
BZT-TP1  C6H5N3O 135.0433 [M+H]+ C6H6N3O 136.0511 136.0509 -1.47 10.23 
BZT-TP2 C6H5N3O2 151.0382        
BZT-TP3 C6H5N3O3 167.0331 [M-H]- C6H4N3O3 166.0253 166.0257 2.41 5.24 
BZT-TP4 C6H7N3O3 169.0487 [M+H]+ C6H8N3O3 170.0566 170.0562 -2.35 4.14 
BZT-TP5 C4H3N3O2 125.0225        
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BZT-TP6 C4H5N3O3 143.0331        
BZT-TP7 C5H5N3O3 155.0331        
Methylindole (MLD) C9H9N 131.0735 [M+H]+ C9H10N 132.0813 132.0815 1.51 21.35 
MLD-TP1 C9H9NO 147.0684 [M-H]- C9H8NO 146.0606 146.0602 -2.74 20.95 
MLD-TP2 C9H9NO2 163.0633 [M+H]+ C9H10NO2 164.0712 164.0714 1.22 14.04 
MLD-TP3 C9H11NO2 165.0790 [M+H]+ C9H12NO2 166.0868 166.0863 -3.01 7.43 
MLD-TP4 C9H9NO3 179.0582 [M+H]+ C9H10NO3 180.0661 180.0665 2.22 10.87 
MLD-TP5 C8H9NO 135.0684 [M+H]+ C8H10NO 136.0762 136.0758 -2.94 18.80 
Imidacloprid (ICR) C9H10ClN5O2 255.0523 [M+H]+ C9H11ClN5O2 256.0601 256.0599 -0.78 31.30 
ICR-TP1  C6H4ClNO 140.9981        
ICR-TP2 C7H8ClN5O2 229.0367        
ICR-TP3 C9H10ClN5O4 287.0421 [M+H]+ C9H11ClN5O4 288.0500 288.0508 2.78 12.97 
ICR-TP4 C6H4ClNO2 156.9931        
ICR-TP5 C9H10ClN5O3 271.0472        
ICR-TP6 C9H6ClN3O3 239.0098 [M-H]- C9H5ClN3O3 238.0019 238.0014 -2.10 22.64 
ICR-TP7 C9H8ClN5O3 269.0316 [M+H]+ C9H9ClN5O3 270.0394 270.0391 -1.11 23.44 
ICR-TP8 C9H8ClN5O4 285.0265        
ICR-TP9 C6H7ClN2 142.0298        
Propranolol (PRL) C16H21NO2 259.1572 [M+H]+ C16H22NO2 260.1651 260.1647 -1.54 38.50 
PRL-TP1  C14H19NO4 265.1314 [M+H]+ C14H20NO4 266.1392 266.1393 0.38 28.15 
PRL-TP2 C14H19NO5 281.1263 [M+H]+ C14H20NO5 282.1341 282.1345 1.42 20.64 
PRL-TP3 C16H21NO4 291.1471 [M+H]+ C16H22NO4 292.1549 292.1555 2.05 34.26 
PRL-TP4 C16H21NO5 307.1420 [M-H]- C16H20NO5 306.1341 306.1352 3.59 17.54 
Carbamazepine (CBZ) C15H12N2O 236.0950 [M+H]+ C15H13N2O 237.1028 237.1025 -1.27 32.50 
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CBZ-TP1 C14H9NO2 223.0633 [M+H]+ C14H10NO2 224.0712 224.0716 1.79 28.90 
CBZ-TP2 C15H14N2O3 270.1004 [M+H]+ C15H15N2O3 271.1083 271.1085 0.74 25.31 
CBZ-TP3 C15H10N2O3 266.0691 [M+H]+ C15H11N2O3 267.0770 267.0763 -2.62 28.21 
CBZ-TP4 C15H10N2O4 282.0641 [M+H]+ C15H11N2O4 283.0719 283.0715 -1.41 24.56 
CBZ-TP5 C15H12N2O2 252.0899 [M+H]+ C15H13N2O2 253.0977 253.0976 -0.40 27.38 
CBZ-TP6 C15H12N2O3 268.0848 [M+H]+ C15H13N2O3 269.0926 269.0923 -1.11 26.38 
CBZ-TP7 C15H10N2O2 250.0742 [M+H]+ C15H11N2O2 251.0821 251.0823 0.80 26.65 
CBZ-TP8 C13H9NO 195.0684 [M+H]+ C13H10NO 196.0762 196.0759 -1.53 29.29 
CBZ-TP9 C14H11NO4 257.0688 [M+H]+ C14H12NO4 258.0766 258.0758 -3.10 30.20 
CBZ-TP10 C14H9NO 207.0684 [M+H]+ C14H10NO 208.0762 208.0764 0.96 30.99 
CBZ-TP11 C13H12N2O6 292.0695 [M+H]+ C13H11N2O6 291.0617 291.0611 -2.06 17.98 
CBZ-TP12 C13H10N2O6 290.0539        
CBZ-TP13 C12H8N2O4 244.0484 [M+H]+ C12H9N2O4 245.0562 245.0554 -3.26 21.41 
CBZ-TP14 C14H10N2O4 270.0641 [M+H]+ C14H11N2O4 271.0719 271.0726 2.58 24.12 
CBZ-TP15 C12H7NO3 213.0426 [M+H]+ C12H8NO3 214.0504 214.0501 -1.40 26.92 
Triclosan (TCS) C12H7Cl3O2 287.9512 [M-H]- C12H6Cl3O2 286.9433 286.9437 1.39 41.13 
TCS-TP1  C6H4Cl2O 161.9639 [M-H]- C6H3Cl2O 160.9561 160.9566 3.11 30.56 
TCS-TP2 C6H5ClO2 143.9978        
TCS-TP3 C12H7Cl3O3 303.9461 [M-H]- C12H6Cl3O3 302.9383 302.9377 -1.98 35.35 
TCS-TP4 C12H7Cl3O4 319.9410        
Aminopyrine (AMP) C13H17N3O 231.1372 [M+H]+ C13H18N3O 232.1450 232.1454 1.72 15.02 
AMP-TP1 C13H17N3O3 263.1270       
AMP-TP2 C12H15N3O3 249.1113       
AMP-TP3 C11H15N3O2 221.1164       
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          Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search (continued) 
AMP-TP4 C9H12N2O 164.0950       
AMP-TP5 C11H12N2O4 236.0797       
AMP-TP6 C9H12N2O2 180.0899 [M+H]+ C9H13N2O2 181.0977 181.0979 1.10 6.54 
AMP-TP7 C12H15N3O 217.1215 [M+H]+ C12H16N3O 218.1293 218.1289 -1.83 14.11 
AMP-TP8 C11H13N3O 203.1059 [M+H]+ C11H14N3O 204.1137 204.1132 -2.45 22.27 
AMP-TP9 C11H12N2O2 204.0899 [M+H]+ C11H13N2O2 205.0977 205.098 1.46 28.45 
AMP-TP10 C13H17N3O2 247.1321        
AMP-TP11 C12H13N3O2 231.1008 [M+H]+ C12H14N3O2 232.1086 232.1084 -0.86 29.41 
AMP-TP12 C13H17N3O4 279.1219 [M+H]+ C13H18N3O4 280.1297 280.1301 1.43 16.86 
AMP-TP13 C7H13N3O 155.1059 [M+H]+ C7H14N3O 156.1137 156.1133 -2.56 8.75 
Clarithromycin (CMC) C38H69NO13 747.4769 [M+H]+ C38H70NO13 748.4847 748.4842 -0.67 25.79 
 CMC-TP1 C38H69NO14 763.4718 [M+H]+ C38H70NO14 764.4796 764.4789 -0.92 23.08 
 CMC-TP2 C37H67NO13 733.4612        
Atenolol (ATL) C14H22N2O3 266.1630 [M+H]+ C14H23N2O3 267.1709 267.1704 -1.87 41.92 
ATL-TP1 C8H15NO5 205.0950 [M+H]+ C8H16NO5 206.1028 206.1034 2.91 26.78 
ATL-TP2 C11H16N2O3 224.1161 [M+H]+ C11H17N2O3 225.1239 225.1235 -1.78 15.65 
ATL-TP3 C13H19NO3 237.1365 [M+H]+ C13H20NO3 238.1443 238.1448 2.10 58.66 
ATL-TP4 C12H20N2O5 272.1372 [M+H]+ C12H21N2O5 273.1450 273.1457 2.56 26.18 
ATL-TP5 C14H18N2O4 278.1267        
ATL-TP6 C14H20N2O4 280.1423 [M+H]+ C14H21N2O4 281.1501 281.1503 0.71 31.99 
ATL-TP7 C14H22N2O4 282.1580        
ATL-TP8 C14H22N2O5 298.1529 [M+H]+ C14H23N2O5 299.1607 299.1613 2.01 25.38 
ATL-TP9 C14H22N2O6 314.1478 [M+H]+ C14H23N2O6 315.1556 315.1551 -1.59 24.41 
17β-Estradiol (ESD) C18H24O2 272.1776 [M+H]+ C18H25O2 273.1855 273.1853 -0.73 43.46 
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          Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search (continued) 
ESD-TP1 C18H24O3 288.1725 [M+H]+ C18H25O3 289.1804 289.1797 -2.42 38.92 
ESD-TP2 C18H30O2 278.2246 [M+H]+ C18H31O2 279.2324 279.2318 -2.15 42.60 
Diclofenac (DFC) C14H11Cl2NO2 295.0167 [M+H]+ C14H12Cl2NO2 296.0245 296.0242 -1.01 36.56 
DFC-TP1 C14H11Cl2NO3 311.0116 [M+H]+ C14H12Cl2NO3 312.0194 312.0194 0.00 18.62 
DFC-TP2 C14H9Cl2NO3 308.9959 [M+H]+ C14H10Cl2NO3 310.0038 310.0034 -1.29 16.39 
Metoprolol (MPL) C15H25NO3 267.1834 [M+H]+ C15H26NO3 268.1913 268.1908 -1.86 25.58 
MPL-TP1 C6H15NO2 133.1103 [M+H]+ C6H16NO2 134.1181 134.1177 -2.98 4.76 
MPL-TP2 C8H17NO5 207.1107 [M+H]+ C8H18NO5 208.1185 208.1190 2.40 6.85 
MPL-TP3 C12H19NO3 225.1365 [M+H]+ C12H20NO3 226.1443 226.1447 1.77 21.06 
MPL-TP4 C13H23NO5 273.1576 [M+H]+ C13H24NO5 274.1654 274.1649 -1.82 11.75 
MPL-TP5 C15H25NO4 283.1784 [M+H]+ C15H26NO4 284.1862 284.1865 1.06 12.83 
MPL-TP6 C15H25NO5 299.1733        
MPL-TP7 C15H25NO7 331.1631        
Sulfamethoxazole (SMZ) C10H11N3O3S 253.0521 [M+H]+ C10H12N3O3S 254.0599 254.0597 -0.79 30.83 
SMZ-TP1 C4H6N2O 98.0480 [M+H]+ C4H7N2O 99.0558 99.0560 2.02 20.33 
SMZ-TP2 C10H13N3O5S 287.0576 [M+H]+ C10H14N3O5S 288.0654 288.0659 1.74 21.95 
SMZ-TP3 C10H9N3O5S 283.0263 [M-H]- C10H7N3O5S 281.0106 281.0111 1.78 24.98 
SMZ-TP4 C10H11N3O4S 269.0470        
Ciprofloxacin (CFX) C17H18O3N3F 331.1332 [M+H]+ C17H19O3N3F 332.141 332.1409 -0.30 20.48 
CFX-TP1 C15H16O3N3F 305.1176 [M+H]+ C15H17O3N3F 306.1254 306.1256 0.65 18.92 
CFX-TP2 C13H11O3N2F 262.0754 [M+H]+ C13H12O3N2F 263.0832 263.0825 -2.66 29.18 
CFX-TP3 C17H16O4N3F 345.1125 [M+H]+ C17H17O4N3F 346.1203 346.1206 0.87 26.12 
CFX-TP4 C17H14O5N3F 359.0917 [M+H]+ C17H15O5N3F 360.0996 360.1005 2.50 23.71 
CFX-TP5 C17H16O5N3F 361.1074 [M+H]+ C17H17O5N3F 362.1152 362.1159 1.93 22.08 
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          Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search (continued) 
CFX-TP6 C14H11O4N2F 290.0703 [M+H]+ C14H12O4N2F 291.0781 291.0773 -2.75 27.75 
CFX-TP7 C16H16O5N3F 349.1074 [M+H]+ C16H17O5N3F 350.1152 350.1154 0.57 21.52 
CFX-TP8 C17H18O5N3F 363.1230        
CFX-TP9 C15H14O4N3F 319.0968 [M+H]+ C15H15O4N3F 320.1047 320.1041 -1.87 31.40 
CFX-TP10 C15H14O5N3F 335.0917        
CFX-TP11 C15H18O3N3F 307.1332        
CFX-TP12 C15H16O5N3F 337.1074        
CFX-TP13 C14H16O4N3F 309.1125        
CFX-TP14 C15H16O2N3F 289.1227 [M+H]+ C15H17O2N3F 290.1305 290.1299 -2.07 17.66 
CFX-TP15 C13H16O3N3F 281.1176 [M-H]- C13H15O3N3F 280.1097 280.1103 2.14 17.49 
CFX-TP16 C13H14O2N3F 263.1070 [M+H]+ C13H15O2N3F 264.1148 264.1155 2.65 13.95 
Norfloxacin (NFX) C16H18O3N3F 319.1332 [M+H]+ C16H19O3N3F 320.141 320.1413 0.94 17.02 
NFX-TP1 C14H16O3N3F 293.1176 [M+H]+ C14H17O3N3F 294.1254 294.1261 2.38 14.20 
NFX-TP2 C12H11O3N2F 250.0754 [M+H]+ C12H12O3N2F 251.0832 251.0836 1.59 24.49 
NFX-TP3 C16H16O4N3F 333.1125 [M+H]+ C16H17O4N3F 334.1203 334.1211 2.39 21.56 
NFX-TP4 C16H14O5N3F 347.0917 [M+H]+ C16H15O5N3F 348.0996 348.0999 0.86 19.95 
NFX-TP5 C15H16O4N3F 321.1125        
NFX-TP6 C16H18O5N3F 351.1230        
NFX-TP7 C14H14O4N3F 307.0968 [M+H]+ C14H15O4N3F 308.1047 308.1051 1.30 25.69 
NFX-TP8 C14H14O5N3F 323.0917        
NFX-TP9 C15H18O4N3F  323.1281        
NFX-TP10 C14H18O3N3F  295.1332 [M+H]+ C14H19O3N3F  296.1410 296.1419 3.04 12.69 
NFX-TP11 C14H16O5N3F  325.1074 [M+H]+ C14H17O5N3F  326.1152 326.1144 -2.45 6.92 
NFX-TP12 C13H16O4N3F 297.1125 [M+H]+ C13H17O4N3F 298.1203 298.1198 -1.68 9.45 
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          Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search (continued) 
NFX-TP13 C14H16O2N3F  277.1227 [M+H]+ C14H17O2N3F  278.1305 278.1313 2.88 13.49 
NFX-TP14 C12H16O3N3F  269.1176 [M-H]- C12H15O3N3F  268.1097 268.1088 -3.36 13.31 
NFX-TP15 C12H14O2N3F 251.1070 [M+H]+ C12H15O2N3F 252.1148 252.1153 1.98 12.29 
Paracetamol (PCM) C8H9NO2 151.0633 [M+H]+ C8H10NO2 152.0712 152.0709 -1.97 15.15 
PCM-TP1 C8H9NO3 167.0582 [M+H]+ C8H10NO3 168.0661 168.0659 -1.19 14.46 
Acesulfame (ACF) C4H5NO4S 162.9939 [M-H]- C4H4NO4S 161.9861 161.9864 1.85 23.97 
ACF-TP1 C2H4NO6S 169.9759 [M-H]- C2H3NO6S 168.9681 168.9677 -2.37 14.72 
Cephalexin (CPX) C16H17N3O4S 347.0940 [M+H]+ C16H18N3O4S 348.1018 348.1023 1.44 31.81 
CPX-TP1 C16H17N3O5S 363.0889 [M+H]+ C16H18N3O5S 364.0967 364.0956 -3.02 17.77 
CPX-TP2 C16H19N3O7S 397.0944 [M+H]+ C16H20N3O7S 398.1022 398.1028 1.51 19.41 
CPX-TP3 C16H17N3O6S 379.0838 [M+H]+ C16H18N3O6S 380.0916 380.0920 1.05 26.44 
Penicillin G (PG) C16H18N2O4S 334.0987 [M+H]+ C16H19N2O4S 335.1066 335.1069 0.90 50.71 
PG-TP1 C16H18N2O5S 350.0936 [M+H]+ C16H19N2O5S 351.1015 351.1007 -2.28 26.24 
Progesterone (PGT) C21H30O2 314.2246 [M+H]+ C21H31O2 315.2324 315.2330 1.90 43.86 
PGT-TP1 C20H30O4 334.2144 [M-H]- C20H29O4 333.2066 333.2067 0.30 7.92 
PGT-TP2 C21H30O4 346.2144 [M-H]- C21H29O4 345.2066 345.2073 2.03 33.26 
Tramadol (TMD) C16H25NO2 263.1885 [M+H]+ C16H26NO2 264.1964 264.1959 -1.89 36.84 
TMD-TP1 C16H25NO3 279.1834 [M+H]+ C16H26NO3 280.1913 280.1910 -1.07 15.26 
TMD-TP2 C16H23NO3 277.1678 [M+H]+ C16H24NO3 278.1756 278.1758 0.72 15.40 
TMD-TP3 C15H23NO2 249.1729 [M+H]+ C15H24NO2 250.1807 250.1804 -1.20 19.19 
TMD-TP4 C14H18O4 250.1205 [M-H]- C14H17O4 249.1127 249.1135 3.21 32.31 
TMD-TP5 C14H21NO2 235.1572 [M-H]- C14H20NO2 234.1494 234.1489 -2.14 15.53 
TMD-TP6 C14H18O3 234.1256 [M+H]+ C14H19O3 235.1334 235.1335 0.43 21.20 
TMD-TP7 C15H21NO3 263.1521        
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          Table 5.12:     LC-Q-TOF-MS data obtained for the detected compounds using molecular-feature extraction database search (continued) 
Venlafaxine (VFX) C17H27NO2 277.2042 [M+H]+ C17H28NO2 278.2120 278.2116 -1.44 24.22 
VFX-TP1 C17H27NO3 293.1991 [M+H]+ C17H28NO3 294.2069 294.2064 -1.70 21.64 
Bezafibrate (BZR) C19H20ClNO4 361.1081 [M+H]+ C19H21ClNO4 362.1159 362.1165 1.66 32.64 
BZR-TP1 C10H10ClNO3 227.0349 [M+H]+ C10H11ClNO3 228.0427 228.0419 -3.51 11.12 
BZR-TP2 C17H18ClNO6 367.0823        
BZR-TP3 C19H20ClNO6 393.0979 [M-H]- C19H19ClNO6 392.0901 392.0909 2.04 25.91 
BZR-TP4 C19H20ClNO7 409.0928 [M+H]+ C19H21ClNO7 410.1007 410.1015 1.95 31.06 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument 
Compound 
Peak area 
WW before 
ozonation 
WW after 
ozonation 
WW final 
effluent 
Surface water 
Bisphenol A (BPA) 762330 129237 53708 22835 
BPA-TP1 ND 30572 ND ND 
BPA-TP2 ND 68654 29718 8492 
BPA-TP3 ND 71830 36586 11036 
BPA-TP4 ND ND ND ND 
BPA-TP5 ND ND ND ND 
Caffeine (CAFF) 818050 381696 137185 94725 
CAFF-TP1 ND 165986 ND ND 
CAFF-TP2 ND 303756 ND ND 
CAFF-TP3 ND ND ND ND 
CAFF-TP4 ND 22623 ND ND 
CAFF-TP5 ND 61360 ND ND 
CAFF-TP6 ND 87568 ND ND 
Estrone sulfate (EST-S) 1583923 763315 352764 290138 
EST-S-TP1 ND 738145 351032 105817 
EST-S-TP2 ND 258088 160371 75324 
EST-S-TP3 12952 574894 217482 146392 
EST-S-TP4 ND 472706 216204 136288 
EST-S-TP5 ND 79844 ND ND 
EST-S-TP6 ND 206490 ND ND 
EST-S-TP7 ND 847592 194825 141294 
EST-S-TP8 ND 304785 ND 95381 
EST-S-TP9 71083 403992 152972 ND 
Trimethoprim (TMP) 15588353 6890242 2540171 1160638 
TMP-TP1  ND 331223 107382 73829 
TMP-TP2 ND ND ND ND 
TMP-TP3 ND 654672 340173 107384 
TMP-TP4 ND ND ND ND 
TMP-TP5 ND 1702639 853702 382941 
TMP-TP6 ND ND ND ND 
TMP-TP7 ND 446738 ND ND 
TMP-TP8 ND 111624 ND ND 
TMP-TP9 ND ND ND ND 
TMP-TP10 ND 603150 108204 ND 
TMP-TP11 ND 1919237 961730 417392 
TMP-TP12 ND 4193945 1503817 ND 
TMP-TP13 ND ND ND ND 
TMP-TP14 84912 3051127 130729 ND 
TMP-TP15 ND 49929 ND ND 
Roxithromycin (ROX) 14733337 2319396 1462941 209049 
ROX-TP1 ND 5001038 3171962 1162932 
ROX-TP2 ND 564813 ND ND 
ROX-TP3 ND 127267 ND ND 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument  
                       (continued) 
ROX-TP4 ND 529349 149827 ND 
ROX-TP5 51482 1709411 850824 107273 
4-methyl-1H-benzotriazole (4-MBZ) 10235604 3238204 1101159 769635 
4-MBZ-TP1 ND 94713 ND ND 
4-MBZ-TP2 ND 48902 ND ND 
4-MBZ-TP3 ND 3957181 974103 811639 
4-MBZ-TP4 ND 147926 ND ND 
4-MBZ-TP5 ND 93301 ND ND 
4-MBZ-TP6 ND ND ND ND 
4-MBZ-TP7 ND ND ND ND 
4-MBZ-TP8 ND ND ND ND 
4-MBZ-TP9 ND ND ND ND 
4-MBZ-TP10 ND ND ND ND 
4-MBZ-TP11 ND ND ND ND 
Imazalil (IMZ) 137295 58095 ND ND 
IMZ-TP1  ND 11393 ND ND 
IMZ-TP2 ND ND ND ND 
IMZ-TP3 ND 85311 ND ND 
IMZ-TP4 ND 73925 11806 ND 
Ketoprofen (KPR) 3784129 228297 134747 74750 
KPR-TP1  ND ND ND ND 
KPR-TP2 ND 77064 ND ND 
KPR-TP3 61937 1977094 921852 69038 
KPR-TP4 ND 108287 ND ND 
Levoﬂoxacin (LVX) 2934988 1049104 610047 482730 
LVX-TP1  ND ND ND ND 
LVX-TP2 ND 572409 194720 117594 
LVX-TP3 ND 253046 ND ND 
LVX-TP4 27510 612551 392581 217047 
LVX-TP5 ND ND ND ND 
LVX-TP6 ND 96438 38174 ND 
LVX-TP7 ND 23706 ND ND 
Chlorophene (CLP) 3219428 193636 ND ND 
CLP-TP1 ND 522592 135039 53852 
CLP-TP2 ND 47854 ND ND 
CLP-TP3 ND ND ND ND 
CLP-TP4 ND 947140 51482 24928 
CLP-TP5 ND 224685 145920 ND 
CLP-TP6 ND 405367 ND ND 
CLP-TP7 ND ND ND ND 
CLP-TP8 ND 176063 28716 ND 
CLP-TP9 ND 675430 191046 ND 
CLP-TP10 ND 110585 ND ND 
Acyclovir (ACV) 986501 391101 86105 ND 
ACV-TP1 ND 281429 ND ND 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument  
                       (continued) 
1H-benzotriazole (BZT) 3271285 961734 645675 471384 
BZT-TP1  ND 491530 320481 ND 
BZT-TP2 ND ND ND ND 
BZT-TP3 ND 128894 82613 46910 
BZT-TP4 ND 51791 ND ND 
BZT-TP5 ND ND ND ND 
BZT-TP6 ND ND ND ND 
BZT-TP7 ND ND ND ND 
Methylindole (MLD) 1030875 415362 203975 136729 
MLD-TP1 ND 19305 ND ND 
MLD-TP2 26849 558115 173972 ND 
MLD-TP3 ND 135868 ND ND 
MLD-TP4 ND 122155 ND ND 
MLD-TP5 ND 163077 93021 47285 
Imidacloprid (ICR) 349061 139503 116119 14407 
ICR-TP1  ND ND ND ND 
ICR-TP2 ND ND ND ND 
ICR-TP3 ND 84196 ND ND 
ICR-TP4 ND ND ND ND 
ICR-TP5 ND ND ND ND 
ICR-TP6 ND 60974 ND ND 
ICR-TP7 ND 42143 ND ND 
ICR-TP8 ND ND ND ND 
ICR-TP9 ND ND ND ND 
Propranolol (PRL) 26223227 14270423 2075446 1289726 
PRL-TP1  ND 623672 218319 ND 
PRL-TP2 ND 275805 ND ND 
PRL-TP3 ND 1135072 549127 129061 
PRL-TP4 ND 907574 459182 171078 
Carbamazepine (CBZ) 57081435 20489929 17341322 13190381 
CBZ-TP1 ND 789916 ND ND 
CBZ-TP2 78269 4918603 849137 466558 
CBZ-TP3 ND 450302 ND ND 
CBZ-TP4 ND 365442 ND ND 
CBZ-TP5 ND 1285809 769638 204676 
CBZ-TP6 84104 1440487 483891 ND 
CBZ-TP7 ND 682459 160932 ND 
CBZ-TP8 ND 854816 529160 150342 
CBZ-TP9 ND 75895 ND ND 
CBZ-TP10 ND 127209 ND ND 
CBZ-TP11 ND 239823 ND ND 
CBZ-TP12 ND ND ND ND 
CBZ-TP13 ND 12299 ND ND 
CBZ-TP14 ND 806706 440179 172961 
CBZ-TP15 ND 32254 ND ND 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument  
                       (continued) 
Triclosan (TCS) 9471036 3756209 1603852 971844 
TCS-TP1  ND 58401 ND ND 
TCS-TP2 ND ND ND ND 
TCS-TP3 ND 819362 ND ND 
TCS-TP4 ND ND ND ND 
Aminopyrine (AMP) 6051791 1295179 333184 142216 
AMP-TP1 ND ND ND ND 
AMP-TP2 ND ND ND ND 
AMP-TP3 ND ND ND ND 
AMP-TP4 ND ND ND ND 
AMP-TP5 ND ND ND ND 
AMP-TP6 ND 699876 125648 79550 
AMP-TP7 ND 206801 122661 ND 
AMP-TP8 ND 720856 252127 19899 
AMP-TP9 ND 146573 ND ND 
AMP-TP10 ND ND ND ND 
AMP-TP11 ND 576390 ND ND 
AMP-TP12 78126 618046 147872 ND 
AMP-TP13 ND 153155 ND ND 
Clarithromycin (CMC) 179370262 85271934 51294611 13839528 
 CMC-TP1 ND 8181717 772146 133325 
 CMC-TP2 ND ND ND ND 
Atenolol (ATL) 7662520 2985864 1542781 600184 
ATL-TP1 ND 35369 ND ND 
ATL-TP2 ND 645487 209614 127403 
ATL-TP3 ND 622554 288105 ND 
ATL-TP4 ND 304221 ND ND 
ATL-TP5 ND ND ND ND 
ATL-TP6 ND 813595 314701 239925 
ATL-TP7 ND ND ND ND 
ATL-TP8 ND 479514 322915 147972 
ATL-TP9 ND 434989 ND ND 
17β-Estradiol (ESD) 37276031 15547844 8975829 1085064 
ESD-TP1 51219 1521119 876815 361898 
ESD-TP2 ND 735936 347685 ND 
Diclofenac (DFC) 77366189 21401404 9305391 6463740 
DFC-TP1 ND 5365976 3090425 2283741 
DFC-TP2 ND 57607 ND ND 
Metoprolol (MPL) 87524001 40063093 26812037 14736202 
MPL-TP1 ND 601043 177572 ND 
MPL-TP2 ND 264238 ND ND 
MPL-TP3 ND 518536 288764 ND 
MPL-TP4 88434 1677484 756027 204778 
MPL-TP5 ND 168770 ND ND 
MPL-TP6 ND ND ND ND 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument 
                       (continued) 
MPL-TP7 ND ND ND ND 
Sulfamethoxazole (SMZ) 14487916 5121821 3421006 2122616 
SMZ-TP1 ND 40926 ND ND 
SMZ-TP2 ND 1537973 59209 ND 
SMZ-TP3 ND 2204444 706005 320463 
SMZ-TP4 ND ND ND ND 
Ciprofloxacin (CFX) 1033647 354843 226893 95126 
CFX-TP1 ND 9976 ND ND 
CFX-TP2 ND 49387 13628 ND 
CFX-TP3 ND 22347 6975 4546 
CFX-TP4 ND 19245 6628 3545 
CFX-TP5 ND 23157 7420 ND 
CFX-TP6 ND 26028 ND ND 
CFX-TP7 ND 10674 ND ND 
CFX-TP8 ND ND ND ND 
CFX-TP9 ND 65310 ND ND 
CFX-TP10 ND ND ND ND 
CFX-TP11 ND ND ND ND 
CFX-TP12 ND ND ND ND 
CFX-TP13 ND ND ND ND 
CFX-TP14 ND 22719 14410 ND 
CFX-TP15 4074 54861 24076 17222 
CFX-TP16 ND 22274 ND ND 
Norfloxacin (NFX) 8354410 2121008 980437 848464 
NFX-TP1 ND 435276 ND ND 
NFX-TP2 ND 39751 ND ND 
NFX-TP3 ND 786872 299916 128136 
NFX-TP4 ND 716277 440794 137372 
NFX-TP5 ND ND ND ND 
NFX-TP6 ND ND ND ND 
NFX-TP7 ND 529395 187421 ND 
NFX-TP8 ND ND ND ND 
NFX-TP9 ND ND ND ND 
NFX-TP10 ND 170884 104533 38293 
NFX-TP11 ND 80479 ND ND 
NFX-TP12 ND 121486 74218 ND 
NFX-TP13 ND 510187 98293 66737 
NFX-TP14 ND 32093 ND ND 
NFX-TP15 ND 66539 ND ND 
Paracetamol (PCM) 62169628 30491863 17126342 6506015 
PCM-TP1 ND 8172924 2826511 936328 
Acesulfame (ACF) 9743236 3563214 860603 261659 
ACF-TP1 ND 505524 ND ND 
Cephalexin (CPX) 3196208 809421 327194 87079 
CPX-TP1 ND 93184 40790 ND 
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Table 5.13:     Peak areas obtained for compounds in different water matrices using LC-Q-TOF-MS instrument 
                       (continued) 
CPX-TP2 ND 75107 ND ND 
CPX-TP3 ND 32387 ND ND 
Penicillin G (PG) 5012305 2165469 807900 167935 
PG-TP1 ND 1891004 1010924 ND 
Progesterone (PGT) 6167935 1266133 408936 167912 
PGT-TP1 ND 1354894 889716 53848 
PGT-TP2 ND 1079206 ND ND 
Tramadol (TMD) 54061728 6611543 5885412 3990035 
TMD-TP1 ND 7177516 2546070 980532 
TMD-TP2 ND 1000557 597208 306875 
TMD-TP3 30717 2094721 691728 ND 
TMD-TP4 ND 1650152 ND ND 
TMD-TP5 ND 2353811 1183445 632704 
TMD-TP6 ND 176445 ND ND 
TMD-TP7 ND ND ND ND 
Venlafaxine (VFX) 34824989 14214829 3509104 2812246 
VFX-TP1 ND 439091 194612 70409 
Bezafibrate (BZR) 11427071 4733424 2140821 1190497 
BZR-TP1 ND 226576 111439 79942 
BZR-TP2 ND ND ND ND 
BZR-TP3 ND 851374 120158 ND 
BZR-TP4 ND 27659 ND ND 
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